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In this project, a gold nanoparticle system has been developed that is able to detect SNP 
variations through a DNA based anthracene probe. A second probe is bound to the gold 
nanoparticle which allows the fluorescent output of the anthracene probe to be normalized. 
This allows the detection of SNP variations without the need for an initial reading, opening 
the possibility for using this system for cellular SNP identification. Through this work a new 
method for coating gold nanoparticles in oligonucleotides has been developed. 
In further work, the use of gold nanoparticles to deliver siRNA into cells and induce gene 
inactivation was investigated. Efforts to improve the knockdown efficiency of these siRNA-
gold nanoparticles were made by integrating a second probe onto the nanoparticle surface, 
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2.1.1 Structure of DNA  
 
The molecule deoxyribonucleic acid (DNA) carries the genetic instructions for the 
development, function and reproduction of all known living organisms. DNA is a large 
polymer made up of monomers called nucleotides. Each nucleotide consists of a pentose 
sugar, a heterocyclic base and a phosphate group. In DNA there are 4 different nucleobases; 
adenine (A), cytosine (C), guanine (G) and thymine (T). The bases are split into two groups; 
the purines (A and G) consisting of a five membered ring bound to a six membered ring, and 
the pyrimidines (C and T) formed of a single six membered ring. Each strand of DNA has 
directionality which is caused by the position of the two hydroxyl groups on the nucleotides, 
3’ (secondary hydroxyl) and 5’ (primary hydroxyl) (Figure 2.1). Oligomers are formed by 
covalently binding a phosphate group at the 5’ end of a nucleotide to the hydroxyl group at 
the 3’ end of another nucleotide, forming a phosphodiester bond. At physiological pH (7.4), 
the phosphate groups exist as anions, therefore DNA is a highly negatively charged molecule.  
 
Figure 2.1 Chemical structure of DNA 




Franklin and Wilkins established that the common structure of DNA was as a double 
stranded molecule and Watson and Crick1 showed that this structure was formed by bases 
on opposite strands, hydrogen bonding to each other. The purine base A always pairs with 
the pyrimidine T forming two hydrogen bonds, whilst the purine G always pairs with the 
pyrimidine C through 3 hydrogen bonds (Figure 2.2).  
 
Figure 2.2 Hydrogen bonding between DNA bases  
Hydrogen bonding between complementary base pairs in DNA, G-C and A-T (dashed blue lines denote 
H-bonds)  
 
There are alternative mechanisms of base pairing, such as Hoogsteen pairing; these are less 
common yet their importance in nature is becoming increasingly apparent.2 The Watson-
Crick binding rules state that one strand of the DNA defines the sequence of the other 
strand; therefore the strands are complementary to one another. The two strands run anti-
parallel to one another with the 5’ of one strand opposite the 3’ of the other. The two 
strands wrap around each other forming a right handed double helix; the hydrophobic base 
pairs in the centre of the duplex, and the charged phosphate groups forming a hydrophilic 
surround. In the duplex, the bases stack on top of one another in a planar fashion. This base 
stacking, along with the H-bonding, is what gives the DNA double helix its stability. In the 
most common form of DNA, B-DNA, the distance between each base is 0.34 nm, whilst one 
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complete helical turn is made every 10.5 bases. B-DNA contains a large major groove and a 
narrow minor groove. Other forms of DNA such as A and Z DNA have been discovered ( 
 Figure 2.3). 
 
 Figure 2.3 The different structures of DNA duplexes.3 
 
2.1.2 Ribonucleic Acid 
 
Ribonucleic acid (RNA) transforms the information held within DNA into proteins, within a 
cell. RNA can take multiple forms, such as messenger RNA (mRNA), transfer RNA (tRNA) and 
ribosomal RNA (rRNA). In the ribosomes, these RNA molecules are required to bring 
together specific amino acids, the building blocks of proteins. RNA is very similar in structure 
to DNA, however there are important differences. In RNA, the base thymine is replaced with 
uracil which has no methyl group at carbon-5. Also, the sugar ring in RNA contains an 
additional 2’-OH group (Figure 2.4). RNA mainly exists in single stranded form, however if it 
forms a duplex it is in the A-form of DNA (Figure 2.3). The A-form duplex has a much deeper 
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major groove and a shallow minor groove, DNA will only adopt this form under low humidity 
conditions.  
 
Figure 2.4 A comparison of the structure of deoxythymidine with uridine 
 
2.1.3 Artificial oligonucleotide synthesis 
 
In 1955, Michelson and Todd reacted two deoxythymine nucleosides together to form the 
first recorded synthesis of a dinucleotide.2 Khorana developed a phosphodiester method,3 
which enabled the synthesis of much longer oligonucleotides. Letsinger utilised 
phosphotriester chemistry.5 Importantly, he synthesised oligonucleotides on solid 
polystyrene supports;6 once synthesised, the oligonucleotide could be cleaved from the 
support. The method used today was developed by a student of Letsinger and Khorana, 
Marvin Caruthers. Caruthers developed the phosphoramidite chemistry,7 whilst also 
discovering controlled pore glass (CPG) as a superior solid support to polystyrene.8 The 




Scheme 2.1 Chemical synthesis of artificial DNA 
 
This method is still widely used today and has allowed for the ready synthesis of 





2.2 Single Nucleotide Polymorphisms 
 
Upon the completion of the initial phase of the Human Genome Project, many variations in 
DNA sequence among the population were found, the most common of these variations 
(~90%) being single nucleotide polymorphisms (SNPs).9 A SNP is a single nucleotide variation 
at a specific locus (position of gene in a chromosome) within a sequence giving rise to alleles 
(different versions of a gene), with the least frequent allele being found in more than 1% of 
the population. If the frequency of the variation is any less than 1%, then the variation is 
classed as a mutation.9 On average, SNPs occur once every 1000-2000 base pairs, although 
they are not evenly distributed throughout the genome. Most SNPs are found in the non-
coding regions of DNA; variations found in the coding region cause alterations to protein 
structure and therefore affect a protein’s function, leading to the possible development of 
disease.  Identifying these SNPs is therefore an area of great interest as they can be used as 
molecular markers in the field of disease genetics.10,11 Consequently, there is growing 
research into techniques that can be used to distinguish the variants at SNP sites. There is 
also growing interest into the link between SNPs and a patient’s response to medicine, with 
the ultimate goal being personalised medicine.13 Next generation sequencing is a fast 
developing technique which allows a whole genome to be sequenced; whilst this will give 
the identity of SNP sites, it is still expensive and also looks at the whole genome when only a 
small region (i.e. the SNP site) needs to be observed.14,15 Therefore, alternative methods for 
determining the variant of a specific SNP site of interest exist. Present methods for SNP 
sensing mainly rely upon the difference in hybridization affinity between the SNP site 
containing DNA strand and a sensing probe. Differences in hybridisation affinity allow the 
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sensing probe to differentiate between the SNP variants, as one will bind with a higher 
affinity than the other, various techniques are detailed in the following section. 
2.3 Fluorescent DNA detection 
2.3.1 Molecular Beacons 
 
Molecular beacons are a commercial example of a DNA sensing technique; it involves 
oligonucleotide hybridization probes which can sense the presence of specific nucleic acids. 
These probes are short oligonucleotide sequences held in a hairpin conformation, with a 
fluorophore and quencher at either end of the sequence. In the hairpin conformation, the 
fluorophore and quencher are close enough together so that the fluorescence from the 
fluorophore is quenched. However, upon binding to the complementary target of the 
sequence, the hairpin unwraps and the fluorophore and quencher dye are no longer held in 
close proximity, resulting in the restoration of fluorescence from the fluorophore.16,17  
 
Figure 2.5 Molecular beacon mechanism  
Upon hybridisation with target strand, the fluorescent probe moves away from the quencher 
molecule and its signal increases. Within set temperature windows, only fully complementary probes 





Taqman™ is a technique which involves two probe strands of DNA that differ only in one 
base. One probe is fully complementary for one SNP variant, the other complementary to 
the other variant. Each probe contains a reporter fluorescent dye at the 5’- end (the two 
probes have a different fluorescent dye attached to them) and a quencher dye at the 3’- 
end. The dyes are close enough that the reporter dye is quenched by the quencher dye. 
When the probes find a complementary DNA sequence, the probe with the highest binding 
affinity will bind preferentially to the target strand (i.e. probe with complete base matching). 
During the Polymerase Chain Reaction (PCR), Taq DNA polymerase cleaves the probe/target 
duplex in the 5’→3’ direction. The reporter dye will be released from the quencher, leading 
to an increase in its fluorescence intensity (Figure 2.6). As each probe targeting each SNP 
variant has a different fluorescent probe bound to it, the SNP site present in the target 
strand can be identified. Taqman™ has been used for SNP detection by Ralston et al..18 
However one problem with Taqman™ is the requirement for PCR, which is currently difficult 
to do in cells. Rolling Circle Amplification (RCA) has been developed which could potentially 





Figure 2.6 Mechanism of Taqman assay  
Mechanism of action for Taqman mediated SNP detection. (Top) The probe with highest affinity 
hybridises to the target site. (Bottom) Taq polymerase chews up double stranded pieces of DNA in the 
5’->3’ direction, releasing the fluorescent probe from the quencher molecule, leading to an increase in 
its emission. Careful temperature control results in only probe strands complementary to the SNP site 
to bind, allowing for SNP detection.  
  
2.3.3 Scorpion Probe 
 
Another SNP sensing method is the scorpion probe, which was initially developed by Little et 
al. as a probe for monitoring the products of PCR.16 The scorpion probe (Figure 2.7) consists 
of a specific probe sequence held in a hairpin loop configuration by complementary stem 
sequences on the 5′ and 3′ sides of the probe, similar to a molecular beacon. The 
fluorophore attached to the 5′-end is quenched by a quenching fluorophore at the 3′-end of 
the loop. The hairpin loop is linked to the 5′-end of a primer via a PCR stopper; the PCR 
stopper helps to eliminate detection of non-PCR events e.g. primer dimers. After extension 
of the primer during PCR amplification, the specific probe sequence is able to bind to its 
complement within the same strand of DNA. This hybridisation event opens the hairpin loop 





Figure 2.7 Scorpion probe mechanism  
(A)i) A Scorpions primer carries a 5’ extension comprising a probe element, a pair of self-
complementary stem sequences, and a fluorophore/quencher pair. The extension is “protected” from 
copying by a blocking HEG monomer. ii) After PCR extension from the primer, a newly synthesized 
target region is now attached to the same strand as the probe. iii) Following a second round of 
denaturation and annealing, the probe and target hybridize. (B) Identical procedure except 
hybridisation does not occur at iii) due to base mismatch, allowing detection of SNP variant.16 
 
The probe was found to be specific enough to identify single base changes within a sequence 
and therefore its potential for SNP detection has been investigated, showing it is able to 
detect heterozygous SNP variants.17,18 It was found that the Scorpion probe outperformed 
Taqman and Molecular Beacons, being quicker in identifying the target, which is particularly 
useful for high through-put screening.  
2.3.4 HyBeacon™ 
 
Hybridisation beacons (HyBeacon™) are another type of SNP detecting probe developed by 
French et al..35,36,37 These probes contain a fluorescent molecule bound to a uracil base 
within a sequence of DNA. Upon binding to the fully complementary sequence, the emission 
of the fluorescent molecule increases greatly. The emission is lower when bound to a 




Figure 2.8 Mechanism of action for SNP detection using a Hybeacon™ 
 
By using the melting temperature difference between the fully matching and single 
mismatching targets (i.e. the two SNP variants); they are able to observe the fluorescence 
change only for the target desired. This not only allows the real time analysis of PCR 
products, but also real time determination of whether a sample is homozygous or 
heterozygous.  
 The two main issues encountered by these hybridisation based methods are the reliance on 
a significant difference in hybridisation affinity between the two SNP sites and the 
requirement to heat the samples. The difference in hybridization affinities may be very small 
as it is only a single base variation within a sequence that is being distinguished. This 
problem will amplify with increasing sequence length. Heat requirement limits the use of 
some of these techniques to cuvette studies, as the heat would damage cells, leading to cell 




2.3.5 DNA modification 
 
An alternative route for SNP detection is to use a molecular probe that gives a different 
response for different targets; these systems are often called base discriminating 
fluorophores (BDF). The change in fluorescent readout is caused by a change in the 
environment that the fluorophore is held in. The advantage of these systems is that they do 
not rely on differences in hybridisation binding strength, obviating the need for a 
temperature window. Saito et al. were able to identify the presence of a thymine base at a 
specific position using a pyrene residue, the pyrene showed significant quenching when 
hybridised opposite a thymine.26 They have also modified nucleosides to differentiate 
between purine bases by fluorescent changes.27 Tanaka et al. integrated an acridine 
fluorophore into the DNA backbone via a threoninol linker. They found that upon duplex 
formation, the acridine successfully intercalated into the duplex where a change in its 
immediate environment resulted in an increase in the acridine emission.28 The group of Seitz 
has also worked on base discriminating fluorophores; their work has mainly been based 
around the use of thiazole orange (TO) (Figure 2.9). 
 





 Initially the TO was integrated into the middle of a strand of Polymeric Nucleic Acid (PNA) 
(Figure 2.10) and was able to discriminate between bases on a binding DNA strand, showing 
both an increase and decrease in fluorescence dependent on the base opposite the TO 
modification.29,30 More recently the Seitz group has developed DNA based probes.31 The 
group have also used the PNA probe to image different targets within cells,32,33 although not 
SNP sites. 
2.4 Cellular delivery of DNA probes 
 
Two major problems associated with the use of fluorescent DNA probes within cellular 
systems (in vitro) include the stability of the oligonucleotide to enzymatic degradation, and 
the ability of oligonucleotides to cross the cell membrane. As oligonucleotides are highly 
negatively charged and large molecules, they do not pass the lipid bilayer easily. The lipid 
bilayer consists of a charged outer region and a lipophilic core; the lipophilic region does not 
allow charged molecules to pass through easily. There are a number of methods to 
internalise oligonucleotides into cells; positively charged transfection agents,27,28 
microinjection 29 or to permeabilise the cell membrane e.g. electroporation.30 With all these 
methods requiring an external input to facilitate the uptake. Once delivered into cells, 
oligonucleotides are quickly broken down by DNA nucleases;36 this is a significant problem 
for DNA probes. There have been multiple attempts to chemically modify DNA probes to 
make them resistant to degradation. Examples include locked nucleic acids (LNA),31 peptide 




Figure 2.10 DNA chemical modifications to overcome nuclease degradation 
(a) Natural phosphodiester linked DNA, (b) LNA, (c) PNA and (d) 2’-OMe modified bases 
. 
A new variety of nucleic acid established by the Mirkin group has been termed Spherical 
Nucleic Acids (SNA). These give good cellular stability and are discussed in more detail in 
Section 2.6. This variant of nucleic acid constitutes oligonucleotides bound to gold 
nanoparticles (AuNP), forming a 3D conformation of oligonucleotides which gives the SNA 
unique properties. SNA have been shown to be readily taken up by cells without the need 
for chemical transfection agents, whilst also protecting the oligonucleotides from enzymatic 
degradation. Therefore there is much interest in attaching fluorescent sensors onto AuNPs 
to form SNA fluorescent sensors.41 
 
Figure 2.11 Mirkin representation of spherical nucleic acid  
Gold nanocore, with oligonucleotide (green) coating. Showing the attachment group (blue) and 
spacer group (yellow).42 
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2.5 Gold nanoparticles 
 
The optical properties of AuNPs have been of interest to scientists for centuries. The first 
paper written describing AuNPs was by Faraday in 1857, which explained that their red 
colour was caused by the colloidal nature of the nanoparticles.28 The absorption which gives 
the nanoparticles their characteristic red colour was rationalised by Mie in 1908, using 
Maxwell’s equations. This absorption band at 520 nm (for 13 nm AuNP) is termed the 
Surface Plasmon Resonance (SPR) which is a specific characteristic of colloidal AuNP. The SPR 
band is caused by collective oscillation of the conduction band electrons induced by the 
interacting electromagnetic field (Figure 2.12).29,30 
 
Figure 2.12 The origin of the localised surface plasmon of a gold nanoparticle 
Under the influence of an excitation wave with wavelength greater than the dimension of the 
particle, the electrons oscillate as a whole and the system can be viewed as an oscillating dipole. 
 
Due to the size of AuNPs (1-100nm, between single molecule and bulk metal size) they have 
specific physical properties which are very dependent on their size, shape, inter-particle 
distance and surface environment.31 The SPR peak shifts as the dielectric constant of the 
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local surrounding medium changes, caused by changes in coating of the AuNP surface.32 The 
sensitivity of the SPR can therefore be used to track the coating of a particle surface; when 
there is no further shift in SPR it is assumed there is no further change in the surface 
environment of the AuNP, therefore the surface is assumed to be fully coated. 
The most common method for synthesising citrate stabilised AuNPs was established by 
Turkevich et al. in 1951.33 Starting with the commercially available HAu(III)Cl4, the gold is 
reduced by citrate ions. Dicarboxyacetone (a result of the oxidation of citrate ions) stabilise 
the  AuNP formed, which is formed of aurous salt assembling onto Au(0) atoms.34 The layers 
of capping agents (in this case citrate ions) coating the AuNPs cause a coulombic repulsion 
force which is greater than the Van der Waals interactions between AuNPs, which induces 
stability that prevents the AuNPs from aggregating. This produces AuNPs coated in citrate 
ligands, which can be subsequently displaced by a ligand of choice. The Turkevich method 
has been modified and improved.35,36 Recently Shulz et al.37 have developed a modified 
protocol which produces AuNPs (Figure 2.13) with a remarkably narrow size distribution.  
 




There are alternative methods for the synthesis of AuNPs using different stabilising ligands. 
The Brust-Schiffrin method38 forms thiolate stabilised AuNP, whilst Schmid’s Au55 cluster
39 
forms phosphine stabilised AuNPs. The coating of these particles cannot be altered once 
synthesised, however the stabilising groups can be tuned to contain functional groups which 
can be modified with external molecules to further functionalise the particles.40  
The advantage of Turkevich’s citrate reduction method is that it produces larger particles 
than the Brust-Schiffrin method, which are more suitable for applications in nanomedicine 
due to their lower toxicity. In addition, the Au-citrate bond is weak and can therefore be 
easily displaced post synthetically. Therefore, citrate stabilised AuNPs can be modified easily 
to form more valuable AuNP materials.41,42 The most common binding ligand which displaces 
the citrate ions, is thiol modified ligands; this is because of the formation of the relatively 
strong S-Au bond, the exact nature of which is an area of great research.48   
Another property of AuNPs that needs to be considered is their ability to quench 
fluorescence. At small distances (>10 nm), a quenching efficiency of up to 99% is observed. 
This is caused by two equally important effects: firstly the AuNPs increase the non-radiative 
rate of the fluorophore molecules, and secondly the radiative rate of the molecules is 
decreased due to the molecular dipole and the AuNPs dipole radiating out of phase.59,60 It is 








2.6 Spherical Nucleic Acids 
 
The binding of oligonucleotides to AuNPs was initially driven by the desire to controllably 
form nanostructures, utilising the specific base pairing of DNA. This was first discovered by 
the groups of Mirkin41 and Alvisatos38 who independently showed that nanostructures could 
be manipulated based upon the DNA sequences bound to the nanoparticles.  
Although DNA is usually modified before binding it to AuNPs, it can also bind in a non-
specific manner.63 Salt is required to overcome the repulsion between the DNA and the 
gold,64 resulting in non-specific binding to the gold possibly via the bases.65 However it has 
also been shown that un-modified double stranded DNA (i.e. in which the bases are hidden 
inside the duplex) will also bind to AuNPs.66 Generally though, it is more common for either 
the oligonucleotide or the AuNPs to be modified in some way to improve binding, since non-
specific binding is fairly weak. The two main routes of chemical modification are to either 
modify the oligonucleotide with a functional group which can covalently bind to the gold, or 
to modify the AuNP so it can electrostatically bind to the oligonucleotide. The most common 
way to covalently attach oligonucleotides to AuNPs is through a thiol modification on the 
strand of DNA, forming a covalent S-Au bond. However, Dougan et al. have developed a 
thioctic acid binding group, which when bound to AuNPs was found to be much more stable 
relative to the single thiol bond (Figure 2.14).67 Another method for binding oligonucleotides 
to AuNPs is to modify the surface of the AuNPs with a highly cationic compound, such as 
quaternary ammonium chains. The negatively charged DNA is then bound to the cationic 
AuNPs through electrostatic interactions (Figure 2.14). This has been used by Sandhu et al. 




Figure 2.14 Methods for binding oligonucleotides to AuNPs  
 
As discussed earlier (2.5), AuNPs quench fluorescence. This property has been used to 
develop fluorescent probes that increase in fluorescence upon finding their target, as will be 
discussed later. However, this property also means that there are issues with false positive 
measurements. If the fluorescent probe is not attached strongly to the AuNPs it can detach 
and an increase in signal will be seen, which will be interpreted as the target being found. 
Therefore, for fluorescent sensing technologies, the probe is most commonly attached to 
the AuNPs surface covalently. 
The most widely used method for covalently coating particles with thiol modified DNA is the 
‘salt ageing’ method developed by the Mirkin group.69 The thiolated oligonucleotides are 
added to the AuNP in one addition, before the salt concentration is slowly increased. This 
increase in salt concentration is done over a period of many hours, as adding too much salt 
at once causes the citrate stabilised AuNP to aggregate. The salt allows maximum coating of 
the particles as it reduces the repulsion between the negatively charged oligonucleotides 
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allowing for closer packing on the AuNP surface.70 Among alternative coating methods, 
Zhang et al. found that lowering the pH of the solution to 3.0 during the DNA attachment 
step allowed for rapid coverage of AuNPs.71  
There have been investigations into varying the region between the surface binding group 
and oligonucleotide, sometimes referred to as the spacer region, and the affect that this has 
on the SNA properties. Mirkin et al. have used a polyethylene glycol (PEG) linker group, and 
found that it increased the loading of oligonucleotides onto the AuNP surface, when 
compared to a spacer group consisting of just 10 A bases or 10 T bases.69 In the same 
experiments they found that sonication greatly increased the level of DNA coating on AuNP. 
It was proposed that sonication could reduce the amount of non-specifically bound DNA, 
exposing more of the AuNP surface for the DNA to bind to. 
2.6.1 Cell uptake and stability of SNA 
 
The two major benefits of SNAs are that they are readily taken up by cells,72 and the 
oligonucleotides that are bound to the AuNP show a much increased stability to enzymatic 
degradation.73,74 The size, shape and functionality of AuNPs have been known to 
dramatically affect how readily they are taken up by cells,75 whilst the type of cell being 
investigated also needs to be taken into account.75 The Mirkin group have investigated the 
mechanism of uptake that these SNA particles exhibit. They have shown that they are 
successfully taken up by over 50 cell types,76 and the greater density of oligonucleotides on 
the particle surface, the greater the cellular uptake of SNAs.72 It is proposed that the SNAs 
interact with proteins in the cell serum; these positively charged proteins aid the uptake of 
the particles. Patel et al. proposed that the mechanism for uptake was the serum coated 
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SNAs interacting with class A scavenger receptors in a lipid raft mediated uptake (Figure 
2.15).77 Choi et al. showed the mechanism was dependant on the 3-D structure of the SNA; 
they were able to cross link the oligonucleotides once bound to the AuNP surface, retaining 
its 3D structure, then dissolve the AuNP.78 These ‘hollow SNAs’ still retained the cell uptake 
properties of the AuNP-containing SNAs.79  
 
Figure 2.15 SNA interacting with scavenger receptors before passing through the cell membrane 
 
The observed increase in stability that DNA displays in DNA-AuNPs, (it has been shown to 
have a 4 times longer half-life) has been investigated.74 The high density of the DNA strands 
was initially thought to prevent the binding of enzymes to the DNA; however it has been 
shown that nucleases may in fact show increased binding affinity to SNAs in comparison to 
single stranded DNA. The major reason for the increased stability has therefore been 
attributed to the high charge and local salt concentration surrounding the particles.74 
2.6.2 SNA as fluorescent DNA detection probes 
 
Due to the increased stability and ready uptake by cells, there has been much research in 
coating AuNPs with fluorescent probes.80 The group of Libchaber have integrated AuNPs into 
molecular beacon systems, replacing the quencher dye with a AuNP.81 They found that small 
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AuNPs (1.4 nm) showed greater quenching efficiencies in a molecular beacon system than 
the commonly used quencher, DABCYL. Maxwell et al. has also employed AuNPs in a similar 
fashion, using 2.5 nm particles.82 However these small AuNPs were found to be not suitable 
for in vitro work due to their cytotoxicity. The scaffold provided by the AuNP allows for 
multiple different tags to be bound to a single AuNP. Song et al. have developed a 
multicolour system for sensing multiple DNA targets using multiple AuNP bound molecular 
beacons (Figure 2.16).83 
 
Figure 2.16 Nano molecular beacons83 
Upon binding to their targets, the fluorophores move away from the quenching nanoparticle. 
 
The Mirkin group have developed a method for gene detection termed ‘nanoflares’, which 
utilises the quenching property of AuNP plus the highly specific nature of DNA to elicit a 
switch ON detector of target DNA.84 A nanoflare consists of an SNA whose oligonucleotides 
are complementary to the target DNA to be detected. A short strand of DNA modified with a 
fluorophore, the flare, is then hybridised to the AuNP bound oligonucleotide. The flare is 
close enough to the AuNP so that its fluorescence is significantly quenched. Importantly 
though, the flare is shorter than the AuNP bound DNA. Therefore in the presence of the 
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target strand, the flare will be displaced by the longer target resulting in an increase in 
fluorescence (Figure 2.17). This technique has been used for cellular detection of mRNA.85  
 
Figure 2.17 Mirkins nanoflare system 
Upon addition of larger and more specific target DNA strand, the flare is displaced from the duplex. 
Once clear of the quenching AuNP the fluorophore increases in fluorescence, indicating the presence 
of target DNA. 
 
The system was improved to identify multiple targets, by coating the particles with multiple 
different nanoflares. Each target was identified by the increased fluorescence of its specific 
fluorophore.86 Li et al. have used this system to identify multiple mRNA tumour markers in 
cell samples to help identify cancerous cells.87 
2.7 Luminescent probes 
 
Fluorescence and phosphorescence are photon emission processes that occur during 
molecular relaxation from electronic excited states. In fluorescence, a photon is absorbed by 
a molecule, exciting an electron from the ground singlet state into an excited singlet state. 
The electron quickly relaxes to the lowest vibrational energy state through internal 
conversion. This relaxation process, in the region of picoseconds, is responsible for the 
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wavelength of emitted photons being longer than that of the absorbed photons, i.e. the 
Stokes shift. The length of time the electron remains in the lowest vibrational level of the 
excited state; is termed the fluorescence lifetime. The electron drops down to an available 
ground state vibrational level, emitting a photon of light. The photon of light emitted is what 
is detected in fluorescence studies (Figure 2.18). 
 
Figure 2.18 Jablonski diagram showing the energy transfer processes involved for fluorescence and 
phosphorescence. 
 
Phosphorescence is different to fluorescence due to another relaxation process that can 
occur called intersystem crossing. This involves electrons from the excited singlet state 
moving to an excited lower energy triplet state. Phosphorescence emission occurs as the 
excited triplet electron drops to the ground singlet state; this transfer is spin forbidden and 
therefore takes much longer than internal conversion which leads to an extended lifetime, in 
the order of micro seconds to seconds. The large energy change between the singlet and 
triplet state, results in phosphorescence having a larger Stoke shift than fluorescence. 
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Anthracene is a polyaromatic molecule which upon UV irradiation fluoresces in the region of 
390-550 nm; these properties make it a molecule of interest for sensing systems. 
Anthracene has been used for a variety of sensing applications, such as metal ions88 and 
pH.89 It has been integrated into oligonucleotides as a BDF. Brown and Saito have both used 
anthracene as a BDF, varying both the binding groups to the anthracene and also the 
position at which the anthracene was bound (Figure 2.19).90,91 Both groups found that the 
anthracene emission increased upon hybridisation.     
 
Figure 2.19 Anthracene as a BDF 
Examples of anthracene as a BDF, (a) Brown et al.90 (b) Saito et al..91 
 
Previous work within the Tucker group has incorporated anthracene tags into the DNA 
backbone via initially a serinol linker92 or more recently using a threoninol linker,93,94 a more 
in depth introduction to the Tucker group system is found in Section 3.1. 
Owing to its long fluorescence lifetime and large Stoke shift, tris(bipyridine)ruthenium(II) 
(Ru(II)(bpy)3) complexes have been used widely in imaging.
95,96 They have been used to 
detect oxygen levels within a cell using Fluorescent Lifetime Imaging Microscopy (FLIM).97 
More recently modification to the ligands has allowed the complexes to be able to bind to 
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nanoparticles. Zanarani et al. modified a bipyridine ligand to contain a trimethoxysilane 
group, which was then used to bind the ruthenium complex to silica nanoparticles (Figure 
2.20).98 Rogers et al have modified a bipyridine ligand with two thiol terminating “legs” 
which allows the probe to be bound to AuNP (Figure 2.20).99  
 
Figure 2.20 Ru(II)(bpy)3 molecule 
Ru(II)(bpy)3 complex able to bind to AuNP by Rogers et al.
99 (b) Ru(II)(bpy)3 complex able to bind to 
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3.1 Introduction to SNP sensing  anthracene probe 
 
The discovery that our genetic code contains a multitude of information regarding our health 
and wellbeing has led to the invention of multiple ways to read and understand how 
variations in this information affect the human body.1 Single Nucleotide Polymorphisms 
(SNPs) are single base variations in our genome that are present in more than 1% of the 
population. It is thought that whilst they may not directly cause diseases, they give an insight 
into the likelihood of disease development. The ability to detect Single Nucleotide 
Polymorphisms has therefore become an area of great interest.2 As discussed earlier in 
Section 2.3, current methods include: Taqman, molecular beacons, Hybeacons and Scorpion 
probes. However, one drawback is that these methods rely upon the difference in 
hybridisation energies and can therefore only work within narrow temperature windows. As 
described below, the Tucker group has created an assay which does not rely on the 
differences in hybridisation energies to identify base changes at a SNP site in a strand of 
target DNA. 
 An anthracene tag is integrated into the DNA molecule through a threoninol unit (Figure 
3.1) which inserts into the DNA backbone, with the anthracene mimicking a base. The strand 
then forms a duplex with the target strand of interest. It is designed to be complementary to 
the target strand, and single base variations are then detected through changes in the 
emission intensity of the anthracene. The structure of the anthracene probe is crucial to its 
SNP sensing capabilities. The anthracene probe can be varied through the carbon linker 
group between the peptide bond and the ether (labelled n in Figure 3.1). This linker can be 
from n = 1 to n = 7 (n = 2 cannot be synthesised). There are also two stereoisomers of the 
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threoninol unit, l and d (the stereogenic centre is highlighted at * position in Figure 3.1). 
Changing these two variables affects how the anthracene probe reacts to different SNP 
targets.   
 
Figure 3.1 Anthracene threoninol unit  
Carbon linker can be varied at n(n = 1-7 n ≠ 2). Stereocentres at *. 
 
Based upon the structural variations in the anthracene probe, two different systems have 
been developed for SNP sensing. The first system named base-adjacent sensing is used for 
the majority of this chapter, whilst the second system, base-opposite sensing, will be 
introduced in Section 3.8.4. The base adjacent system requires a short linker length to the 
anthracene probe, (n = 1) and its synthesis is shown in Scheme 3.3. The probe strand is able 
to detect base variations in the target strand at the position adjacent, in the 3’ position, to 





Figure 3.2 Schematic of base adjacent sensing system 
The identity of the base opposite adjacent the anthracene tag determines the level of intercalation 
into the DNA duplex, (red base is variation). 
 
The presence of a mismatch (i.e. indicating the other variant of the SNP site) is detected 
through a change in emission of the anthracene probe; a completely matching strand leads 
to a decrease in emission whereas a single base mismatch at the position opposite adjacent 
the probe leads to an increase in emission (Figure 3.3).  
 
Figure 3.3 Fluorescence response of 1L anthracene probe upon target addition  
Upon duplex formation, an increase in anthracene emission intensity is observed for mismatch target 
and a decrease in emission intensity for fully matching target (pH = 7.0, 10 mM phosphate buffer, 100 
mM NaCl, 293 K,  λex = 350 nm). 
 



























These differences in intensity can be explained by the extent to which the anthracene 
excited state can be quenched, which is linked to the position of the anthracene and in 
particular the amount of intercalation into the DNA duplex (Figure 3.2). For the fully 
matched duplex, the anthracene intercalates into the duplex and the anthracene excited 
state is quenched due to π-stacking interaction with proximate base pairs (Figure 3.2 a). 
Other groups have undertaken studies on this type of system, most notably using pyrene.3 
However, for the mismatch target (containing the other SNP variant) the cavity into which 
the anthracene intercalates is larger; this is due to the lack of H-bonding between one 
mismatching base pair next to the anthracene unit. The anthracene is therefore not 
quenched to the same extent by the nearby base pairs (Figure 3.2 b). In fact, as there is more 
room for it to be intercalated further into the duplex, the anthracene probe is screened from 
quenching water molecules. This hydrophobic environment leads it to display increased 
emission relative to the probe alone.  
The probe has been tested in cuvettes successfully; however the ultimate goal is for cellular 
(in vitro) SNP detection in RNA and DNA. In vitro detection would allow the process of SNP 
detection to be done quickly and cheaply, as there would be no need for isolation of genetic 
material before sensing the target of interest. There are, however, multiple problems 
associated with in vitro delivery of oligonucleotides, which include the delivery of nucleic 
acids into cells, the stability of nucleic acids within a cellular environment and the amount of 
target material available to bind to the probe.4 
To start to overcome the problems associated with in vitro delivery of oligonucleotides and 
their stability in cells, a modified anthracene probe that can be bound to gold nanoparticles 
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(AuNP) has been developed. Attaching oligonucleotides to AuNPs increases the stability of 
the oligonucleotide to enzyme degradation. Furthermore, these DNA-AuNP particles can be 
taken up by a variety of cell types without the need for chemical additives. Seferos et al. 
found that by increasing the oligonucleotide density on the surface of the AuNP, nuclease 
mediated degradation decreased.5 Originally this increased stability was thought to stem 
from the densely packed oligonucleotides hindering the enzyme’s ability to bind to the 
oligonucleotides. However, more recent model studies have suggested that increasing the 
packing of the nanoparticle surface actually results in an enhancement in enzyme binding.5 
However, it was found that the high salt concentration surrounding the DNA coated particles 
inhibited the enzyme’s ability to hydrolyse the DNA. This high salt concentration is a direct 
result of the densely packed, negatively charged oligonucleotides, which therefore attract a 
large concentration of monovalent counter cations (e.g. Na+ and K+). It has been shown that 
monovalent cations, such as Na+ inhibit DNase I and other nucleases by displacing Ca2+ and 
Mg2+ ions which are bound to enzymes and required for activity. Seferos et al. found that the 
DNA-AuNPs were over four times more stable in salt-dependant conditions compared to free 
DNA molecules. 
Gold nanoparticles have long been used for the delivery of compounds into cells,6 and 
investigations into the uptake of DNA-coated AuNPs show that they are readily up-taken into 
multiple cell types, although the method of cell uptake is still debated (see Section 2.6.1).7,8,9  
3.2 Modified DNA synthesis 
 
Non-functionalised DNA can bind to AuNP in a non-specific manner.10,11,12 It can adsorb on to 
AuNP through the nitrogen containing groups within the DNA bases.13  However binding in 
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this manner does not allow for the controllable binding of DNA to AuNP as the strands can 
easily detach from the surface of the AuNP. For the purposes of delivering the probe into 
cells and forming stable particles, DNA has to be covalently bound to the surface; therefore 
the DNA needs to be modified with a suitable group. Sulphur groups are commonly used for 
binding molecules to AuNP, as it can form a strong S-Au bond. The nature of the binding 
mode between the gold and sulphur has been the subject of many studies.14 Most work with 
AuNPs has been done using mono-thiolated DNA,15 but tetrathiolated DNA has also been 
investigated.16 Following work by Graham et al.,17 where it was found that a thioctic acid 
modified DNA strand was more stable once bound to AuNP than a thiolated DNA strand, it 
was decided to modify the probe strands with a thioctic acid. This forms a bis-thiolated 
adduct upon reduction of the disulphide which binds to the gold through both sulphur 
atoms.18,19 
To modify the DNA, an activated ester form of the thioctic acid was synthesised as per 
Stokes et al.,20 this could then be coupled to amine terminating DNA forming a thioctic acid 







Scheme 3.1 Modifying DNA strand with thioctic acid analogue  
(A) Formation of the activated NHS ester of thioctic acid. (B) Activated NHS ester is coupled to amine 
modified DNA strand, yield estimated from semi-prep HPLC (7.4).  
 
3.3 Coupling NHS ester to DNA 
 
The DNA was first modified with an amine group to which the activated ester could be 
coupled. A 5’ amine C6 modification was added as the final base on the DNA synthesiser, 
giving an amine terminated probe strand. Initially, problems were encountered during the 
deprotection of the amine-modified DNA, with the total mass of the major product after 
purification being 53 Daltons higher than expected. This increase in molecular weight was 
ascribed to a side reaction occurring during the removal of the cyanoethyl protection from 
the phosphate backbone; acrylonitrile is produced once the cyanoethyl is removed (Scheme 





Scheme 3.2 Side reaction forming +53 adduct on amine modified DNA 
(a) Formation of acrylonitrile. (b) Acrylonitrile reacting with deprotected 5’ amine modification. 
 
To prevent this side reaction, the resin was treated with 20% Diethylamine (DEA) in 
anhydrous acetonitrile followed by washing with acetonitrile prior to the amine 
deprotection step. The DEA removed the cyanoethyl group, allowing the reactive 
acrylonitrile to be washed away before deprotecting the amine. The activated ester was 
then coupled to the amine modified DNA in an overnight coupling reaction (Scheme 3.1). For 





3.4 Anthracene probe synthesis 
 
The phosphoramidite of the anthracene probe was synthesised following the route shown in 
Scheme 3.3 and as described previously,21,22 (full experimental details see Section 6.1.4) 
before being inserted into the DNA sequence via standard phosphoramidite chemistry. 
 
Scheme 3.3 Synthesis for 1L anthracene probe 
Reagents and conditions: (a) Ethyl Bromoacetate, K2CO3, acetone, reflux o/n. (b) i) 10% NaOH (aq) 
soln- EtOH (1:1) , reflux, o/n, ii) HCl. (c) L-threoninol, HBTU, DIPEA, DMF, 40°C , 40 hours. (d) DMT-Cl, 




The anthracene probes synthesised for the first section of work were the 1L and 1D probes. 
The number 1 refers to the carbon linker length between the anthracene molecule and the 
threoninol unit. The L and D indicate the isomer of threoninol used in the synthesis. 
3.5 Gold Nanoparticle Synthesis  
The size of AuNP chosen for this work was 13 nm due to their water solubility, ease to 
functionalise their surface and also because they are relatively non-toxic to cells. Citrate 
stabilised particles were chosen as their synthesis is relatively simple and also it is easy to 
displace the citrate ions to functionalise the AuNP. Initially, citrate stabilised gold 
nanoparticles were synthesised as per Grabar et al.,23 however it was later found that the 
particles made when using the new improved Turkevich method were more monodisperse.24 
Details of the Turkevich method for synthesising the particles can be found in Section 6.2, 
the calculations for determining the particle concentration are outlined in Section 7.1.1. The 
particles synthesised were sized at 12 nm (+/- 3 nm) using DLS (6.2.1). The absorption peak 
for the SPR was 520 nm (Figure 3.4).  
 
Figure 3.4 UV-vis absorbance spectra of AuNP  
















 λ/nm  
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3.6 Attaching DNA to AuNP 
The anthracene probe used for this work is a sequence already investigated by the Tucker 
group; this sequence is a randomly designed 15-mer which will not display any secondary 
structure. The strands of DNA synthesised are highlighted in Table 3.1. P.UM is probe 
sequence; P.AF is probe sequence with thioctic acid modification. The probe strands (P.UM, 
P.AF, P.1L and P.1D) are the strands that are bound to the gold nanoparticles and used to 
detect the target strands (DNA-T.1, DNA-T.2). Each strand was synthesised on an Applied 
Biosystems 9394 DNA/RNA Synthesizer within the group; for full experimental details of the 
DNA synthesis see Section 6.1.1. They were purified by reverse phase HPLC and 
characterised by mass spectrometry. 
Table 3.1 Probe and target strands of DNA synthesised 
Oligonucleotide strands synthesised. W = thioctic acid modification. L = 1L anthracene probe. D = 1D 
anthracene probe. 
 
Strand name Strand sequence 
P.UM       5’ TGG ACT CTC TCA ATG 3’ 
P.AF 5’ W-TGG ACT CTC TCA ATG 3’ 
P.1L 5’ W-TGG ACT CLC TCA ATG 3’ 
P.1D 5’ W-TGG ACT CDC TCA ATG 3’ 
DNA-T.1       5’ CAT TGA GAG AGT CCA 3’ 
DNA-T.2       5’ CAT TGA GAA AGT CCA 3’ 
 
The most common method for coating AuNP with DNA uses the salt aging technique 
developed by Chad Mirkin’s group.25,26 There are alternative coating methods such as the 
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low pH method used by Liu et al..27 The salt aging coating technique involves slowly 
increasing the salt concentration in a solution of AuNP and thiolated DNA; this takes place 
over many hours. The thiolated DNA will displace the citrate ions which stabilise the 
particles, whilst the salt allows the DNA to pack together more tightly on the AuNP surface. 
The salt cannot be added too quickly as the particles would aggregate. Based upon previous 
work within the Pikramenou group, the aim was to develop a new controlled method of 
binding DNA to AuNPs. Previous work in the group involved binding pH responsive peptides 
to AuNP,28 to aid cell uptake. Davis et al. titrated in small amounts of protein whilst tracking 
the SPR band of the AuNP to monitor the particles coating, it is known that small changes in 
the environment of the particles’ surface causes a shift in its SPR band. When no further 
change in the SPR is observed, it can be assumed that there is no further change to the 
properties of the surface and consequently the AuNP surface is saturated. This technique 
has since been used to coat AuNP with various molecules.29,30 To coat the AuNP with the 
anthracene-DNA probe, small amounts of DNA were titrated into a solution of citrate 
stabilised AuNP, and the UV spectrum taken after each addition. This allows the binding of 
DNA to be tracked in real time, and a level of control to be exerted. 
 To track the shift in SPR, a MatLab algorithm was used which was written by Dr Sunil Claire; 
it involves fitting a Gaussian curve to the UV spectrum from which an accurate value for the 
SPR maximum can be calculated.31 The position of the SPR maximum can then be plotted 





3.6.1 Comparing thioctic acid modified DNA vs non-thiolated DNA 
 
As discussed earlier, modifying the DNA strands with sulphur groups was expected to give a 
level of control with regards to the orientation of the bound probe on the nanoparticle 
surface. However, given the propensity of unmodified DNA to also bind to gold nanoparticles 
through non-specific interactions,11,12 the desired binding mode had to be verified. This was 
done by comparing the thioctic acid modified DNA (P.AF, P.1L, P.1D) with an identical strand 
without the thioctic acid modification (P.UM). A schematic representation of how the 
thioctic acid modified DNA binds to AuNP compared to non-modified DNA can be seen in 
Figure 3.5. The thioctic acid modified DNA binds through the sulphur groups, with the 
negatively charged DNA repelling strands nearby so that a relatively ordered surface should 
form with the DNA standing perpendicular to the surface. In contrast, for the non-modified 
DNA it is hard to envisage any organised structure forming on the particle surface, as bases 
can bind in a non-specific manner and the strand would be expected to wrap around the 
particle in a random manner. 
 
Figure 3.5 Envisaged binding  of 13 nm gold nanoparticles coated in thioctic acid modified DNA 




The optimum nanoparticle concentration for coating had to be established, so a range of 
concentrations were investigated: 3 nM, 6 nM and 9 nM. Higher concentrated particles did 
not appear to be as stable during coating and did not give as reproducible results when 
monitoring their SPR shift; therefore it was decided to continue the studies with 
nanoparticles at 3 nM concentration.  
To test whether any differences in binding occurred when the two different probe strands 
(P.UM vs P.1L) were added to the particles alone, a UV experiment was set up to track the 
SPR shift of the particles every 60 minutes over 13 hours. An excess of DNA, 3 µM, was 




Figure 3.6 UV-vis absorption monitoring SPR band for non-thiolated and disulphide modified DNA 
binding to AuNP  
(A) UV-vis absorption spectra of AuNP (3 nM, 13 nm) in H2O (line), upon addition of 3 µM non-
thiolated DNA (dash). (B) UV-vis absorption spectra of AuNP (3 nM, 13 nm) in H2O (line), upon 
addition of 3 µM disulphide modified DNA (dash).(C) SPR  band shift for A (green) and (red), control 
AuNP (3nM, 13nm) in H2O with titrations of deionised water(blue). 
 
Monitoring the SPR band shifts gives an insight into what is happening on the surface of the 
nanoparticles. With just the addition of deionised water, there is no variation in the SPR shift 





































































the particles surface, it does however inform us that any change in SPR shift, must be due to 
what is added to the particle and not just as a result of experimental factors. When the DNA 
strands were added to the nanoparticles, there was a noticeable shift in the particle’s SPR 
band of 1 nm (Figure 3.6). It is interesting to note that the shift appears to be very similar for 
both the DNA strands added, suggesting that the surface chemistry of the particles is altering 
in a similar fashion for both particles. This implies that both strands are interacting with the 
particles through similar surface chemistry and that either the thioctic acid group is not 
binding directly to the particles under these conditions, or that it is binding yet the strands 
are still wrapping around the particles in a similar fashion to the non-thiolated DNA strands. 
Terne et al.13 found that the presence of a buffer was crucial in coating gold surfaces with 
thiolated DNA molecules, as they found little difference in coating between non-thiolated 
and thiolated DNA without the presence of a buffer. It was proposed that intermolecular 
electrostatic repulsion between strands of DNA is minimised under the high ionic strength 
conditions, as the charged strands are better electrostatically shielded. This would then 
allow for a higher surface coverage for the thioctic acid modified DNA strands as they could 
now begin to extend away from the gold particles surface, the buffer providing counter ions 
to allow neighbouring DNA strands to pack more densely and allowing a higher surface 
coverage. Therefore, the effect of buffer on the binding process was then investigated, 









Figure 3.7 UV absorption of SPR band tracking non-thiolated and disulphide modified DNA binding 
to AuNP in the presence of 10 mM phosphate buffer  
(A) UV-vis absorption spectra of AuNP (3 nM, 13 nm) in H2O and 10 mM phosphate buffer (line), upon 
addition of 3 µM non-thiolated DNA (dash). (B) UV-vis absorption spectra of AuNP (3 nM, 13 nm) in 
H2O and 10 mM phosphate buffer (line), upon addition of 3 µM disulphide modified DNA (dash).(C) 
SPR  band shift for A (green) and (red), control AuNP (3nM, 13nm) in H2O and 10 mM phosphate 



































































As expected, the buffer had no effect on the bare AuNP as the SPR band did not shift 
throughout the experiment ((C) Figure 3.7, and (C) Figure 3.6). Additionally, once again only 
a small SPR shift was observed (ca. 1 nm) for the non-thiolated DNA ((A) and (C) Figure 3.7), 
which was consistent with the non-thiolated DNA strands again adsorbing onto the 
nanoparticle surface. However, now a more pronounced SPR shift of 2.5 nm was observed 
for the thioctic acid modified DNA ((B) and (C) Figure 3.7). The difference in SPR shift 
indicates a different change to the surface environment of the AuNP in comparison to the 
non-thiolated DNA AuNP; this would indicate a difference in interaction and stabilisation of 
the final species as a result of the thioctic acid group. 
3.6.1.2 Testing the effects of sonication on DNA binding to AuNP 
 
 It was suggested in the literature that short periods of sonication could increase the surface 
coverage of DNA on a nanoparticle surface. Hurst et al.25 found that sonication during the 
binding process resulted in nearly double the amount of DNA binding to the AuNP than 
without it. As previously shown in Figure 3.7, when the thioctic acid modified DNA (3 µM) 
was left to bind to AuNP (3 nM) in a cuvette with only initial stirring, the process took nearly 
8 hours.  As it was possible to track the degree of DNA binding, it was thought that a short 
period of sonication may speed up the binding process. The DNA was added in small 
titrations (2.0 µL, 100 µM) to amplify the predicted effects of sonication, subjecting the 





Figure 3.8 UV absorption of SPR band tracking non-thiolated and disulphide modified DNA binding 
to AuNP in the presence of 10 mM phosphate buffer with 20 seconds sonication after each addition 
(A) UV-vis absorption spectra of AuNP (3 nM, 13 nm) in H2O and 10 mM phosphate buffer (line), upon 
titration of non-thiolated DNA with 20 seconds titration between each titration (dash). (B) UV-vis 
absorption spectra of AuNP (3 nM, 13 nm) in H2O and 10 mM phosphate buffer (line), upon titration 
of disulphide modified DNA with 20 seconds sonication between each titration(dash).(C) SPR  band 
shift for A (green) and (red). 
 
The total time required for the SPR maximum to be reached was just 30 minutes, which 
included the time taken for all of the additions (additions done at 3 minute intervals). 






























































to the non-sonicated binding (8 hours, Figure 3.7), it is clear that the sonication is having an 
effect on the rate that DNA is binding to the AuNP. The effect of sonication is to break off 
parts of the weakly adsorbed DNA, allowing for more space on the particle surface for 
disulphide groups on other DNA strands to bind. Binding through the disulphide bond is both 
entropically favourable (more degrees of movement when strand bound through a single 
group) and enthalpically favourable (strong Au-S bond), sonication appears to speed this 
process up. 
 The number of additions required to still coat the particles in a reduced amount of time  
was then investigated, as the speed at which the particles could be covered may also have 
been hindered by the large number of small additions used in the previous experiment 
(Figure 3.8). The amount of DNA coating the AuNP surface was established by titrating in 
known amounts of target until no further change in anthracene emission was observed 
(discussed in 3.8.1). It was found there were about 360 strands of anthracene probe per 
AuNP, however to increase the rate of binding, an excess of DNA was added to help drive 
the equilibrium to completion. Therefore, fewer larger additions were tried, culminating in 
the final protocol of three equal additions of DNA to 3 nM AuNPs, with a final total DNA 
concentration of 2.97 µM. After each DNA addition, the AuNP-DNA solution was stirred for 2 
minutes with a magnetic stirrer and then sonicated for 20 seconds. After the DNA had been 
added to the particles, the particles were passed through a Sephadex G-50 column to 
remove any excess unbound DNA (for full experimental see 6.2.4.1). This is confirmed by 
assessing the UV spectra of DNA-AuNPs before and after they have been purified. A clear 
decrease in the DNA peak (260 nm) can be observed (Figure 3.9), normalising the graphs at 
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the SPR peak (523 nm) which is an indication of the AuNP concentration, shows the decrease 
in DNA concentration is greater than a dilution effect.  
 
Figure 3.9 UV-vis absorption spectra of DNA coated AuNP before and after Sephadex G-50 column 
(line) UV-vis absorption of P.1L-AuNP before column (3 nM, 13 nm). (dash) UV-vis absorption 
spectrum of P.1L-AuNP once passed through Sephadex G-50 column using H2O as eluent. Both graphs 
are normalised by their SPR peak to correct for dilution.  
 
An estimate of the DNA coverage can be found using the differences in the before and after 
values at 260 nm. Knowing the total amount of DNA added, the difference can be subtracted 
and the final concentration of DNA calculated; this gave values in the region of 4-600 strands 
of DNA per AuNPs, across a range of samples. However, it should be stressed that this 
remains an estimate as the absorption spectra of the particles does change once it is passed 
through the sephadex column, resulting in a decrease in the absorption at wavelengths 





















3.6.2 Experiments to prove disulphide modification is binding to the AuNP 
 
To provide further evidence that thioctic acid modified DNA was bound to the particles 
through its disulphide group, a series of studies were devised to compare the modified 
particles with those treated with non-thiolated DNA. It was immediately apparent in the 
purification process that the thioctic acid modified DNA AuNPs were more stable than their 
non-thiolated DNA counterparts through a G-50 Sephadex column; this traps any unbound 
DNA, whilst the large coated particles pass straight through the column. It was found that 
bare citrate coated nanoparticles could not pass through the Sephadex column, remaining 
stuck at the top, this was also observed for the particles which were coated in the non-
thiolated DNA (Figure 3.10).  
 
Figure 3.10 Sephadex size exclusion column showing the non-thiolated DNA coated particles are 
unable to pass though the column 
 
In contrast, the thioctic acid modified AuNPs travelled through the column under the same 
conditions which provided good evidence that these DNA functionalised particles were more 
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stable, again indicating that the DNA was binding to the particles through the thioctic acid 
group. 
3.6.2.1 Salt stability studies 
 
Bare AuNPs are not stable in salty conditions, a fact observed by the need for slow increases 
in salt concentration in Mirkin’s salt aging method.15 In citrate coated particles an increase in 
salt concentration causes aggregation as the salt allows the AuNPs to approach each other 
very closely, upon which van der Waals force dominates, inducing aggregation.32 However, 
when the particles are coated, they are much more stable to salty conditions. Therefore, to 
ensure that the new DNA coating method established was coating particles through the 
thioctic acid modification and creating stable particles, a simple experiment was set up 
which would test the particles’ relative stabilities to increasing salt concentration. As 
previously described, the non-thiolated DNA coated AuNP could not be purified by passing 
through a Sephadex column (Figure 3.10). Therefore an alternative method for particle 
purification had to be used. The particles were centrifuged at 13000 rpm for 30 minutes and 
the supernatant removed, removing any excess unbound DNA, before re-dispersing them in 
de-ionised water. To ensure consistency, this method of purification was used for both the 
thioctic acid modified DNA and also the non-thiolated DNA coated particles during this 
experiment. Once purified, titrations of NaCl (2 µL, 5 M NaCl per titration) were added to the 




Figure 3.11 Comparing salt stability of DNA coated AuNP by UV-vis absorption  
(A) UV-vis absorption spectrum of disulphide modified DNA coated  13 nm AuNP in H2O ( 1mL, 2 
nM)(line), upon subsequent titrations of NaCl (2 µL, 5 M)(dash). (B) UV-vis absorption spectrum of 
non-thiolated DNA coated AuNP in H2O (1 mL, 2 nM)(line), upon subsequent titrations of NaCl (2 µL, 5 
M)(dash). Progression of graphs indicated by arrows.  
 
From their UV spectra (Figure 3.11) it is clear that the thioctic acid modified DNA coated 



































particles. The UV spectrum of the latter shows a large growth of an absorption band at 720 
nm, which is an indication of plasmon coupling between agglomerating nanoparticles. 33 
There is also a rapid loss of the 520 nm SPR band, indicating a loss in small 13 nm particles. 
These observations become apparent at a salt concentration of just 0.01 M. Visible 
observation of the particles show the non-thiolated particle solution becoming clear and 
small black aggregates forming with increasing salt concentration.  
The thioctic acid DNA coated AuNP remained stable to salt up to the final concentration of 
0.1 M NaCl, this is biologically relevant as the NaCl concentration within a cell is no higher 
than 0.015 M34 therefore proving these particles will remain stable in cells. There was no 
evidence of any 720 nm band growth and only a slight decrease in the 520 nm band. This 
decrease in the 520 nm band was shown to be only a dilution factor.  
It can be hypothesised that the non-thiolated DNA is displaced from the surface of the 
nanoparticles upon the addition of salt, allowing the particles to approach each other and 
aggregate. In contrast, the thioctic acid modified DNA is more strongly bound to the AuNP 
surface, therefore the negatively charged DNA molecules will not allow the particles to 
approach each other and aggregate, even in the presence of salt. This experiment proved 
that this new rapid method for coating AuNP in DNA produced particles which are stable to 






3.7 Characterising particles 
3.7.1 Dynamic Light Scattering 
 
Dynamic Light Scattering (DLS) was used to determine the size of the AuNP particles with 
and without coating, and also to measure the zeta potential of the particles. 
Particles suspended in liquid are in Brownian motion due to random collisions with solvent 
molecules. This motion causes the particles to diffuse through the medium; the diffusion 






Equation 3.1 Stokes-Einstein Equation 
D = diffusion coefficient, kB = Boltzmann’s constant, absolute temperature, η0 = viscosity,                     
d= hydrodynamic diameter 
 
From this equation (Equation 3.1), it is clear that larger molecules will have a smaller 
diffusion coefficient and move more slowly than smaller particles; therefore the size of a 
particle can be deduced from the speed that the particles diffuse in a given media. Dynamic 
Light Scattering (DLS) measures the scattering of laser light; this random scattering is caused 
by the particles and its intensity at any one point depends upon the relative positions of the 
particles. As the particles are in motion, their relative position changes and therefore the 
scattering intensity changes. The speed of these scattering fluctuations can then be used to 
define the speed at which the particles are moving, and therefore the size of the particles.   
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The particles sized were: bare citrate coated AuNP, non-thiolated DNA-AuNP and thioctic 
acid modified DNA-AuNP. Throughout this chapter, different types of the anthracene probe 
are bound to AuNP, so for completeness, the sizing of them all is displayed in Table 3.2. 
Table 3.2 DLS sizing and zeta potential of particles coated with DNA 
Sized using a Malvern Zeta sizer nano ZEN5600, particles at 2 nM in deionised water. 
 








21 (± 6) 
(100%) 
48 (± 34) 
(96%) 
48 (± 32) 
(96%) 
34 (± 17) 
(96%) 




-35 mV (100%) 
(± 10 mV) 
-32 mV (57%)  
(± 10 mV) 
7 mV (42%) (± 8 
mV) 
-37 mV (97%) 
(± 12 mV) 
-23 mV (99%) 
(± 8 mV) 
-26 mV (96%) 
(± 7 mV) 
 
The sizing of the particles shows that there is not much change in the size of the particles 
once coated with DNA; all the measured sizes are within error of each other. An increase in 
size would be expected due to the addition of an estimated 3 nm long strand surrounding 
the particles, for the full extension of the DNA, additional salt or buffer may be required. It 
has been shown in the literature that the increase in size expected does not necessarily 
correlate with the size observed when measured by DLS, for example a 19 base pair DNA 
strand bound to a 13 nm AuNP increased in size by only 3 nm.35,11 Other papers have 
reported much larger increases in particle size upon the addition of DNA strands, however 
these were measured in phosphate buffered saline (PBS) solution.8  
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The zeta potentials also give an interesting insight into the coating of the particles. Zeta 
potential is a measure of the magnitude of charge repulsion/attraction between particles, 
and is therefore a very useful tool in determining the stability of particles. The greater the 
zeta potential of a colloidal solution the more repulsion between the particles there is and 
therefore the particles are less likely to aggregate. Once coated in the DNA the particles 
remain relatively stable, with a high zeta potential, except for the P.UM-AuNP. The particles 
coated in the non thiolated DNA have a large proportion (42%) with a small zeta potential, 
indicating that many of these particles are not stable. This again reiterates the requirement 
of the disulphide modification to form stable particles.  
3.7.2 Transmission electron microscopy 
 
Transmission electron microscopy (TEM) images confirmed the mono dispersity of the DNA 
coated AuNPs, whilst the sizing corresponds with the DLS measurements (Figure 3.12).  
 
Figure 3.12 TEM image of P.1L-AuNP 




3.7.3 ICP-MS data  
 
In Section 3.8.1, the SNP sensing probe is used to estimate the number of DNA strands 
bound to each AuNP. Initially however, ICP-MS was used to quantify the number of DNA 
strands that were bound to the AuNP. Dr Lijiang Song at the University of Warwick is 
acknowledged for running the samples. From ICP-MS the gold: phosphorus ratio was 
obtained, from this the number of DNA strands bound to each AuNP could be calculated 
(Table 3.3), for calculations see Section 7.1.2. 
Table 3.3 ICP-MS data giving approximate number of DNA strands per AuNP  
Values given assume particles are 13 nm in size, containing 100082 gold atoms. 3 mL of 1 nM AuNP 
dissolved in 5% aqua regia. 
 
 P.AF-AuNP P.1L-AuNP 
Strands of DNA per particle 1042   1570  
The values obtained were much larger than expected, literature values vary from 150 
strands per particle26 to the maximum level of particle coating reported as 250 strands per 
AuNP.15 The maximum coating was observed for 15-mer oligonucleotides, the same length 
used in these studies; however the oligonucleotides were modified with a thiol terminating 
PEG spacer group. Whilst ICP-MS will give a large error as it is a coating average, with a large 
variation in coating as well as particle size, the much larger than expected value would 
indicate that there is an issue using this method. There is the potential for false positives 
when detecting phosphorus caused by [15N 16O]+ and [14N 16O 1H]+ at m/z 31, which may 
contribute to this high value.36 The coating process was done in the presence of phosphate 
buffer and whilst the particles were columned in deionised water to remove larger 
molecules such as DNA, some phosphate buffer will inevitably be carried through. The 
presence of the phosphate buffer will lead to false positive counts for phosphorus, giving a 
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much greater phosphorus ratio being counted. To overcome this problem, attempts to coat 
the particles in the presence of an alternative buffer, Tris (2-Amino-2-hydroxymethyl-
propane-1,3-diol), were made. However they proved unsuccessful as the particles 
aggregated upon addition of the buffer. Therefore, it was established that ICP-MS is not the 
best method for calculating the DNA coverage of AuNPs. 
3.7.4 Duplex formation: Variable Temperature UV spectroscopy 
 
Once the particles were coated in single stranded DNA, it was crucial to this work that the 
strands were still available for hybridisation with a target strand. Mirkin et al. showed that 
they were able to monitor duplex formation on particles through variable temperature UV 
spectroscopy, monitoring the 260 nm band.37 The absorption at 260 nm is caused by the 
DNA bases and is at its maximum when strands are un-hybridised. Upon duplex formation 
the absorption of the bases decreases due to the stacking of the DNA once it forms the 
helical structure.38 The melting temperature given as the Tm value is the temperature at 
which 50% of the duplex is dissociated and gives an indication of a duplex’s stability.39   
Table 3.4 Duplex melting temperatures comparing free DNA with DNA bound to AuNP  
Experiments run at 1µM of DNA samples in 10 mM Phosphate Buffer, 100 mM NaCl. DNA-T.1 is the 
fully matching target, whilst DNA-T.2 contains a single base mis-match. Tm values are given in °C. 
 
Probe DNA-T.1 DNA-T.2 
P.AF 54     40 
P.1L 47 40 
P.1D 45 34 
P.AF-AuNP  53 39 
P.1L-AuNP 49 38 




When a random target is added to the DNA-AuNP, no Tm value is observed indicating that 
the observed values are a consequence of duplex formation only. The Tm values of the AuNP 
bound DNA are similar to the values obtained from the duplexes alone. The similarity in Tm 
values between AuNP bound DNA and free DNA is also seen in the literature for DNA coated 
AuNP when the DNA is bound via a thiol modification.40  
3.7.5 Duplex formation: CD spectroscopy   
 
 
Figure 3.13 CD spectrum indicating duplex formation for DNA-AuNP 
(main) CD spectrum of P.1L-AuNP (dashed black) and after addition of complementary target (solid 
black). (inset) Difference between the two spectra (red). P.1L-AuNP at 2 nM in 10 mM Phosphate 
Buffer, 100 mM NaCl, room temperature. 
 
CD studies were performed for DNA coated AuNPs with the intention of observing an 
induced dipole where the AuNPs absorb as an indication that the DNA had bound to the 
particles. According to the literature, an induced dipole would only be observed if the DNA 
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(P.1L-AuNP + DNA-T.1) - (P.1L-AuNP)
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coated AuNP was ran; with a single stranded probe, there is an observable B-DNA structure 
(peaks 265 and 285 nm). This would indicate that once bound to the particles, the DNA 
adopts a fairly helical structure. However, once the complementary target strand is added, 
an increase in intensity of the bands at 285 and 265 nm is observed, indicating a tighter 
packed B-DNA structure, as expected. Subtracting the final spectra from the initial spectra 
shows the differences in the spectra (Figure 3.13, inset); the increase in these B-DNA bands 
can be clearly seen. A broad band can also be observed at 520 nm; correlating with the SPR 
band of the AuNPs and would suggest that the particles have some induced chirality, which 
indicates that the particles are indeed coated and interacting with the target DNA. The 
increases in these bands do not occur upon addition of a non-complementary target. The 
exact reason why this induced CD peak appears at the AuNP SPR band, and in this case why 
it is only apparent for duplex DNA, is unclear. Some reports suggest it is caused by the chiral 
adsorbate (i.e. chiral DNA molecules attached to the metal surface) influencing the 
electronic states of the metal nanoparticle.42 Theoretical models predict that the mechanism 
may be due to optical absorption of the nanocrystal-molecule complex due to the chiral 
currents inside the metal nanocrystal induced by the dipole of the chiral molecule.41 The 
observation of the band does however confirm there is an interaction between the AuNP 






3.7.6 Anthracene excitation and emission 
 
It is known that the emission of an organic fluorophore when placed near a metallic 
nanoparticle is greatly reduced, up to 99.8%.43 This quenching is caused by two factors; the 
first is that AuNPs increase the non-radiative rate of decay of the molecules due to energy 
transfer. The second factor, is the radiative rate of the molecules is decreased, this is due to 
the molecular dipole of the dye and the dipole induced on the AuNP radiating out of phase if 
the molecules are oriented tangiently to the AuNPs surface.44,43 Once the particles had been 
coated in the anthracene probe, an excitation and emission spectrum was taken (Figure 
3.14). The spectra observed confirmed the presence of the anthracene probe on the 
particles once they had been purified. To measure the level of quenching caused by the 
nanoparticles, the emission of the unbound probe was collected for a comparison. Problems 
in calculating the exact number of probe molecules in a solution of DNA-AuNP caused by a 
lack of knowing the exact concentration of nanoparticles once synthesised means this 
comparison contains errors; efforts to minimise this concentration problem are explained in 
Section 7.1.3. However it does indicate that there is a large amount of quenching of the 





Figure 3.14 Excitation and emission scans of 1L probe when free and bound to AuNP 
Excitation scan of free P.1L at 1 µM (dashed red) and when bound to AuNP, P.1L-AuNP (dashed blue) 
Emission scan of free P.1L at 1 µM (solid red) and when bound to AuNP, P.1L-AuNP (solid blue), (pH = 
7.0, 10 mM phosphate buffer, 100 mM NaCl, 293 K,  λex = 350 nm, λem = 426 nm.). 
 
3.8 SNP sensing on particles 
 
Once it had been shown that the SNP sensing probe was available for hybridisation and its 
emission could be observed once it was bound to AuNPs, the project moved on to testing 
the SNP sensing ability of the AuNP bound probe. 
3.8.1 Base adjacent sensing 
 
For the base adjacent SNP sensing system, the SNP target site is adjacent to and on the 3’ 
side of the base that is opposite the anthracene tag (Figure 3.2). The particles were coated 
with the P.1L probe as described in Section 3.6.1.2, purified by passing through a sephadex 


































100 mM NaCl as standard duplex forming conditions. To test whether the SNP sensing would 
work, initially a large excess (20 µL, 175 µM) of DNA target (DNA-T.1, DNA-T.2) was added to 
ensure that all of the probe would be bound.  
 
Figure 3.15 Emission for P.1L-AuNP upon target addition 
Anthracene emission for P.1L-AuNP 1 mL, 3 nM (dashed black), after addition of excess 
complementary target DNA-T.1 (red) and after addition of excess single base mis-match target DNA-
T.2 (blue) both 20 µL, 175 µM, (pH = 7.0, 10 mM phosphate buffer, 100 mM NaCl, 293 K,  λex = 350 
nm,  λem = 370-570 nm). 
 
Gratifyingly when AuNP-bound, the probe was still able to differentiate between the two 
SNP targets, as clearly shown in Figure 3.15. Furthermore, the percentage changes in 
emission of the anthracene probe upon binding two different targets (Table 3.5) were similar 
to those obtained when not bound to AuNP. This is interesting as it indicates that the degree 
to which the anthracene signal is quenched by the AuNP is similar, regardless of whether the 
anthracene moiety is duplex intercalated (upon addition of target) or not (no target added). 
Duplex DNA is more rigid in its structure compared to single stranded DNA, so it was thought 
that the quenching may be more pronounced for the single stranded DNA when compared 

































single strand due to its increased flexibility. This consistent quenching has two explanations; 
the first is that the anthracene tag is so close to the AuNP surface that any difference in 
proximity is negligible. Another explanation is that the probe is so tightly packed onto the 
AuNP that it is in a fairly rigid duplex-like structure when it is single stranded. This would 
agree with the small changes in CD signal for the single stranded AuNP when compared to 
duplex coated AuNP (Section 3.7.5).  
As the binding stoichiometry of the target strands to the probe strands is 1:1 then this SNP 
sensing system can be used to determine the amount of DNA coating the AuNP. Titrating in 
known amounts of target to a sample of probe coated AuNPs allows an estimate of the 
surface coverage to be obtained. It remains an estimate as the concentration of the AuNP is 
difficult to monitor. Whilst the initial concentration of AuNP synthesised can be identified by 
sizing the particles and knowing the amount of gold used whilst making them (Section 7.1.1), 
the AuNP concentration can only be estimated from then on, using the intensity of the SPR 
band. However, Mie theory indicates there is a scattering contribution to the absorption 
spectra which does not involve electron transfer, therefore the Beer-Lambert law cannot be 
used to determine the AuNP concentration. Nevertheless, the intensity of the SPR band can 
be used to monitor the dilution of the particles from their initial known concentration 
(Section 7.1.3). For a 2.5 nM solution of P.1L-AuNP, plateauing of the anthracene signal was 
seen after 900 nM (final concentration) of target strand was added. After each addition of 
target, the solution was left for 10 minutes before the measurement being taken to ensure 
duplex formation. This plateau point suggested that the total amount of DNA bound to each 
AuNP was 360 strands of probe; this is greater than the level of particle coverage seen in the 
literature (~150 strands per particle), however it is consistently seen with all probes bound 
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to the AuNP (Figure 3.18) and also agrees with the estimates from the UV-vis subtraction in 
Figure 3.9.  
 
Figure 3.16 Monitoring percentage change in anthracene upon target titrations  
Percentage change of anthracene emission intensity at 426 nm calculated relative to initial emission 
level of P.1L-AuNP. Change in anthracene upon addition of fully matching target (red) and single base 
mis-match target (blue). Each point represents an addition of target, error bars indicate the standard 
deviation of three repeats using three different P.1L-AuNP syntheses (AuNP at 2 nM, pH = 7.0, 10 mM 
phosphate buffer, 100 mM NaCl, 293 K,  λex = 350 nm,  λem = 370-570 nm). 
 
The small standard deviation seen in Figure 3.16 for three separate repeats of probe coated 
nanoparticles suggests that using the intensity of the SPR band is an accurate way of 
monitoring the nanoparticle concentration. The envisaged tightly packed surface of the 
nanoparticle does not appear to affect the binding of the target DNA. The linearity of the 
titration graph would suggest that there are no steric effects preventing the probe and 
target binding when the particle is covered in mostly duplex DNA. Importantly, upon the 
addition of a random DNA target sequence, no change in anthracene emission is observed. 
It is known that the P.1L probe binds less strongly to the target DNA-T.2 than DNA-T.1 from 
their respective Tm values (DNA-T.2 = 38°C DNA-T.1 = 49°C). Consequently, these fluorimetry 










































However, the weaker binding for the DNA-T.2 system may explain the increased error seen 
in the curve for the P.1L-AuNP - DNA-T.2 binding profile. 
Varying the SNP sensing probe to the P.1D variant, in which the stereochemistry of the 
threoninol unit to the anthracene tag is switched from l to d, again gives results which are 
comparable to the free probe in solution, with the anthracene emission decreasing for both 
variations of the SNP targets. The initial emission of the anthracene probe is higher for the 
P.1D-AuNP when compared to the P.1L-AuNP, this was again expected as the 1D anthracene 
probe has a higher quantum yield than the 1L probe.22  As for the 1L system, it can be seen 
that there is larger error for the DNA-T.2 target compared to the DNA-T.1 target, and again 
this is probably due to the lower Tm of the P.1D - DNA-T.2 duplex. 
  
Figure 3.17 1D-AuNP emission response to target addition  
(Left) Anthracene emission for P.1D-AuNP (dashed black), after addition of complementary target 
DNA-T.1 (red) and after addition of single base mis-match target DNA-T.2 (blue).(Right) Percentage 
change in anthracene emission at 426 nm calculated relative to initial emission level of P.1D-AuNP. 
Each point represents an addition of target, error bars indicate the standard deviation of three 
repeats using three different preps of P.1D-AuNP. (AuNP at 2 nM, pH = 7.0, 10 mM phosphate buffer, 









































































Table 3.5 Percentage change in anthracene emission once probe strand is fully hybridised to 
different DNA target strands 
Percentage change in anthracene emission upon the addition of fully matching target (DNA.T-1), 
single base mismatch (DNA.T-2) and random target. λex = 350 nm, λem = 426 nm. AuNP at 2 nM, 10 
mM pH 7.0 phosphate buffer, 100 mM NaCl, 293 K. 
 
PARTICLE DNA-T.1 DNA-T.2 RANDOM 
P.1L-AUNP -  66% + 98% -  3% 
P.1D-AUNP -  65% -  59% -  4% 
P.1L -77% +89% -  2% 
P.1D -72% -61% -  3% 
 
3.8.2 Varying distance of anthracene probe from AuNP surface 
 
As a potential imaging probe in biological media, the emission from the anthracene tag 
needs to be as high as possible to overcome background fluorescence. As previously 
described, anthracene is not an ideal fluorophore for imaging in vivo due to its excitation and 
emission wavelengths being similar to natural compounds found in the cell, e.g. tryptophan. 
As discussed earlier in Section 3.7.6, gold nanoparticles are known to quench the emission of 
fluorophores bound near to the surface. As there is a distance-dependent relationship for 
the quenching mechanism, varying the distance between the anthracene probe and the 
AuNP surface was considered to be an effective way to minimise the quenching and 
ultimately lead to a more emissive and more sensitive imaging probe. Increasing the number 
of bases between the thioctic acid modification and the sequence of interest allowed the 
distance between the tag and the surface to be controlled in a precise manner. The probes 
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subsequently synthesised are shown in Table 3.6 with the number of additional bases 0, 5 
and 10 for P.1L, m.P.1L and l.P.1L respectively.  
Table 3.6 Probe strands used to investigate how distance from the particle surface affects the 
anthracene probe emission 
 X = 1L anthracene probe, W = thioctic acid modification.  
 
Strand name Strand sequence 
P.1L 5’ W-TGG ACT CXC TCA ATG 3’ 
m.P.1L 5’ W-AAAAA TGG ACT CXC TCA ATG 3’ 
l.P.1L 5’ W-AAAAAAAAAA TGG ACT CXC TCA ATG 3’ 
 
The number of bases was not increased too greatly due to concerns about how this may 
alter the loading onto the AuNP. It has been widely reported that varying the spacer group 
has a large effect on the loading of DNA onto nanoparticles.25,45,46  
Table 3.7 Duplex melting temperatures of varied length anthracene probe free DNA and varied 
length probe DNA bound to AuNP  
Experiments run at 1µM of DNA, 2 nM AuNP. Samples in 10 mM Phosphate Buffer, 100 mM NaCl. 
DNA-T.1 is the fully matching target,  DNA-T.2 contains a single base mis-match. Tm values are given 
in °C.  
 
Target P.1L m.P.1L l.P.1L P.1L-AuNP l.P.1L-AuNP 
DNA.T-1 47 45.5 46.5 49 47 
DNA.T-2 40 38.5 37.5 38 37.5 
 
The Tm values for m.P.1L and l.P.1L showed a slight decrease in stability of the duplexes for 
the longer strands (Table 3.7). To begin with, the variation in the anthracene emission and 
SNP sensing of the probes alone (not bound to AuNP) was tested (Figure 3.18) by tracking 
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the change in anthracene emission upon addition of aliquots of each target strand (DNA-T.1 
and DNA-T.2). 
 
Figure 3.18 Varied length anthracene probe emission response 
Variation in anthracene emission of probe alone after addition of target DNA. Red = P.1L, Green = 
m.P.1L, Blue = l.P.1L. Error bars are standard error of the mean of 3 repeats. λex = 350 nm, λem = 426 
nm. AuNP at 2 nM, 10 mM pH 7.0 phosphate buffer, 100 mM NaCl, 293 K. 
 
All probes were able to detect the different SNP targets, with the single mismatch target 
resulting in an increase in anthracene emission, and the fully matching target resulting in a 
decrease in anthracene emission. The percentage anthracene emission increase appears to 
be greater for the shorter P.1L, this is not unexpected when we consider the higher Tm value 
that the P.1L has over the m.P.1L and l.P.1L. The higher Tm indicates a tighter duplex 
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surrounding quenching molecules, resulting in a greater increase in emission for the 
anthracene. 
Once the strands were fully characterised, they were bound to the nanoparticles in the same 
method as explained earlier (Section 3.5). The SPR bands were tracked for each set of AuNP 
and compared against one another, as expected, all the strands gave a very similar shift 
(Section 7.1.4), (P.1L-AuNP SPR = 522 nm, m.P.1L-AuNP SPR = 522 nm, l.P.1L-AuNP SPR = 
522 nm) which would indicate that the coating coverages are similar. Once purified, the 
particles were sized by DLS and the resulting data are displayed in Table 3.8. 
Table 3.8 DLS sizing of varied length 1L probes on AuNP  
DLS sizing data (number intensity) of AuNPs (2 nM in deionised water) with varied length DNA probes 
bound.  






P.1L – AuNP 13 (± 4) 34 (± 17) (96%) 
m.P.1L – AuNP 14 (± 3) 24 (± 12) (96%) 
l.P.1L – AuNP 15 (± 4) 39 (± 21) (97%) 
 
Whilst they are all within error, and the differences in size are very small (Table 3.8), it is 
interesting to note that the increase in sizing corresponds to the increased length of 
anthracene probe bound to the particle. This again indicates that the DNA strands on the 
AuNP surface are extended away from the surface. 
The emission spectra of the different probes on AuNPs were then investigated, again using 
the intensity of the SPR band as a measure of the particles concentration. As expected, the 
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emission increased and decreased for mismatched and matched duplexes as shown in Figure 
3.19.   
   
Figure 3.19 Comparing anthracene emission response for varied length 1L probes on AuNP  
(Left) SNP sensing titrations showing fluorescent emission of short (red), medium (green) and long 
(blue) anthracene probes when bound to AuNP. (Right) SNP sensing titrations showing percentage 
change in anthracene emission when fully matching target (DNA-T.1) and single mis-match 
containing target (DNA-T.2) added to short (red), medium (green) and long (blue) anthracene probes 
when bound to AuNP. λex = 350 nm, λem = 370-550 nm. AuNP at 2 nM, 10 mM pH 7.0 phosphate 
buffer, 100 mM NaCl, rt. 
 
The emission intensity of the anthracene for the varied length probes shows the effect of 
varying the distance between the anthracene and the AuNP surface (left Figure 3.19). The 
initial emission of each probe increases with the increased distance the anthracene is from 
the surface, P.1L < m.P.1L < l.P.1L, with the l.P.1L-AuNP having almost double the emission 
intensity of the P.1L-AuNP before target is added. However, when the SNP sensing of the 
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anthracene probe (indicated by plateau of anthracene signal). The best explanation for this 
is that the loading on the AuNPs is higher for the longer anthracene probes. Another reason 
could be that the particle concentration is underestimated; however this was checked by 
SPR measurements multiple times, and has been shown throughout this project to be an 
appropriately accurate way to determine the AuNP concentration. As the amount of target 
added is known, along with the concentration of AuNP, the coating on each particle could be 
calculated. The increased emission counts observed were shown to correlate to with the 
increased level of loading (Section 7.1.5). A possible reason for this is that the packing 
density is higher through better alignment of longer strands. 
Of greater interest are the percentage changes in emission (Right, Figure 3.19), with the 
anthracene probes acting in much the same way as they do when not bound to particles. It is 
apparent that the P.1L anthracene probe has a much greater increase in emission when 
compared to the m.P.1L and l.P.1L once it is bound to AuNPs, a similar trend to that seen 
when the probes are free in solution (Figure 3.18). The distance the anthracene is away from 
the AuNP is roughly 4 nm for the P.1L-AuNP and 7 nm for l.P.1L-AuNP in duplex form; this 
may not be a great enough difference in length to investigate the effect of distance.   
3.8.3 Sensing RNA 
 
Although the sensing of DNA is in itself of interest; for in vitro imaging of SNPs, it is more 
useful to sense RNA. There are a number of reasons for this; the first is because within a 
cellular environment the vast majority of available nucleic acid information is in the form of 
RNA. The information within DNA is mainly super-coiled in the nucleus and relatively 
inaccessible for a probe. There are however available RNA strands within the cytoplasm of 
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the cell, in the form of mRNA. This single stranded RNA is much shorter than genomic DNA, 
making finding the target easier. Also there are multiple identical RNA strands made from 
the same gene, this is due to there being only a single copy of a gene in a cell within the 
DNA. Having multiple identical copies of RNA enables the cell to synthesise the required 
amount of a protein much more rapidly than if the DNA alone were used as the direct 
template.47 Due to the need for the anthracene probe to be fully hybridised with its target, 
the amount of probe added cannot outnumber the amount of target present. Therefore 
targeting RNA, which is more abundant in the cell, allows for a greater amount of probe to 
be used; resulting in a stronger signal to analyse over background.  
The ability of the probe to detect RNA SNP targets was tested. The only chemical difference 
between RNA and DNA is the presence of the 2’OH on the phosphate sugar and uracil bases  
instead of thymine. The RNA sequences are shown in (Table 3.9); and synthesised using 
phosphoramidite chemistry (Section 6.1.1.3). 
Table 3.9 RNA target strands synthesised 
 
Strand name Strand sequence 
RNA-T.1  5’ CAU UGA GAG AGU CCA 3’ 
RNA-T.2 5’ CAU UGA GAA AGU CCA 3’ 
 
Duplex melting temperature experiments confirmed that the RNA targets were still able to 





Table 3.10 Duplex melting temperatures for anthracene probe with RNA targets 
Duplex melting temperatures for 1µM RNA, 2 nM AuNP. Experiments run in 10 mM Phosphate Buffer, 
100 mM NaCl. RNA-T.1 is the fully matching target, whilst RNA-T.2 contains a single base mis-match. 
 
Probe RNA-T.1 RNA-T.2 DNA-T.1 DNA-T.2 
P.AF 58 44 54 40 
P.1L 46 37 48 40 
 
The Tm values show that the DNA-RNA duplexes are stronger than the DNA-DNA duplexes for 
the unmodified probe. However in the presence of the anthracene probe, the duplexes 
formed are not as strong which is thought to result in less intercalation of the anthracene 
probe.    
3.8.3.1 SNP sensing of RNA 
 
The RNA targets were then sensed using the P.1L – AuNP probe in the same way as 
described previously (Section 3.8.1).  
 
Figure 3.20 Anthracene probe response for 1L-AuNP upon RNA target addition  
(left) Percentage change in anthracene emission after each titration of target. Error bars indicate the 
standard deviation of three repeats using three different preps of probe coated AuNP. (right) 
Percentage change in anthracene emission once probe is fully hybridised to target. λex = 350 nm, λem = 































Molar equivalents of target 
P.1L-AuNP + RNA-T.1
P.1L-AuNP + RNA-T.2
 RNA-T.1 RNA-T.2 
P.1L -55% +115% 
P.1L-AUNP -  52% + 137% 
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In Figure 3.20 it is shown clearly that the anthracene probe when bound to AuNPs is still able 
to detect the two different RNA SNP variants. The SNP sensing results are again very similar 
to the free probe with RNA (Figure 3.20). The difference in percentage emission change 
between fully bound AAG compared to the fully bound GAG is very similar to the DNA 
sensing. However, each individual SNP targets percentage change has been shifted more 
positive by around 20 %, this has been previously observed with the free probe and may be 
due to differences in the conformation of the duplexes formed as a result of the differences 
in Tm, and levels of anthracene intercalation.
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3.8.4 Base opposite sensing 
 
Another reason for targeting RNA in vitro is because of the interest in detecting the 
transcription of heterozygous DNA for SNP sites of interest. As our genome is made up of 
pairs of chromosomes, one from each parent, a person can have three possible 
combinations of the SNP site of interest, depending on the SNP variant their parents have. 
Either both their chromosomes will contain one of the SNP variants, or they could have one 
chromosome with one version of the SNP and the other chromosome containing the other 
SNP variant as shown in Figure 3.21. If a person has two different bases at the SNP site in 




Figure 3.21 Homozygous vs heterozygous SNP sites  
Possible chromosome combinations for a SNP site with two variations. 
 
The level that each of the two SNP variants is produced is of growing importance in the 
prediction of disease, and also with regards to personalised medicine.49 The Tucker group 
has developed a technique which is able to discern the percentage of each SNP in a mixture 
of two SNP samples. This is done using the base opposite method for SNP sensing, using a 
different anthracene probe. This method uses the same anthracene probe synthesised in 
Scheme 3.3 only the linker length between the threoninol and the anthracene is 5 carbon 
bases (in the synthesis replace Ethyl Bromoacetae with Ethyl Bromohexanoate, Section 3.4). 
Thanks have to be given to Jonathan Hays for the synthesis of the 5L anthracene linker. This 





Figure 3.22 Base opposite SNP sensing system  
Typically seen when n > 1 for anthracene probe. 
 
The SNP site investigated is a biological SNP site that affects the onset of Alzheimer’s 
disease, it has two variants an A base and a C base. The sequences synthesised are shown in 
Table 3.11. The anthracene emission intensity increases when bound to the A SNP, but 
decreases when it binds to the C SNP. This system is able to differentiate between two SNPs 
in a mixture; because the Tm of the P.5L probe with both targets is very similar, see Table 
3.12; therefore neither target will bind preferentially. It was found that the anthracene 
emission could be tracked in a linear fashion when plotted against the percentage of each 
SNP target. This calibration curve allows the percentage of each SNP variant in a sample to 
be determined. This method of percentage SNP sensing is novel and would be of great 
benefit were it possible for it to be done in vitro, as real time variations in SNP transcription 
could be monitored in response to experimental changes to a cell. As described previously 
(Section 3.1), using the anthracene probe bound to AuNP will enable cellular delivery of the 




Table 3.11 Strands synthesised for base opposite system 
Oligonucleotide strands synthesised for base opposite system W = thioctic acid modification. X = 5L 
anthracene probe modification. 
 
Strand name Strand sequence 
UM.P1       5’ AGT CGC GXC TCA GCT 3’ 
P.5L 5’ W- AGT CGC GXC TCA GCT 3’ 
DNA.T3      5’ AGC TGA GAC GCG ACT 3’ 
DNA.T4      5’ AGC TGA GCC GCG ACT 3’ 
 
The P.5L probe was bound to the AuNP in the same manner as the P.1L probe (Section 
6.2.4.1), the P.5L-AuNP was characterised: number distribution = 15 nm (± 4 nm), intensity 
distribution = 32 nm (± 16 nm) (97%) SPR = 522 nm. Once bound to AuNP the Tm of the 
probe with both targets remained similar so the probe could be used for the base opposite 
method percentage SNP sensing.  
Table 3.12 Duplex melting temperature comparing free 5L probe with 5L-AuNP 





A mixture of targets was then added to the P.5L-AuNP probe and after 10 minutes, the 
anthracene emission level was recorded. The linear response of varying the percentage of 
each SNP in a mixture shows that the probe is still able to work for the base opposite 
sensing. 
Probe C SNP A SNP 
P.5L 58.5 58 




Figure 3.23 Percentage change in anthracene emission for 5L-AuNP upon addition of varied 
mixtures of SNP targets 
Emission measured at 426 nm after probe is fully hybridised with target. Percentage of target that 
contains the A SNP variant (DNA.T3) or the C SNP variant (DNA.T4) SNP on x-axis. Error bars are 
standard deviation of three repeats with three separate AuNP syntheses. λex = 350 nm, λem = 426 nm. 
Samples 2 nM modified AuNP, 10 mM pH 7.0 phosphate buffer, 100 mM NaCl, rt. 
 
3.9 Cell uptake studies 
 
Binding the anthracene probe to AuNPs was done for stability and cell uptake with no need 
for any chemical transfection agents. It was also proposed that concentrating the 
anthracene probe around a single scaffold unit (the AuNP) would aid imaging as a stronger 
signal would be observed, compared to the disperse probe. This would help overcome the 
anthracene probes emission limitations, the fact it coincides with autofluorescence, by giving 
small concentrated regions of signal that could be easily observed and quantified from an 
image.  





































Percentage of DNA-T.3 SNP target 
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Initially it had to be determined whether the particles were taken up by cells when coated in 
the anthracene probe. Due to the difficulties envisioned with the anthracene probes 
emission, it was decided to use 100 nm AuNP for these initial experiments. Using these 
larger DNA coated AuNPs will indicate whether the DNA coating prevents cellular uptake, for 
the UV-vis binding of DNA to 100 nm AuNP see section 7.1.6. The benefit of using larger 
particles is that they can be observed using reflectance microscopy, this has been done 
before to confirm smaller particle uptake.29 Reflectance microscopy is similar technique to 
confocal fluorescence microscopy; however the excitation and detection wavelengths of 
light are the same, therefore only light that has been reflected back through the objective 
lens is measured (Figure 3.24).  
 
Figure 3.24 Confocal reflectance microscope set up 
Fluorescence microscope set up is the same.  
 
In vitro work has been done using the anthracene probe previously within the group,48 this 
has worked on Chinese Hamster Ovary cells (CHO). DNA coated particles have been shown 
to be taken up by CHO cells, work with this cell line was continued. Details of cell culture, 
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freezing and seeding can be found in experimental (6.3.2 - 6.3.4). This work concentrated on 
investigating the uptake of the P.1L-AuNP probe.   
 
          
   
Image 3.1 Reflectance microscopy images of 100 nm 1L-AuNP uptake into CHO cells 
(Top) Z-stack of Reflectance microscopy images showing slices of CHO cell treated with 4 pM P.1L-100 
nm AuNP. Images taken after cells treated for 2 hours. Slices taken at 0.24 µM intervals. (Bottom) 3D 
projection of Z-stack showing distribution of particles throughout cell in yz (a) and xz (b) dimensions. 
Images taken on a Leica SP2 inverted confocal microscope using a 100 x objective lens.  
 
From Image 3.1 it is clear that the particles are readily taken up into cells within 2 hours, 
which coincides with previous work which suggested that most uptake of particles occurs 




within the cell, there is also a notable region in the middle where there are no particles 
present (Image 3.1 (b)), this corresponds to the nuclear region. Overlaying the reflectance 
and transmission images (Image 3.2) show the particles do not enter the nucleus, they only 
overlay on the nucleus above or below it (brightfield image 7.1.7). 
 
Image 3.2 Overlaying reflectance and transmission microscopy images for 100 nm 1L-AuNP cell 
uptake  
Z-stack overlaying reflectance and transmission microscopy images showing slices of CHO cell treated 
with 4 pM P.1L-100 nm AuNP. Images taken after cells treated for 2 hours. Slices taken at 0.24 µM 
intervals. Red spots indicate reflectance from particles. Images taken on a Leica SP2 inverted confocal 








3.10 Conclusions and future work 
 
In this chapter, a SNP sensing DNA probe has been successfully modified so that it can be 
attached to AuNPs. To bind the probe to AuNPs a new method was developed, this method 
is both much quicker than previously published methods, whist also allowing for the coating 
process to be monitored. Once bound to the AuNP the SNP sensing probe retains its SNP 
sensing capabilities, for both DNA and RNA, giving similar percentage emission changes as 
seen for the free probe. The particles themselves were stable to large changes in 
temperature (15-85°C) and also stable in much higher salt concentrations (0.1 M) than those 
observed in vitro. It was shown that the probe coated AuNP were readily taken up by cells 
without the need for chemical transfection. However there were problems in attempting to 
image the anthracene probes emission; this is due to a number of factors including 
quenching of anthracene emission by the AuNP, access to suitable excitation lasers and also 
cell autofluorescence.  
Due to the problems encountered attempting to image the anthracene probe in vitro, the 
work in varying the length of the anthracene probe should be further investigated. It has 
been shown that the distance a fluorophore is from the surface of AuNPs greatly affects its 
emission intensity. Fluorophores which are held within 10 nm of the AuNP surface are 
significantly quenched, however the fluorescence of fluorophores beyond this range can be 
enhanced.52 Therefore probe strands should be synthesised containing spacer groups which 
will extend the distance of the anthracene probe to >10 nm from the AuNP surface. If 
fluorescence enhancement is observed, this may allow for the probe to be imaged within a 
cellular environment, leading to in vitro SNP detection.  
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The particles must be free to bind to the target strands once inside the cell, therefore the 
localisation of the probe coated particles once inside a cell needs to be established. It has 
been shown that upon uptake, functionalised AuNPs are often internalised into endosomes,6 
if the probe coated AuNP are retained inside these, they will not be able to bind to the 
target. Uptake studies should therefore be done, whereby the destination of the particles at 
different time points can be accurately determined by TEM. TEM studies have been used to 
investigate the uptake mechanism of DNA coated AuNP,7 however there has been no study 
of their distribution once inside the cell. If the particles are retained in endosomes upon 
uptake, then further modification of the surface to include groups which may aid the 
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4 RATIOMETRIC SNP SENSING AuNPs CONTAINING A SELF-





























Quantification of in vitro fluorescent signals is difficult to achieve with single fluorophore 
probes; this is due to the variation in cell uptake of foreign molecules across a cell 
population. This variation is due to a cell population not being uniform; each cell is unique 
and its decisions are affected by both single molecule interactions and also larger scale 
interactions with nearby neighbours. This is a significant issue for nanoparticles; especially 
given that the exact method of their uptake is not fully understood.1–4 The variation in 
cellular uptake of AuNPs can be as large as 10 fold across a population;5 in viral particles this 
variation has been attributed to the cell size, local cell density and receptor molecule 
distributions.6 For AuNPs, the local aggregation level of the particles has been shown to be a 
significant factor.7  
The variation in uptake of the probe will therefore lead to a variation in the initial 
fluorescence intensity, making quantification of a change in fluorescence difficult. As the SNP 
detection of the anthracene probe is based upon a percentage change in emission from a 
baseline value, an initial emission intensity of the anthracene probe is required. This is 
simple to do in cuvette studies, where an initial intensity value of the probe can be taken 
before adding the target strand. However for in vitro work, it is not possible to take an initial 
emission level as the uptake of probe into each cell will not be consistent. Therefore the 
samples can only be analysed once the probes have entered the cells. Upon entering the 
cell, the probes will bind to their target before an initial intensity level can be recorded; this 




The variation in cell uptake and an inability to establish an initial intensity reading leads to a 
further problem in determining the SNP variant present. Not knowing the concentration of 
anthracene probe in a cell, means that two cells containing the same anthracene probe and 
giving an identical emission intensity reading could actually be detecting two different SNP 
targets. One cell could contain a target that causes a decrease in the anthracene emission 
but has many probes present, whilst the other cell could contain a target that causes an 
increase in emission but has fewer probes present. The final result of this would be two cells 
with very similar emission intensities, yet two different targets.  
To overcome these problems, it was proposed to utilise the scaffold nature of AuNPs and 
attach a second fluorescent probe onto the AuNP surface; this second probe would act as an 
internal standard for the anthracene probes emission to be normalised to (Figure 4.1). 
Ideally, this second fluorophore would not interact with the anthracene probe and thus not 
fluctuate in emission upon the anthracene probe hybridising with the different targets. The 
ratio of the anthracene signal relative to the standard could then be used give a 
concentration-independent emission level of the anthracene.  
 
Figure 4.1 AuNP coated in both the anthracene probe and an additional fluorophore. 
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The idea of an internal standard for the anthracene probe has previously been considered 
within the group; a second fluorophore was attached to the end of the anthracene probe, 
although the emission of the second fluorophore fluctuated considerably upon binding to 
the targets.8 
There are previous literature examples of the use of ratiometric fluorophore systems to 
overcome the problems of variable cell concentrations; the main requirement is that both 
fluorophores must be delivered together, with no possibility of any differences in their 
relative concentrations. Woodroofe et al. used a single molecule, which upon entering the 
cell was cleaved into two separate fluorophores by esterase enzymes. One of the 
fluorophores quantified zinc ion concentration, whilst the other quantified the concentration 
of probe within the cell.9 Quantum dots have also been used to form ratiometric sensors 
capable of detecting a variety of molecules; here the studies utilise the inherent 
fluorescence of quantum dots to determine the concentration of probe delivered into the 
cell.10,11 Prigodich et al. used multiple fluorophores to integrate an internal standard into 
their nanoflare gene detection system (Figure 4.2).12 Two different flares were bound to 
AuNPs, with one detecting the gene of interest and the second flare specific for a gene which 
was assumed to be at constant expression level across a cell population, therefore giving a 





Figure 4.2 Nanoflare probe 
Prigoditch et al. nanoflare probe.12 The two different flares are specific for different nucleic acid 
targets. Upon binding to the target, a flare is released and is no longer quenched by AuNP. Using two 
different fluorophores allows a ratio of two targets to be found. 
 
To decide upon a suitable probe to act as an internal standard, a number of factors needed 
to be considered: firstly the anthracene probe excitation and emission profiles should not 
overlap with the internal standard probe as this would introduce errors such as fluorescence 
bleed through when exciting each probe. Secondly, the probe had to be sufficiently modified 
so that it could be bound to AuNP in a manner which would not disrupt the DNA binding to 
the AuNP. 
The probe chosen for this work to act as the internal standard is a ruthenium based probe 
developed within the group, ruthenium-4,4’-Di(5-lipoamido-1-pentoxy)-2,2’-bi-pyridine 
(RubpySS) (Figure 4.3). The probe was initially synthesised by Adams et al. for the use of 
metal imprinting onto gold surfaces.13 The reason for using this RubpySS probe is because of 
the attractive properties that photoactive transition metal complexes possess, particularly 
for imaging applications.14,15 These properties include photostability, excitation and emission 
profiles within the visible region (more compatible with conventional imaging techniques) 
and large Stokes shifts. The RubpySS probe excitation (465 nm, MLCT band) and emission 
(550-800 nm) bands are red shifted when compared to the anthracene probe (λex = 350 nm, 
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λem = 370-570 nm), and are therefore much removed from the anthracene signal and also, 
importantly with regards to imaging, away from autofluorescence excitation wavelengths. 
 
 
Figure 4.3 RubpySS probe 
 
Dr Sam Adams is acknowledged for providing the RubpySS as its [PF6]
- salt. However, with a 
[PF6]
- counter ion, the probe was not water soluble, and was therefore not suitable for 
binding to the citrate/DNA stabilised AuNPs. This was converted to the [Cl]- salt using Dowex 
beads to give a water soluble complex (section 6.1.2). 
As described below, the RubpySS probe was bound to gold nanoparticles alongside the 
anthracene probe. The presence of the two disulphide terminating legs on the ruthenium 
probe allowed it to bind to the gold nanoparticles in a similar fashion to the anthracene 
probe as previously described (section 3.6). Investigations into how well the RubpySS works 





4.2  Binding of DNA and RubpySS to AuNP 
 
Previous work in the Pikramenou group showed that a surfactant layer was required on the 
AuNP surface before a ruthenium probe, similar to the RubpySS complex used here, could be 
added.16 This surfactant layer helped prevent the particles from aggregating once the 
positively charged ruthenium probes were added. It was proposed that the DNA molecules 
once bound to the gold nanoparticles, may act as a surfactant themselves, with their 
negatively charged phosphate groups providing enough repulsion between particles to 
restrict particle aggregation.  
Table 4.1 DNA probe and target strands synthesised 
Strands synthesised. W = thioctic acid modification. X = 1L anthracene probe. Y = 1D anthracene 
probe. 
 
Strand name Strand sequence 
P.1L 5’ W-TGG ACT CXC TCA ATG 3’ 
P.1D 5’ W-TGG ACT CYC TCA ATG 3’ 
l.P.1L 5’ W-AAAAAAAAAA TGG ACT CXC TCA ATG 3’ 
P.AF 5’ W-TGG ACT CTC TCA ATG 3’ 
DNA-T.1       5’ CAT TGA GAG AGT CCA 3’ 
DNA-T.2       5’ CAT TGA GAA AGT CCA 3’ 
 
The DNA strands used to coat the AuNPs were the same as those used in Chapter 1, and are 
shown in Table 4.1. It was envisaged that upon coating the particles in DNA, the RubpySS 
would then be added and, as they are significantly smaller and oppositely charged to the 
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DNA, bind to the particles in the gaps between DNA strands. The DNA would be bound to 
the particles in the same way as described previously in Chapter 1.  
To test whether the DNA would indeed act as a protective surfactant layer and stabilise the 
particles from aggregating upon addition of RubpySS, two samples of AuNPs were 
synthesised, one that was not coated in DNA (i.e. citrate stabilised AuNP) and one that was 
fully coated in DNA (P.1L-AuNP). To these particles, RubpySS was titrated in, with 20 minutes 
stirring between each addition (each addition = 1.33 µM RubpySS probe, 3 nM AuNP), after 
which an UV/Vis absorption scan of the particles was taken (Figure 4.4). The SPR band was 
then used to monitor the binding of the RubpySS and also the stability of the AuNPs.  
 
Figure 4.4 UV absorption upon addition of RubpySS probe to bare AuNP and P.1L-AuNP  
(Left) UV-vis absorption spectrum of bare AuNP with titrations of ruthenium probe added in aliquots 
of 1.33 µM. Arrows denote the decrease in 520 nm band and increase in band at 700 nm. (Right) UV-
vis absorption spectrum of DNA coated AuNP (P.1L-AuNP) monitoring the addition of ruthenium 
probe. Arrow denotes the direction of graph movement upon increasing additions (not all additions 
shown). Samples of 3 nM AuNP in deionised water and 10 mM pH 7.0 phosphate buffer at room 
temperature. 
 
As can be seen in Figure 4.4 (left), uncoated AuNPs begin to aggregate immediately with the 



































and the decrease in the SPR band at 520 nm, which is why a surfactant is usually used to 
stabilise the AuNPs prior to coating.16 On the other hand, the DNA coated particles (P.1L-
AuNP) appear to be stabilised, with no sudden appearance of the 700 nm absorption band. 
However, for the DNA coated AuNPs, there is no point at which the SPR band stops shifting 
to indicate total coverage of the surface of the AuNP. As previously discussed, the SPR band 
shifting is indicative of further changes to the surface of the AuNP and once it stops shifting, 
the surface environment of the AuNP is assumed to be constant, i.e. fully coated. It 
appeared then that although the DNA coating stabilises the particles compared to the citrate 
stabilised AuNPs, upon the addition of too much RubpySS, aggregation occurs, as indicated 
by the large red shifting of the SPR band (up to 560 nm) and observable colour change from 
red to blue.  
By analysing the UV-Vis scan, it was established that the P.1L-AuNPs were beginning to 
aggregate after the addition of 8 µM of RubpySS (indicated as red coloured spectrum in 
Figure 4.4). Therefore 6.67 µM of RubpySS was added to the DNA coated AuNPs (in 10 mM 
pH 7.0 phosphate buffer) before passing these newly formed P.1L-AuNP-Ru particles 
through a Sephadex G-50 size exclusion column to remove any unbound molecules. Upon 
testing the ruthenium emission levels however, it was found that the ruthenium emission 
was very low. Therefore the amount of DNA initially coating the particles was investigated. 
Reducing the amount of DNA bound to the AuNP surface would allow more space for the 




By analysing the SPR shift of the particles during DNA coating (Figure 4.5), the amount of 
DNA required to not quite fully saturate the surface was established as being the point just 
before the SPR band stopped shifting, 0.98 µM of DNA (a third of the total DNA used when 
fully coating the particles). Reducing the DNA content further was investigated, however this 
resulted in particle aggregation upon addition of RubpySS. 
 
Figure 4.5 SPR shift for P.1L binding to AuNP to identify concentration required for partial coverage 
SPR shift tracking aliquots of P.1L binding to AuNP, lines indicate concentration chosen for partial 
surface coverage. Samples of 3 nM AuNP in deionised water and 10 mM pH 7.0 phosphate buffer at 
room temperature. 
 
Once the particles were coated in the lower concentration of DNA, the amount of ruthenium 
probe that could be added was established. From previous work in the group, it was known 
that when coating zonyl stabilised AuNPs with a similar ruthenium probe the coating levels 
were of the order 103 probes per AuNP.16 Similar additions of RubpySS were tested and it 
was found that a 4.5 µM concentration of RubpySS (1500 probes per particle) could be 

























Figure 4.6 Comparing relative salt stabilities of P.1L-AuNP coated in various amounts of RubpySS  
UV-vis spectrum tracking the stability of partially coated 1L-AuNPs (1 mL 2 nM) coated with (a) 4.5 
µM of ruthenium probe (b) 3.0 µM of ruthenium probe. Each scan is titration of NaCl (2 µL, 5 M NaCl) 
up to 100 mM (not all peaks shown). Arrows represent trend of peaks. Samples of 2 nM AuNP in 
deionised water and 10 mM pH 7.0 phosphate buffer at room temperature. 
 
With this information, salt was added to the purified particles because the particles needed 
to be stable at 100 mM NaCl for in vitro work. However, it was found that upon addition of 
aliquots of NaCl (each aliquot = 10 mM NaCl) it was evident that particles coated at 4.5 µM 
of ruthenium were unstable and aggregated (Figure 4.6, (a)). Reducing the amount of 
RubpySS added to 3.0 µM gave P.1L-AuNP-Ru particles that were stable at the required salt 
concentrations (Figure 4.6, (b)). 
4.2.1 Characterisation of AuNPs coated with DNA plus RubpySS 
 
The final protocol for the synthesis of the P.1L-AuNP-Ru particles was therefore established. 
Citrate coated AuNPs (13 nm, 3 nM) are made up in 10 mM pH 7.0 phosphate buffer, coated 
initially in 0.98 µM of DNA (in 3 equivalents) with 2 minutes stirring and 20 seconds 
sonication between each addition. To these particles, 3.0 µM of RubpySS is added (in 2 
additions) with 20 minutes of stirring in between each addition, after which the particles are 




































SPR shift for the AuNP is 2.5 nm upon DNA addition and then a further 1.5 nm once the 
RubpySS has been added, Figure 4.7. 
  
Figure 4.7 Tracking SPR peak through binding of P.1L and RubpySS to AuNP 
(Left) UV spectrum of each stage of the coating process. (Right) Tracking the shifting of the SPR peak 
throughout the coating process. Samples of 3 nM AuNP in deionised water and 10 mM pH 7.0 
phosphate buffer at room temperature. 
 
The particles were sized by DLS (Table 4.2), with TEM images confirming the majority of 
particles are mono-disperse (Figure 4.8). Some larger particles are seen by TEM, these may 
explain the error seen in the DLS sizing data.  
Table 4.2 DLS sizing of all particles coated with DNA and RubpySS used within chapter.  
















12 nm  
± 3 nm  
14 nm 
± 4 nm 
14 nm 
± 4 nm 
14 nm 
± 4 nm 
16 nm 
± 5 nm 
15 nm 
± 4 nm 
Intensity 
distribution 
21 nm ± 6 
nm 100%  
40 nm ± 19 
nm 97% 
34 nm ± 17 
nm 96% 
23 nm ± 9 
nm 87% 
286 nm ± 97 
nm 10% 
36 nm ± 6 
nm 96%  










































Figure 4.8 TEM image of P.1L-AuNP-Ru. 
Imaged using a JEOL 1200 TEM. 
 
Once the particles were purified, it was clear from the UV-vis scan that the anthracene probe 
and ruthenium probe were present on the particles (Figure 4.9). Again, the relative 
intensities of the UV scan for the particles cannot be used for accurate concentration 
calculations; as mentioned in section 3.6.2.  
  
 
Figure 4.9 UV-vis absorption scan of P.1L-AuNP-Ru showing presence of fluorophores  
(a) UV-vis absorbance spectra for RubpySS (red) and P.1L (blue) in deionised H2O. (b) UV-vis 
absorption scan of 2nMcitrate coated AuNP (dashed) and 2 nM P.1L-AuNP-Ru after purified through 
Sephadex G-50 column (line). (c) UV-vis absorption spectrum of P.1L-AuNP-Ru once a scan of 2 nM 
citrate coated AuNP is subtracted from it, showing the presence of both P.1L and RubpySS probes. (d) 









































































The MLCT absorption band appears slightly distorted, although this can be attributed to the 
shift in the SPR of the particles when they are coated affecting the background subtraction, 
however it is clearly present in the excitation scan of the isolated particles (Figure 4.10).  
The emission of the P.1L-AuNP-Ru particles was assessed by inspecting both the anthracene 
and ruthenium emission (Figure 4.10). Comparing their emission intensities, the anthracene 
was much more emissive than the ruthenium probe. ICP-MS showed that the number of 
ruthenium complexes coating the particles was of the order of 100’s (150-400) (section 7.2) 
which is ten times lower than was found for previous ruthenium coatings,16 although this 
might be expected as only a 1000 times excess could be added to the particles, which also 
explains the relatively low emission counts for the ruthenium. 
 
Figure 4.10 Excitation and emission spectrum for P.1L-AuNP-Ru 
(a) Excitation spectrum of P.1L-AuNP-Ru, (Blue, full) Anthracene probe excitation spectrum, λem = 426 
nm (Red, dash) RubpySS probe, λem = 630 nm. (b) Emission spectrum of P.1L-AuNP-Ru. (Blue, full) 
anthracene probe, λex = 350 nm. (Red, dash) RubpySS probe, λex = 465 nm. 2 nM P.1L-AuNP-Ru in 
deionised water with 10 mM pH 7.0 phosphate buffer, 100 mM NaCl at room temperature. Slit widths 
for anthracene: excitation = 5 nm, emission = 10 nm. Slit widths for RubpySS: excitation = 15 nm, 

































































4.3 SNP sensing AuNPs containing RubpySS 
 
 Initially, it had to be established whether the anthracene probe was still able to detect SNPs 
when the ruthenium probe was also bound to the AuNP. The SNP sensing was tested using 
the P.1L probe and also the P.1D probe (Table 4.1), when bound to AuNPs with the RubpySS 
also attached to the particles. The variation in the anthracene emission upon the addition of 
DNA-T.1 and DNA-T.2 was then plotted as a percentage change in  
Figure 4.11. 
 
 P.1L-AuNP-Ru P.1D-AuNP-Ru P.1L-AuNP P.1D-AuNP 
DNA-T.1 -66 -71 -66 -65 
DNA-T.2 +65 -63 +98 -59 
 
Figure 4.11 SNP sensing for 1L-AuNP-Ru and 1D-AuNP-Ru 
Percentage change in anthracene emission for AuNP coated with anthracene probe and also 
ruthenium probe (P.1L-AuNP-Ru/ P.1D-AuNP-Ru). DNA-T.1 is fully complementary target, whilst 
DNA-T.2 contains single base mismatch. Each point indicates the addition of target. 2 nM AuNP 
sample in deionised water with 10 mM pH 7.0 phosphate buffer, 100 mM NaCl at room temperature. 


















































It was clear that the anthracene probe was still able to detect SNP targets; with the response 
of the anthracene emission being the same as previously seen in Section 3.8.1. The 
anthracene emission intensity increases for 1L + mismatch whilst all other combinations 
show a decrease. However, the percentage increase in anthracene emission for the P.1L + 
DNA-T.2 duplex was lower than expected. Previously (Section 3.8.1), it was found that the 
P.1L-AuNP + DNA-T.2 duplex showed an increase of 98%. However, the result of the P.1L-
AuNP-Ru + DNA-T.2 duplex only showed a 65% increase in anthracene emission at 426 nm. 
Comparing the variation in emission intensity of the anthracene probe for the probe alone 
(P.1L = +89%), the probe bound to AuNPs (P.1L-AuNP = +98%) and the probe bound to 
AuNPs with RubpySS (P.1L-AuNP-Ru = +67%) it is evident that the 1L mismatch duplex (1L + 
DNA-T.2) is sensitive to its environment. We know that the anthracene probe once in duplex 
form, is still a dynamic system, shown by the anthracene having 3 lifetimes.17 The 1L + DNA-
T.2 duplex has the lowest Tm of the tested strands; therefore it will be most susceptible to a 
change in the surrounding environment. The number of anthracene probes bound to the 
AuNP was calculated once more from the titration experiments, giving 230 anthracene 
probes bound to each AuNP, which is lower than the 360 anthracene probes per AuNP 
calculated previously (section 3.8.1). 
Once it was established that the anthracene probe was still able to differentiate between 





Figure 4.12 Anthracene and ruthenium emission response upon duplex formation for P.1L-AuNP-
Ru and P.NA-AuNP-Ru. 
(Top) Emission of P.1L-AuNP-Ru probe before (dashed black) and after addition of DNA-T.1 (blue) and 
DNA-T.2 (red).(Below) Percentage change in emission for anthracene (grey) and ruthenium (dashed 
line) probes after the addition of SNP targets: fully complementary DNA-T.1 and single mismatch 
DNA-T.2, and also random target. Error bars indicate the standard deviation of three independent 
repeats. All AuNP samples ran at 2 nM in deionised water with 10 mM pH 7.0 phosphate buffer, 100 
mM NaCl at room temperature. Anthracene signal (λex = 350 nm λem = 426 nm, slit widths excitation = 
5 nm, emission = 10 nm), ruthenium signal (λex = 465 nm λem = 630 nm, slit widths excitation = 15 nm, 







































































The addition of target strands induced a decrease in the RubpySS emission centred at 630 
nm. Figure 4.12 shows the percentage change in emission for the RubpySS (dashed bar) 
alongside the anthracene change in emission (grey bar), a table of the values is found in 
7.2.1. However, whilst there is a decrease in emission, it appears to be a constant decrease. 
Upon duplex formation, regardless of SNP target, the RubpySS emission decreases by 20%. 
This ruthenium decrease trend was also seen for the P.1D-AuNP-Ru (shown in 7.2.2). It 
appears that the decrease in emission is not a result of any interference between the 
anthracene and the ruthenium probes, as the drop in ruthenium emission is still seen when 
the particles are coated in anthracene free probe strand (far right, P.AF-AuNP-Ru + DNA-T.1, 
Figure 4.12). 
Investigating the effect of adding a random DNA target to P.1L-AuNP-Ru gives an insight into 
what may be causing the reduction in ruthenium emission. The random target does not bind 
to the SNP sensing probe, as evidenced by the lack of a Tm and there being no change in 
anthracene emission upon its addition, except for dilution effect (section 3.8.1). For the 
addition of this strand, the ruthenium emission does not decrease (giving in fact a slight 
increase of 6%); this would suggest that the formation of a duplex upon the surface of the 
AuNP may be causing this reduction in ruthenium emission. This in itself is an interesting 
result as it appears that the ruthenium is able to sense the presence of target DNA binding 
to the anthracene probe. This would be a very useful property for detecting the presence of 
a particular DNA strand in vitro regardless of its SNP identity, and would be especially useful 
for the base opposite SNP sensing system (discussed later in section 4.3.3).  
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The reason for this observed decrease in ruthenium emission is thought to be due to a 
change in the environment surrounding the RubpySS upon duplex formation. This could be a 
consequence of duplex DNA having a more rod-like structure than the more flexible single 
stranded form. When the AuNP surface is less densely coated with DNA (P.1L-AuNP-Ru 
coated in less DNA than P.1L-AuNP) in its single stranded form, the anthracene has more 
flexibility and may therefore partially conceal the ruthenium from quenching molecules from 
the medium. The decrease in emission of the RubpySS upon duplex formation, was 
consistent for all targets making it relatively straightforward to standardise the emission of 
the anthracene probe. This was done by dividing the anthracene signal at 426 nm by the 
ruthenium signal at 630 nm, giving a ratio which would then indicate the identity of the base 
in the SNP (Figure 4.13).  
  
Figure 4.13 Ratio of anthracene to ruthenium signal upon target addition to P.1L-AuNP-Ru 
Ratio of anthracene to ruthenium emission for the P.1L-AuNP-Ru before (left) and after (right) the 
addition of the SNP targets: fully complementary DNA-T.1 and single mismatch DNA-T.2. Error bars 
are the standard deviation of 6 independent repeats. 2 nM AuNP samples in deionised water with 10 
mM pH 7.0 phosphate buffer, 100 mM NaCl at room temperature. Anthracene signal (λex = 350 nm 
λem = 426 nm, slit widths excitation = 5 nm, emission = 10 nm), ruthenium signal (λex = 465 nm λem = 
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There are errors in the initial ratio which then continue into the final ratio; these are 
associated with variations in coating of the particles and with the concentration of the 
particles, as discussed earlier in Section 3.6. With each new batch of P.1L-AuNP-Ru 
synthesised, a slightly different ratio of anthracene: ruthenium signal is observed, caused by 
variation in coating levels as experimental error (error bars on the initial readings for Figure 
4.13). However, the error in the final ratio measurement can be reduced by normalising each 
new batch of synthesised P.1L-AuNP-Ru to its own initial anthracene: ruthenium emission 
ratio. The result of this approach using six separate and freshly prepared samples is shown in 
Figure 4.14. 
 
Figure 4.14 Normalised ratio of anthracene to ruthenium emission upon target addition 
Ratio of anthracene to ruthenium emission for the P.1L-AuNP-Ru before (left) and after (right) the 
addition of the SNP targets: fully complementary DNA-T.1 and single mismatch DNA-T.2. Each 
measurement is normalised to the initial anthracene: ruthenium ratio for the batch of particles made. 
Error bars are the standard deviation of 6 independent repeats. 2 nM P.1L-AuNP-Ru in deionised 
water with 10 mM pH 7.0 phosphate buffer, 100 mM NaCl at room temperature. Anthracene signal 
(λex = 350 nm λem = 426 nm, slit widths excitation = 5 nm, emission = 10 nm), ruthenium signal (λex = 
465 nm λem = 630 nm, slit widths excitation = 15 nm, emission = 15 nm). 
 
 It is clear that using this ratiometric system allows the detection of different SNP variants 
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synthesising a new batch of anthracene/RubpySS coated AuNP, a ratio of the anthracene to 
RubpySS signal can be measured, this ratio can then be used for all subsequent experiments 
using this batch. If the ratio when normalised doubles then the mismatching CA base pair is 
present; however if the ratio halves, then the matching CG base pair is present. Not 
requiring a baseline emission level for each experiment overcomes the problem of being 
able to only take a single measurement of the anthracene emission when detecting SNP 
targets within cells. To overcome this previously,8 the anthracene probe was inserted into 
cells that did not contain any of the target sequence; this emission could then be taken as 
the baseline level. However for real targets, the cells treated will all contain the target 
sequence, with the only difference being which SNP variant is produced. The ratiometric 
sensing also overcomes the problem of the variation in cell uptake of the probe. As long as 
there is surplus target to probe, the ratio of the anthracene to ruthenium signal measured 
will give an accurate reading for what SNP is present in each cell. 
4.3.1 Comparing P.1L-AuNP-Ru and l.P.1L-AuNP-Ru 
 
Notwithstanding the evidence that variations in the surrounding environment led to the 
decrease in the ruthenium emission, the potential for additional processes was investigated. 
Excited state processes such as Förster Resonance Energy Transfer (FRET) and Photoinduced 
Electron Transfer (PET) could also contribute to the decrease in emission of the ruthenium 
probe and the slight difference in the anthracene response in its presence.18 Initial 
fluorescence studies confirmed that there was no emission of the ruthenium probe upon 
anthracene excitation (350 nm), indicating no FRET. To investigate if any other energy 
transfer was occurring, differences in the emission properties of P.1L-AuNP-Ru compared to 
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l.P.1L-AuNP-Ru were investigated. The difference in distance between the anthracene and 
the ruthenium with the l.P.1L-AuNP-Ru and the P.1L-AuNP-Ru is 10 bases, equating to 3.4 
nm, if the DNA is assumed to be fully extended (Figure 4.15). This increased distance 
between the ruthenium and anthracene probe should greatly reduce any energy transfer 
effects, as these are highly distance dependent.19  
 









Figure 4.16 Comparing anthracene and ruthenium emission response upon target addition for P.1L-
AuNP-Ru and l.P.1L-AuNP 
Chart showing the percentage change in emission for anthracene and ruthenium emission for the 
P.1L-AuNP-Ru (dark grey) and the l.P.1L-AuNP-Ru (dashed line) after the addition of the SNP targets: 
fully complementary DNA-T.1 and single mismatch DNA-T.2. Error bars are the standard deviation of 
3 repeats, each repeat is with a fresh preparation of particles. 2 nM AuNP in deionised water with 10 
mM pH 7.0 phosphate buffer, 100 mM NaCl at room temperature. Anthracene signal (λex = 350 nm 
λem = 426 nm, slit widths excitation = 5 nm, emission = 10 nm), ruthenium signal (λex = 465 nm λem = 
630 nm, slit widths excitation = 15 nm, emission = 15 nm) 
 
Plotting the percentage change in emission for both the anthracene and ruthenium probes 
suggests that there is no significant difference in percentage emission change between the 
longer l.P.1L-AuNP-Ru and the shorter P.1L-AuNP-Ru upon duplex formation (Figure 4.16), a 
t-test confirms this (7.2.3). Results when integrating the emission of both fluorophores gave 
similar results see Section 7.2.4. This would suggest that there is no energy transfer between 
the two fluorophores, as the differences in distance between the two fluorophores has little 
effect on their relative emission intensities. Comparing the ratio of anthracene to ruthenium 
signal also indicates there is no difference in emission levels between the longer and shorter 



































The errors for the anthracene probe emission changes when binding to DNA-T.1 are 
consistently smaller than for the DNA-T.2 target, regardless of the distance the anthracene 
probe is from the AuNP surface. This is apparent in the data for Figure 4.17 and Section 
7.2.2. This could be attributed to differences in Tm with the anthracene tag more dynamic 
and more sensitive to subtle environmental changes in the mismatched complex.  
 
Figure 4.17 Comparing the ratio of anthracene to ruthenium signals for P.1L-AuNP-Ru and l.P.1L-
AuNP-Ru 
Chart showing the ratio of anthracene to ruthenium signals for the P.1L-AuNP-Ru (dark) and l.P.1L-
AuNP-Ru (dashed fill) after the addition of the fully complementary target DNA-T.1 (left) and the 
single mismatch target DNA-T.2 (right). Each measurement is normalised to the initial anthracene: 
ruthenium ratio for the corresponding batch of particles made. Error bars are the standard deviation 
of 6 repeats for P.1L-AuNP-Ru and 3 repeats for l.P.1L-AuNP-Ru, each repeat is with a fresh 
preparation of particles. 2 nM AuNP in deionised water with 10 mM pH 7.0 phosphate buffer, 100 
mM NaCl at room temperature. Anthracene signal (λex = 350 nm λem = 426 nm, slit widths excitation = 
5 nm, emission = 10 nm), ruthenium signal (λex = 465 nm λem = 630 nm, slit widths excitation = 15 nm, 
emission = 15 nm) 
 
4.3.2 Single wavelength excitation of both anthracene and RubpySS 
 
As the SNP sensing probe was developed to improve cell-based DNA detection, 
consideration had to be given for its use as a cell sensing probe. It was proposed that to 
further improve the usability of the probe in vitro, it would be useful if both fluorophores 




































The ruthenium probe has another absorption band at 290 nm, which is assigned to the LC π 
→ π* transition20 (Figure 4.9). The excitation scan of anthracene confirmed it could be 
excited at 290 nm (Figure 4.10). Therefore the SNP sensing was repeated by exciting at this 
wavelength (Figure 4.18).  
 
Figure 4.18 Anthracene and ruthenium emission response upon addition of SNP targets for P.1L-
AuNP-Ru when excited at 290 nm 
Emission scans for anthracene probe and ruthenium when excited at 290 nm. Dashed lines indicate 
initial emission levels before addition of targets. Blue line is P.1L-AuNP-Ru + fully complementary 
DNA-T.1 whilst redline is P.1L-AuNP-Ru + single mismatch DNA-T.2. 2 nM AuNP in deionised water 
with 10 mM pH 7.0 phosphate buffer, 100 mM NaCl at room temperature. Anthracene signal (λex = 
290 nm λem = 380-550 nm, slit widths excitation = 10 nm, emission = 10 nm), ruthenium signal (λex = 
290 nm λem = 620-800 nm, slit widths excitation = 10 nm, emission = 10 nm). 
 
A problem which was immediately obvious was the appearance of a major peak at 580 nm. 
This peak is a result of the highly scattering nature of AuNP samples,21 some of the excitation 
wavelength (290 nm) is scattered at 90° and appears as second order diffraction on the 
detector at 580 nm. The scan therefore had to be done in two separate collections, 380-540 



































Table 4.3 Percentage change for P.1L-AuNP-Ru upon addition of target when excited at 290 nm 
Percentage change for probes upon excitation at 290 nm. 2 nM AuNP in deionised water with 10 mM 
pH 7.0 phosphate buffer, 100 mM NaCl at room temperature. 
 
 % anthracene 
emission change 
% ruthenium  
emission change 
Ratiometric sensing 






















Whilst the anthracene probe retains the ability to distinguish between the two targets, the 
percentage increase with the mismatch target (DNA.T-2) is not as great as previously seen. 
This may be due to photoexcitation in a region where the DNA molecules absorb; therefore 
alternative photo-processes may be occurring. However, this is only a preliminary result and 
further investigation is required. 
Whilst the wavelength used (290 nm) is not well suited for cell imaging due to auto 
fluorescence and possible damage to other biomolecules including DNA, it does however 
provide a proof of concept that a single excitation could reveal the SNP identity and 
standardise it. The use of only one wavelength of light is also beneficial for use in cuvette 
samples as this would speed up throughput. 
4.3.3 Base opposite SNP sensing plus ruthenium 
 
It was decided to investigate whether the ratiometric SNP sensing set up could be applied to 
the base-opposite SNP sensing system. An additional incentive was that the response of the 
ruthenium probe could provide a useful tool for detecting duplex formation. An issue with 
the base opposite SNP sensing system, as described in Section 3.8.4, is that the linear plot 
crosses the x-axis. At this point, the percentage change in anthracene emission is zero. This 
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means that in an unknown sample, an alternative explanation to the identification of this 
particular SNP ratio would be that no target was present at all. However, the observed 
independent decrease in ruthenium emission upon duplex formation as shown in Section 
4.3, would in principle indicate that the anthracene probe was indeed hybridised to a target. 
It does however need to be noted that this would still require an initial reading of the 
ruthenium signal, therefore making this a solution only for cuvette studies of unknown 
samples in which probe uptake by the cell is not an issue.  
Table 4.4 Strands synthesised for base opposite system  
W = thioctic acid modification. X = 5L anthracene probe modification. 
 
Strand name Strand sequence 
UM.P       5’ AGT CGC GXC TCA GCT 3’ 
P.5L 5’ W- AGT CGC GXC TCA GCT 3’ 
DNA-T.3      5’ AGC TGA GAC GCG ACT 3’ 
DNA-T.4      5’ AGC TGA GCC GCG ACT 3’ 
 
The particles were coated with the P.5L probe (the strands used are repeated in Table 4.4; 
(UM.P probe strand without disulphide modification, P.5L = probe strand containing 5L 
anthracene unit with disulphide modification, DNA-T.3 = Target containing A base opposite, 
DNA-T.4 = Target containing C base opposite) before adding the ruthenium probe in the 
same way as described in Section 4.2. The particles were again purified through a Sephadex 
G-50 column, eluting with deionised water. They were then tested to show that the 
presence of the ruthenium probe did not affect the linear response of the anthracene probe 





Figure 4.19 Overlaying response of P.5L-AuNP-Ru and P.5L-AuNP upon duplex formation when 
percentage make up of SNP targets is varied 
(Purple diamonds) Percentage variation in anthracene signal (426 nm) for P.5L-AuNP-Ru particles 
once probe is fully hybridised with target. (Green diamonds) For comparison, percentage variation in 
anthracene signal (426 nm) for P.5L-AuNP particles once probe is fully hybridised with target. 
Percentage of the targets containing A (DNA-T.3) or C (DNA-T.4) SNP variant on x-axis. Error bars are 
standard deviation of three repeats.2 nM AuNP in deionised water with 10 mM pH 7.0 phosphate 
buffer, 100 mM NaCl at room temperature. 
 
Figure 4.19 clearly shows that the emission of the anthracene probe still displays the linear 
relationship when exposed to different percentages of the A and C SNP targets for the P.5L-
AuNP-Ru. When comparing the anthracene response for particles with (purple, Figure 4.19) 
and without (green, Figure 4.19) the ruthenium probe, there are evident differences. For the 
P.5L-AuNP-Ru the change in emission of the anthracene is again diminished when compared 
to P.5L-AuNP (for integrated emission see Section 7.2.4). With 100% DNA-T.3 SNP variant, 
the anthracene emission increases by 102%, compared to an increase of 145% seen for the 
R² = 0.9998 
















































same target when the particles are coated in solely anthracene probe. This is also lower than 
the percentage increase seen for the P.5L probe alone of 140%.22 Again this may be 
explained as discussed earlier (section 4.3.1) by changes in the surrounding environment of 
the anthracene probe caused by the presence of the ruthenium complex or by changes in 
distance between neighbouring probes.  
The emission of the ruthenium probe in P.5L-AuNP-Ru however, does not have the same 
response as it does for P.1L-AuNP-Ru. As described earlier (section 4.3.1) the response of 
the ruthenium probe to duplex formation for P.1L-AuNP-Ru was a consistent decrease in 
emission of 20%. For the P.5L-AuNP-Ru however, there appears to be no consistent 
response of the ruthenium (Figure 4.20). In fact within error, there is no difference in 
ruthenium emission upon duplex formation. 
 
Figure 4.20 Ruthenium emission response upon duplex formation in base opposite system 
Percentage variation in ruthenium emission for P.5L-AuNP-Ru particles once probe is fully hybridised 
with target. Percentage of the target containing A (DNA-T.3) or C (DNA-T.4) SNP variant on x-axis. 
Error bars are 1 standard deviation of three repeats.2 nM AuNP in deionised water with 10 mM pH 
7.0 phosphate buffer, 100 mM NaCl at room temperature. λex = 465 nm λem = 630 nm,  slit widths 
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The reason for this lack of response from the ruthenium complex upon duplex formation 
may be associated with the reason why a response is seen for the P.1L-AuNP-Ru system. In 
this case, there may be no change in the surrounding environment of the RubpySS upon 
duplex formation; therefore its emission intensity is retained. There are two major 
differences between the P.5L-AuNP-Ru and the P.1L-AuNP-Ru which may help with this 
explanation; the first is that the anthracene tag in the probe is different, 5L vs 1L, the 5L 
probe having more flexibility compared to the 1L probe due to its longer carbon linker 
(Section 6.1.4). However, the distances between the anthracene tag and the ruthenium 
complex means that it is unlikely that a relatively small change in the linker length would 
affect the environment surrounding the ruthenium. The other difference between the P.5L-
AuNP-Ru and P.1L-AuNP-Ru is the DNA sequences of the probes and their targets. The 
difference in the environment of the ruthenium complex going from the single stranded 
form to the duplex form must be more marked for P.1L-AuNP-Ru than P.5L-AuNP-Ru. 
Further investigations need to be done; if the  effects are still observed when the anthracene 
linkers are changed in each sequence, then any potential effects caused by variations in the 




Figure 4.21 Ratiometric sensing for base opposite system 
Ratio of anthracene signal (λex = 350 nm λem = 426 nm, slit widths excitation = 5 nm, emission = 10 
nm)/ruthenium signal (λex = 465 nm λem = 630 nm,  slit widths excitation = 15 nm, emission = 15 nm) 
for P.5L-AuNP-Ru particles once probe is fully hybridised with target. Percentage of the targets 
containing A (DNA-T.3) or C (DNA-T.4) SNP variant on x-axis. Error bars are 1 standard deviation of 
three repeats. 2 nM AuNP in deionised water with 10 mM pH 7.0 phosphate buffer, 100 mM NaCl at 
room temperature. 
 
Plotting the ratio of the anthracene signal against the ruthenium signal showed that the 
linear relationship was still present when using the ratiometric method for signal output 
(Figure 4.21). This indicates that this 5L-AuNP-Ru probe could be suitable for sensing the 
percentage transcription of two SNP variants within a cell, whilst overcoming the problem of 
variations in cell uptake. However due to the lack of RubpySS response, it does not 
overcome the problem regarding the 0% anthracene emission response. 
 
 








































Percentage of DNA-T.3 SNP variant 
124 
 
4.4 Cell uptake of DNA-Ru-AuNP 
 
It had to be assessed whether the presence of the ruthenium probe inhibited the ability of a 
cell to take up these particles. Following the same protocol as for the P.1L-AuNP particles, 
100 nm particles were coated in the anthracene and ruthenium probes. They were then 
purified by spinning down and redispersing in MilliQ water. The particles were added to the 
cells at a concentration of 4 pM in 10 mM phosphate buffer and 100 mM NaCl at pH 7.0. The 
cells were treated for 2 hours with the 100 nm P.1L-AuNP-Ru before washing, fixing and 
then imaged by reflectance confocal microspcopy. Imaging cross sectional slices of the cells 
allows it to be established whether the particles are uptaken by the cell or stick to the outer 
membrane.  
 
Figure 4.22 Reflectance microscopy images of 100 nm 1L-AuNP-Ru uptake by CHO cells 
Z-stack of reflectance microscopy images showing slices of CHO cell treated with 4 pM P.1L-AuNP-Ru 
100 nm. Images taken after cells treated for 2 hours. Slices taken at 0.24 µM intervals. Red spots 
indicate reflectance from particles. Images taken on a Leica SP2 inverted confocal microscope using a 




Figure 4.23 Overlaying reflectance and transmission images to show cell uptake of 100 nm 1L-
AuNP-Ru 
Z-stack overlaying reflectance and transmission microscopy images showing slices of CHO cell treated 
with 4 pM P.1L-AuNP-Ru 100 nm. Images taken after cells treated for 2 hours. Slices taken at 0.24 µM 
intervals. Red spots indicate reflectance from particles. Images taken on a Leica SP2 inverted confocal 
microscope using a 100 x objective lens. 
 
As was found earlier with the P.1L-AuNP (Section 3.9) the particles appear to be up taken by 
the CHO cells, indicating that the presence of the ruthenium does not inhibit the particles 
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uptake (for bright field images see Section 7.2.8). In
 
Figure 4.22 Figure 4.22 the white dots are the 100 nm particles, imaging above and below the 
cell shows that they are within the cell. Figure 4.23 confirms that the cells are within the 
boundaries of the cell. Imaging the uptake of 13 nm particles was attempted; however the 
ruthenium probe was not emissive enough to be observed within the cell. This is expected 
when the low emission counts from the ruthenium on P.1L-AuNP-Ru (Figure 4.10) are 
considered. To overcome this, a zonyl surfactant layer could be used to coat the AuNP, 
which has been previously shown to enhance the emission of a similar ruthenium probe.13 
4.5 Conclusions and future work 
 
The work has shown that a ruthenium probe can be bound alongside the anthracene probe 
onto a AuNP surface. For the base-adjacent and base opposite systems respectively, the 
probe reacts in a consistent manner upon duplex hybridisation. This has allowed for the 
major issues regarding the anthracene probe to be overcome. It is now possible for the 
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percentage variation of the anthracene probe to be calculated when the initial emission 
level is unknown, i.e. when variation in the uptake of the probe into a cell. Calculating the 
initial fluorescence ratio of the anthracene and ruthenium probes for a batch of coated 
AuNPs before adding them into a sample, allows the percentage change in anthracene 
emission to be calculated by the ratio of the two fluorophores after they have interacted 
with the targets.   
Future work needs to concentrate on increasing the emission of the probes once bound to 
AuNPs. This could be investigated in a number of ways; the use of a surfactant coating the 
particles which may lead to an enhancement in the emission of both probes. The use of 
surfactants have proven to increase the emission of the AuNP bound ruthenium probes,16  
however this has only been done when the particles were used solely as imaging probes, 
therefore the effects that the surfactant coating may have on sensing is unknown. Also the 
reaction of the ruthenium probe to hybridisation when a surfactant coating is present may 
be interesting, considering that the initial hypothesis on its reaction to hybridisation is based 
upon changes in its surrounding environment. 
The ultimate goal is to detect SNPs in vitro, this will most probably involve detection of RNA 
(as discussed in Section 3.8.3), therefore the SNP sensing of RNA targets should be fully 
characterised to investigate the response of the ruthenium probe. With probes that have 
increased emission, the particles could then be used to detect SNPs in vitro. If this is possible 
then it is feasible that real time SNP detection could be attempted, such a process could give 
an insight into the rate of hybridisation once inside the cell as well as the effect of various 
triggers on transcription. During this project, plasmids which transcribed the targets for 
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DNA.T-1 and DNA.T-2 were integrated into cell lines. These cell lines produce the targets 
themselves, which would allow the sensing of targets within a cell that are produced by the 
cell itself. 
Regarding the base opposite system discussed in Section 4.3.3, the differences in the surface 
environment of the 5L-AuNP-Ru and the 1L-AuNP-Ru should be investigated to determine 
why the RubpySS responds differently upon duplex formation. Investigating different DNA 
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5.1 The discovery of siRNA 
 
It was as recent as 1986, that Walter Gilbert put forward the idea of the ‘RNA world’.1 
Previously, RNA was seen as just a carrier molecule which passed information from DNA to 
proteins. Since then, RNA has become a pivotal part of cellular biology. In 1998, Fire and 
Mello showed that double stranded RNA could induce gene silencing in the nematode 
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worm,2 this was termed RNA interference (RNAi). Soon after the discovery of RNAi, it was 
found that artificial double stranded pieces of RNA could induce gene silencing, these small 
artificial duplexes were called short interfering RNA (siRNA).3 The siRNA did not, in most 
cases, initiate an innate immune response, which is unusual as mammalian cells normally 
recognise RNAs as part of an antiviral defence mechanism. There is therefore great interest 
in siRNA delivery to discover the roles of genes and also its potential as a gene therapy 
technique.4,5 
5.1.1 siRNA mechanism for gene knockdown 
 
The understanding of the mechanism for siRNA mediated gene knockdown allows the 
pathway to be hijacked for our benefit. It begins with the insertion of a piece of double 
stranded RNA into the cell cytoplasm; consisting of a sense and antisense strand for the 
mRNA target of interest. The double stranded RNA interacts with a protein complex named 
DICER, which cleaves the ends of the RNA duplex; this clipped RNA duplex is the siRNA.6 
siRNA molecules are short double strands of RNA, ~22 base pairs in length with a 2 base 
overhang at the 3’ end of each strand. In the next step of the mechanism, the siRNA forms a 
ribonulecleoprotein complex called RISC (RNA induced silencing complex). This complex 
contains an unidentified nuclease named SLICER; RISC mediates the unwinding of the double 
stranded RNA. The now single stranded RNA, which is coupled to RISC, binds to the 
complementary sequence of mRNA in the cytoplasm. The binding mediates the cleavage of 
the mRNA by the nuclease SLICER, cutting the mRNA strand in the centre. These newly 
formed mRNA fragments are recognised as aberrant by the cell, and therefore broken down. 
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This stops translation of the peptide from occurring and ultimately silences the gene that the 
mRNA was transcribed from (Scheme 5.1).7,8 
 
Scheme 5.1 Pathway for siRNA mechanism 
a) Double stranded RNA inserted into cytoplasm. b) DICER cleaves end two bases of each RNA strand. 
c) Formed siRNA. d) RISC complex binds to siRNA e) unravels double stranded siRNA. f) Single 
stranded RNA binds to complementary mRNA sequence. g) RISC complex cleaves complementary 








5.2 siRNA delivery into cells  
 
There are currently a number of problems regarding siRNA as a therapy treatment, which 
include off target effects, cross reactions with the miRNA mechanism (micro RNA) and the 
targeted delivery of the siRNA into the body without degrading.4,9 Sequence-specific off 
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target effects are caused by partial complementarity with regions of mRNA that are not 
being targeted, leading to the down regulation of genes that are not targeted.10 The 
discovery of seeding regions in siRNA (bases 2-8 in antisense strand) showed they were the 
main cause of this effect and modifying the bases in this region can reduce the off-target 
silencing.11 The miRNA process is involved in monitoring the correct expression levels of 
genes within a cell, and disruption of this can lead to unwanted side effects. The siRNA 
pathway can interfere with the miRNA mechanism by using cellular machinery which is 
required for miRNA.12 These two problems associated with siRNA treatment can be readily 
solved by lowering the concentration of the siRNA dose; however the targeted delivery of 
intact siRNA into cells is the current major problem and an area of great research.  The 
targeted delivery is especially important because siRNA can act in a catalytic manner. During 
the siRNA mechanism (Scheme 5.1) the RISC complex retains its silencing abilities once it has 
degraded an mRNA strand. Therefore a small concentration of siRNA can give a large 
knockdown affect. Currently the delivery of siRNA into cells is broadly split into two 
methods; the first using a non-viral vector to deliver chemically synthesised siRNA, the other 
approach is to use a viral infection which will retain the siRNA for longer term treatment. In 
this project, the non-viral method is being investigated and so the background to these 
methods is discussed. The delivery of chemically synthesised siRNA suffers from the same 
problems that were associated with DNA (Section 2.4), these are degradation and cell 
uptake, however as siRNA is used in whole animal systems i.e. in vivo, cell targeting also 
needs to be considered. Interestingly, it has been shown that siRNA can be up-taken 
spontaneously by a cell; however this is only possible when the siRNA is locally delivered, 
such as intranasal.13 Local application of siRNA, however, leads to a high concentration of 
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siRNA in a restricted area and is therefore beset by the problems mentioned previously 
associated with a high concentration of siRNA. To overcome the problems regarding 
degradation, many of the same methods used for stabilising DNA in vitro/vivo, have been 
replicated for siRNA. These include LNA, 2’F and 2’OMe. For the 2’F modification it is 
interesting that even though the modifications had a dramatic effect on siRNAs stability in 
serum, the effect on gene knockdown in vivo was not so dramatic, indicating that the 
stability of the siRNA may not be the most important factor.14  As described above, the 
potential for off target gene silencing means that targeted delivery of siRNA is of great 
importance. There have been multiple different methods used for the improving the uptake 
of siRNA into cells; these include modifying the siRNA (such as with cholesterol to increase 
the siRNAs lipophilicity), encapsulating the siRNA in a liposome or using cationic lipids to 
carry the siRNA through the cell membrane (Figure 5.1). 
 
 
Figure 5.1 Different methods for non-viral delivery of siRNA 
(a) cholesterol modified siRNA (b) electrostatically bound siRNA to cationic lipids (c) siRNA encased in 
a liposome. 
 




AuNPs provide a suitable scaffold for the delivery of siRNA into cells. The surface of a AuNP 
can be readily functionalised with a wide variety of molecules, which allows for extra 
targeting/tracking molecules to be bound alongside the siRNA relatively easily. Also, the bio-
inertness of the particles makes them an ideal candidate for in vivo work.  
5.2.1.1 Electrostatically bound siRNA-AuNP 
 
Once inside the cell the siRNA bound to AuNP needs to be either released from the particles 
or accessible enough so that it can be clipped off the particle by the DICER complex. 
Therefore there are more examples of electrostatic binding of siRNA to AuNP than seen for 
fluorescence sensors (Section 2.6.2). Binding the siRNA less tightly to the particle allows for 
easier release once inside the cell. However, there remains the issue of loss of siRNA during 
delivery, which, due to the catalytic nature of siRNA, has the potential for causing noticeable 
off target knockdown. 
Park et al. were able to develop an siRNA delivery system using AuNPs which were co-coated 
with siRNA and polyethyleneimine (PEI).15 PEI was used to form self-assembled 
polyelectrolyte complexes with siRNA, providing them protection from enzymatic 
degradation, enhanced cellular uptake, and endosome escape. However there have been 
issues regarding cell toxicity and instability in vivo.16 Rotello et al. have used AuNPs coated in 
positively charged polymers, which are able to carry the negatively charged siRNA into 
cells.17 These polymer coated particles have an added advantage of being able to force the 
proton sponge affect to aid their release from endosomes. Once internalised into a cell, 
particles are often trapped inside highly acidic endosomes. The release of the siRNA from 
these endosomes is a problem which is often difficult to overcome. The amine groups on the 
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positively charged polymers release H+ once inside the acidic endosome, resulting in a Cl- and 
H2O molecule being internalised for each H
+. This causes the endosome to swell and 
eventually burst, releasing the siRNA into the cytoplasm.18,19 Elbakry et al. have extended the 
use of electrostatic binding of siRNA to AuNP by creating a layer by layer system.20 Initially 
coating the particles in positively charged PEI, the siRNA was then added to coat the 
positively charged particles. A final layer of PEI was added, to aid the uptake of the particles 
whilst also reducing the amount of siRNA lost in delivery.  
5.2.1.2 Covalently bound siRNA-AuNP 
 
Covalently binding siRNA to AuNP minimises the issues regarding off target knockdown, 
whilst also allowing greater control of siRNA attachment onto the surface. It has been 
reported that electrostatically coated gold nanoparticles are prone to aggregation due to 
cross linking of the coating, or loss of coating from the surface.21 A potential issue with 
covalently binding the siRNA to AuNPs is that the siRNA may not be released from the AuNP 
surface and interact in the siRNA pathway.  
Conde et al. compared ionically bound siRNA-AuNP to covalently bound siRNA-AuNP for in 
vivo systems. They found that the covalently bound siRNA had nearly double the knockdown 
efficiency of the ionically bound siRNA.22 The Mirkin group have bound siRNA molecules 
onto AuNPs, modifying the sense strand of the siRNA with a thiolated PEG. They were able 
to coat the particle in the sense strand initially, and then hybridise the anti-sense strand post 
synthesis.23 The use of these covalently modified siRNA-AuNP in vivo has been demonstrated 
by Zheng et al., using the siRNA-AuNP for the topical delivery of siRNA.24 They have also 
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demonstrated that the siRNA-AuNP conjugates show a six times greater half-life and 
prolonged gene knock down compared to free RNA duplexes.25 
To increase the amount of available siRNA in the cell, cleavable linkage groups have been 
investigated. Lee et al. bound an amine terminating PEG chain to AuNP, and conjugated the 
siRNA to the PEG chain through a biodegradable disulphide bond.26 This disulphide bond 






5.3 Chapter aims 
 
The ability to switch off a gene which is known to cause or facilitate disease progression has 
exciting potential as a drug therapy. The concept that this could be targeted to specific 
diseased cells makes siRNA as a treatment extremely appealing and has led to a remarkable 
amount of research.5,27,28 There are other techniques which utilise a similar approach most 
notably CRISPR, which consists of a short strand of RNA which complexes with a specific 
protein and can alter or slice target strands of DNA.29,30  
Currently, the major problem in the development of siRNA as a medical treatment is the 
delivery of the siRNA duplex into the body and cells in a targeted manner. As described 
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previously in Section 2.4, oligonucleotides are notoriously difficult to deliver into cells 
without chemical transfection, and are prone to degradation once inside the body, reducing 
their effectiveness, also the siRNA process is catalytic in its nature. This is a result of the 
RISC-RNA complex remaining intact once a single target RNA has been destroyed, and can 
therefore bind to more target strands (see part g of Scheme 5.1). This catalytic nature means 
that any non-specific delivery of siRNA must be kept to a minimum. 
AuNPs are an appropriate solution to the associated problems of in vitro use of siRNA. As 
previously discussed in section 2.6.1, oligonucleotide coated AuNPs are readily taken up by 
cells, and are stable to nuclease degradation. Also, the AuNP provides a scaffold to which 
additional targeting molecules can be attached. Research into the use of nanoparticles to 
deliver siRNA into cells has been fairly extensive utilising a wide variety of nanoparticles, 
including; magnetic,31 gold and polymer.32 The use of gold nanoparticles for the delivery of 
siRNA has been studied due to their well understood surface chemistry and relative 
inertness within the body.18  
The aim of the work described in this chapter was to create siRNA coated nanoparticles that 
could begin to overcome the problems associated with degradation and duplex loss. In 
particular, controllably coating AuNPs with siRNA through a bis-thiolate attachment would 
ensure as much of the siRNA as possible would reach the target area. Firstly a modified 
siRNA is synthesised to include a bis-thiolate modification, this is then tested to ensure the 
modification does not affect the siRNA mechanism. Secondly, the modified siRNA is bound 





Figure 5.2 Proposed modification of siRNA, leading to coating of AuNP 
 
5.3.1 Target protein to test gene knockdown, CLEC-14A 
 
To monitor the knockdown efficiency of the siRNA-AuNP, the expression level of the 
targeted gene needs to be quantified. The easiest method for this is to target a gene which 
codes for a protein that is easily identifiable; the expression level of the protein is more 
easily determined and will correlate to the level of gene knockdown. For this project the 
gene targeted for knockdown was the gene coding for the protein CLEC-14A. This was 
chosen due to the expertise within the Bicknell group working with this protein, including an 
established method for monitoring the expression of CLEC-14A.  
The protein CLEC-14A is a recently discovered novel endothelial marker and is strongly 
expressed in tumour vasculature when compared to healthy vasculature. It induces filopodia 
and facilitates endothelial migration, tube formation and vascular development in zebra fish. 
The knocking down of CLEC-14A results in anti-angiogenic activity by inhibiting cell migration 
and tube formation.9  
Anti-angiogenic treatment is a method for inhibiting the growth of a cancerous tumour. 
Restricting a tumour’s ability to establish a blood supply limits the growth of a tumour. The 
siRNA-AuNPs therefore will ultimately need to target tumours once inside the body. This 
140 
 
may be achieved by further modifying the surface of the particles with tumour specific 
molecules; however the use of nanoparticles themselves introduces a level of tumour 
targeting. The enhanced permeability and retention effect (EPR),34,35 aids the targeting of 
the siRNA-AuNP to tumours within the body. Around areas of fresh tumour growth, the 
vessels are rapidly forming and therefore contain imperfections resulting in leaky vessels. 
Particles sized 10-100 nm are retained in the blood stream, however upon entering a 
tumours vessels they will leak into the surrounding tissue. Also, tumours do not develop a 
lymph system and so they cannot clear out chemical build up surrounding the vessels. This 
leads to a build-up of particles in tumours as they are pumped around the circulatory 
system. 
 
5.4 siRNA modification 
5.4.1 Amine modified RNA coupling to NHS ester 
 
To attach the siRNA to AuNPs, the siRNA itself must be modified to incorporate a binding 
group onto it. As described previously (Section 5.2.1.2) only one strand of the duplex has to 
be modified to bind it to the AuNP. The first strand is bound to the AuNP, with the 
complementary strand hybridised to form the completed siRNA duplex. It has been shown 
that the orientation of the siRNA when bound to nanoparticles has no effect on its ability to 
silence genes,10 therefore either strand can be modified for binding to the particle surface. 
The binding group chosen was again a cyclic disulphide group as used for binding the 
anthracene probe to AuNP (Section 3.3). The cyclic disulphide was chosen due to the 
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increased strength of the bis-thiolate bonds compared to a single thiol bond. This ensures as 
much of the siRNA remains bound to the AuNP as possible before reaching its target. 
Initially, the 5’ terminus of one of the strands of the siRNA was modified with an amine 
linker group on column as previously done with DNA (Section 3.2). This was then reacted 
with the NHS ester form of thioctic acid once the RNA was cleaved off the column (Scheme 
5.2).  
 
Scheme 5.2 Reaction to form thioctic acid modified RNA using NHS ester route  
Conditions: 0.1 M sodium carbonate buffer, heated at 37°C overnight. 
 
Although this reaction was successful when modifying DNA, when modifying RNA it did not 
work so efficiently. Despite multiple attempts, the product could not be obtained in a pure 
or large enough yield. By HPLC analysis, it was evident that there was degradation of the 
RNA during the coupling reaction. Efforts to obtain enough modified RNA resulted in 
mixtures of either unreacted amine or various degradation products. By MS analysis, it was 
evident that the desired product was formed, but only in very small amounts. The increased 
instability of RNA is attributed to the 2’-OH. If deprotonated (e.g. in alkaline conditions) the 
2’-O- can attack the phosphorus in the phosphodiester bond; resulting in the loss of the next 
nucleotide in the sequence, forming fragments of the RNA sequence (Scheme 5.3). This may 
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explain the observed degradation of the RNA strands during the coupling reaction, as the 
coupling reaction is done in alkaline 0.1 M sodium carbonate buffer. 
 
 








5.4.2 Disulphide phosphoramidite modification 
 
Modification of the RNA using an NHS ester of thioctic acid was unsuccessful, therefore an 
alternative method for modifying the RNA was required. Synthesising a phosphoramidite of 
the thioctic acid (Figure 5.3) would allow the RNA sequence to be modified on column using 





Figure 5.3 Phosphoramidite of thioctic acid 
This thioctic acid phosphoramidite could then be coupled to the RNA sequence using the 
DNA synthesiser, minimising the amount of off-column modification of the RNA strands. 
Therefore maximising the amount of product obtained, whilst also removing any side 
products that may be being formed during the off-column coupling.  
The literature gives conflicting information about the synthesis of a phosphoramidite from  
thioctic acid. Dougan et al.12 reported difficulty in synthesising the phosphoramidite. They 
found the thioctic acid phosphoramidite was unstable, (suggesting this may be due to the 
ring strain within the cyclic disulphide group) with the sulphur atoms in the cyclic disulphide 
possibly reacting with the P(III) centre, allowing for a number of side reactions.  Therefore 
they developed a method for the synthesis of an H-phosphonate form of a thioctic acid 
derivative (Figure 5.4). 
 
 
Figure 5.4 H-phosphonate of a derivative of thioctic acid synthesised by Dougan et al.12 
 
However, contrary to the findings of Dougan et al., there are reports of the target 
phosphoramidite as well as other derivatives of thioctic acid. Seliger et al.13 originally 
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patented the synthesis of a phosphoramidite derivative of thioctic acid, noting its 
importance in immobilising organo/biochemical molecules on noble metals, noble metal 
alloys or semiconductors. Interestingly, Srivastava et al.14 recently patented another 
synthesis of a thioctic acid phosphoramidite to modify oligonucleotides at any point within a 
sequence. They remarked that the synthesis put forward by Seliger et al. was inconsistent 
and only worked for compounds with short carbon chains between the peptide and 
phosphodiester bonds.  
The work in this project was done before the patent by Srivastava et al. was released and 
proposes a slightly different procedure. Initially the thioctic acid was reacted with 2-
amineethan-1-ol to give an available alcohol group. This alcohol group could then be 
phosphitylated to give the target phosphoramidite (Figure 5.5) which was successfully 
characterised in the usual manner (Section 6.1.5). 
 
 
Figure 5.5 Synthesis of phosphoramidite form of thioctic acid derivative.  
145 
 
Reagents and conditions: (a)(i)HOBt, DMF,0°C, EDC, 1 hr (ii) H2N(CH2)2OH, 4-ethymorpholine, rt, o/n, 
73% yield. (b) (i-Pr2N)PClO(CH2)2CN, DIPEA, DCM, rt, 2 hr, 75% yield. 
 
5.4.3 Characterisation of the modified siRNA 
 
The RNA was synthesised on an Applied Biosystems 394 DNA/RNA synthesizer as per 
standard RNA oligo synthesis (Section 6.1.1.3). The strands synthesised are shown in Table 
5.1. 
Table 5.1 RNA sequences synthesised  
(top) RNA sequences synthesised. (bottom) Duplex siRNA when RNA.3 and RNA.4 hybridised. Q = 
Compound 8 modification. 
 
Strand name Strand sequence 
RNA.3 5’  Q-CAA UCA GGG UCG ACG AGA A  3’ 
RNA.4 5’  UUC UCG UCG ACC CUG AUU G  3’ 
 
 
All strands were purified by reverse phase HPLC and characterised by Mass Spectrometry 
(Section 6.1.1.4). The synthesis of the modified RNA (RNA.3) proved problematic and was 
produced in lower yield than the unmodified RNA (RNA.4). The presence of the thioctic acid 
modification was confirmed by MS but it should be noted that the reaction was not always 
successful, often resulting in only the unmodified RNA.3 being isolated. When the reaction 
did occur, the yields of RNA.3 were low e.g. 500µL at 35 µM, compared to RNA.4 which 
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yielded 500µL at 80 µM. A Tm of the siRNA.1 duplex of 63°C confirmed the formation of the 
duplex.  
5.5 CLEC-14A knockdown 
5.5.1 Western Blot introduction 
 
To monitor siRNA knockdown efficiency, the expression levels of the protein formed from 
the silenced genes needed to be quantified. This is done using a technique called a Western 
Blot. This involves treating cells with a siRNA duplex before lysing the cells. A gel of the cell 
lysate is run to separate the proteins present in the lysate based upon their size. The 
proteins are then transferred onto a membrane which can be treated with protein specific 
antibodies. The primary antibody will bind to the protein of interest, photoactive secondary 
antibodies are then added and bind to the primary antibodies. The photoactive antibodies 
can then be seen using photoactive film, allowing the proteins to be identified (Figure 5.6).  
 
Figure 5.6 Developing a Western Blot. 
Protein size marker (blue/red dashes) runs alongside proteins (black dashes) from cell lysate. (a) 
Proteins from cell lysate run on gel and transferred to membrane. (b) Membrane treated with primary 
antibodies for CLEC-14A (purple) and tubulin (pink). (c) Membrane treated with horseradish 
peroxidase (yellow star) containing secondary antibodies. (d) Membrane developed on photoactive 




The proteins analysed were the gene being targeted CLEC-14A, and also Tubulin. Tubulin is a 
protein highly expressed in cells, it polymerises to form microtubules which serve as a 
skeletal system for cells.15 The expression of Tubulin should not be affected by the siRNA 
treatment; therefore it can be used as a control to reference the CLEC-14A expression levels 
against. 
5.5.2 Knockdown using modified siRNA alone 
 
Before testing how effective siRNA coated AuNP would be, it first had to be established 
whether the disulphide modification on RNA.1 affected the knockdown capability of the 
siRNA duplex. Therefore, the siRNA.1 duplex was tested alongside the standard bought 
CLEC-14A siRNA used within the lab (labsiRNA), to compare their relative knockdown 
efficiencies. A random duplex of RNA is used as a control for each experiment run; the 
control shows the normal level of protein expression, from which the knockdown efficiency 
is calculated from. 
  
Figure 5.7 Western blot for CLEC14A knockdown using modified siRNA.1 
(Left) Developed film showing relative expression levels of target protein CLEC-14A and reference 
protein, Tubulin. (a) Negative control experiment showing normal expression levels of both proteins. 





























knockdown of CLEC-14A compared to the negative control, each experiment normalised to its own 
tubulin expression.   
 
The darkness of the band is proportional to the amount of protein expressed. A darker band 
indicates a higher concentration of photoactive secondary antibody, a direct result of higher 
protein concentration. The percentage knockdown efficiency of the siRNA.1 can be found by 
using ImageJ software41 to analyse the average pixel value for each protein band. 
Normalising each experiment to its internal control, tubulin, the relative percentage 
knockdown of CLEC-14A can be found by comparing it to the negative control (Figure 5.7, 
right). The experiments confirmed that the disulphide modification did not affect the siRNA’s 
ability to induce protein knockdown (Figure 5.7). 
5.6 Binding siRNA to AuNP 
5.6.1 Track UV binding upon siRNA addition 
 
Once it was proven that the presence of the disulphide modification did not affect the 
siRNAs knockdown efficiency, the siRNA was bound to 13 nm AuNP. From previous work 
with DNA-AuNP (Section 3.6.2.1), it was known that the AuNP could not be exposed to salty 
conditions until coated in DNA; as the particles would aggregate. Therefore, RNA could not 
be bound to the particles as a duplex since the salt required to form the duplex would cause 
the particles to aggregate. Consequently, the particles would be initially coated with a single 
strand of modified RNA forming particles that are stable to salt addition. The second strand 
of RNA could then be added along with salt allowing the duplexes to form.  
To coat the AuNP with RNA the same procedure was employed as used previously (Section 
3.6). To 13 nm AuNP (1 mL, 3 nM) in 10mM phosphate buffer, the RNA.3 was titrated in 
three equal additions (28 µL, 35 µM). After each RNA addition the AuNP-RNA solution is 
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stirred for 2 minutes with a magnetic stirrer and then sonicated for 20 seconds. The binding 
was monitored by UV-vis absorption tracking the shift of the SPR band of the AuNP (Figure 
5.8). For full experimental details see Section 6.2.4.5. 
 
Figure 5.8 Tracking RNA binding to AuNP 
(left) UV absorption of SPR band showing before and after addition of siRNA.1. (right) Graph plotting 
the shift in SPR band upon titration of RNA.3 (9 µL, 35 µM) to 1 mL of 3 nM AuNP in 10 mM 
Phosphate buffer. 
 
The SPR shift observed was very similar to the SPR shift seen when DNA was bound to the 
AuNP using a thioctic acid modification. This was expected as the SPR band is sensitive to 
changes of the surface environment of the AuNP where the binding takes place. The surface 
environment of the RNA coated particles will be similar to the DNA coated particles as they 
bind through the same thioctic acid modification (Section 3.6). Also, the number of RNA 
molecules coating the particles is assumed to be similar to that of DNA as the presence of 
the 2’-OH groups in RNA should not affect the packing level to any great extent. 
Once the AuNPs were coated with RNA.3, they were passed through a Sephadex G-50 size 
exclusion column to remove any unbound RNA. Once purified the second strand of RNA 
(RNA.4) was added to the particles along with buffer and salt to ensure duplex formation. 


































RNA.3 addition (µM) 
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hybridised particles through a size exclusion column would greatly reduce the salt 
concentration, causing the siRNA duplexes to fall apart. Any single stranded RNA.3 in 
solution would be readily degraded inside the cell, if it was taken up at all. Therefore if any 
single stranded RNA was carried through into cells it would not affect the knockdown 
experiments.  The particles were sized at 14 nm ± 3 nm by DLS, as described previously 
(Section 3.7.1). 
5.6.2 Cell uptake 
 
It had to be established that the particles, once coated in siRNA, were taken up by Human 
Umbilical Vein Endothelial Cells (HUVECs). HUVECs are often used to analyse endothelial 
cells for angiogenesis, as they retain the features of native vascular endothelial cells such as 
endothelial cell specific markers.42 The method for extracting the cells from the umbilical 
vein using collagenase is shown in experimental Section 6.4. As previously discussed, the 13 
nm siRNA.1-AuNP could not be imaged via reflectance as they are too small. Therefore to 
image cell uptake, 100 nm AuNPs were coated in siRNA (Section 6.2.4.7). These particles are 
large enough to be imaged by reflectance microscopy. After purifying the 100 nm siRNA 
coated particles by spinning down, HUVEC cells were dosed at 4 pM of 100 nm for 4 hours. 





Image 5.1 HUVEC uptake of 100 nm siRNA.1-AuNP 
Z stack of images taken by reflectance confocal microscopy of HUVECs treated with 100 nm siRNA.1-
AuNP for 4 hours. Each slice is an increment of 0.45 µM. Particles added at 4 pM in deionised water 
with 100 mM NaCl and 10 mM phosphate buffer. 
 
The uptake of the particles was then imaged by reflectance microscopy (Image 5.1), which 
confirmed the particles were taken up within the same time period used in standard siRNA 
treatment. Therefore direct comparisons could be made between transfection mediated 
siRNA and siRNA-AuNP knockdown. 
5.6.3 Knockdown using siRNA-AuNPs  
 
Once it was shown that the siRNA.1-AuNPs were taken up by HUVECs without the need for 
chemical transfection agents, the knockdown capabilities of the siRNA.1-AuNP was tested. 
The method followed was the same as standard siRNA treatment as already described but 
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without lipofectamine. The siRNA.1-AuNPs (0.25 nM) were added to the cells in deionised 
water with 100 mM NaCl and 10 mM phosphate buffer at pH 7.0. This gave a total 
concentration of siRNA added ≈ 100 nM (assuming around 400 strands per particle as per 
DNA), which was higher than the minimum amount of siRNA shown to induce CLEC-14A 
knockdown under standard treatment (50 nM).33 However, not all particles would be taken 
up by cells and the availability of the siRNA bound to the AuNP was unknown, therefore it 
was decided that concentrations surrounding 0.25 nM of siRNA.1-AuNP were tested. ImageJ 
was again used to analyse the relative expression levels of the proteins of interest. To 
monitor whether the particles induced a protein expression response from the cell 





Figure 5.9 Western blot of CLEC14A knockdown using siRNA.1-AuNP 
(Top) Developed film for a single experiment indicating relative expression levels of target protein 
CLEC-14 and reference protein, Tubulin. (a) Control experiment showing normal expression levels of 
both proteins. (b) siRNA.1 (c) siRNA.1-AuNP (0.025 nM) (d) siRNA.1-AuNP (0.05 nM) (e) siRNA.1-
AuNP (0.25 nM) (f) siRNA.1-AuNP (0.5 nM) (Right) Percentage knockdown of CLEC-14A compared to 
the negative control, each experiment normalised to its own tubulin expression. Average of two 
independent repeats.  
 
The results in Figure 5.9 indicate that the siRNA.1-AuNPs are not able to induce protein 
knockdown. There was no observable decrease in the CLEC-14A protein expression for the 
cells that were treated with siRNA coated AuNPs when they were compared to the control 
















































the levels of CLEC-14A knockdown (Figure 5.9). Extending the time the cells were treated 
with siRNA.1-AuNP from 4 hours to 24 hours showed no difference in the expression levels 
of CLEC-14A, indicating that the lack of gene silencing was not due to the siRNA mechanism 
taking longer as a result of the siRNA being bound to AuNP. It therefore appeared that the 
reason for the inactivity was the siRNAs inability to be cleaved from the AuNP surface. The 
observed increased stability of oligonucleotides when bound to AuNPs has been discussed 
previously (Section 2.6.1); the tight packing of the oligonucleotides and high local salt 
concentration makes the strands stable to enzyme degradation.  
In the first step of the siRNA mechanism, the DICER enzyme clips the double stranded RNA 
into the siRNA form. This step may be being inhibited by the aforementioned tight packing 
and high local salt concentration properties that the siRNA.1-AuNP has. To overcome these 
issues, it was proposed to bind a second molecule to the AuNPs alongside the siRNA. This 
second molecule would act firstly as a spacer molecule, in effect forcing the strands of RNA 
apart from each other and making it more available for the DICER enzyme. Also, it was 
proposed that the second molecule should be positively charged as this would help decrease 
the overall negative charge surrounding the AuNPs, again making the immediate 
environment surrounding the siRNA more accessible (Figure 5.10). The RubpySS probe used 
in chapter 4 was deemed suitable (Figure 4.3). The ruthenium complex can bind to the 
AuNPs through its disulphide terminating legs, forcing the strands of siRNA apart, whilst its 
overall 2+ charge will neutralise the negative charge of the RNA. The ruthenium probe also 
has the additional benefit of being a luminescent probe. The ability to track the siRNA-AuNPs 
probes once inside a cell or animal is of great interest, as the localisation of siRNA-AuNPs 




Figure 5.10 Proposed reasoning behind attachment of second probe to AuNP 
(a) DICER enzyme unable to bind to RNA strands due to high surface density and high negative charge 
(b) DICER complex is able to interact with RNA strands due to lower density and lower negative 
charge due to presence of RubpySS. 
 
5.7 Binding siRNA and ruthenium probe to AuNP 
 
 To coat the AuNPs with both RNA and RubpySS, the procedure for binding the anthracene 
probe alongside the RubpySS was carried out as described previously in Section 4.2. The 
bare AuNPs are made up in 10 mM pH 7.0 phosphate buffer, coated initially in 0.98 µM of 
DNA (three additions of 9 µL, 35 µM RNA.3) with 2 minutes stirring and 20 seconds 
sonication between each addition. To these particles, RubpySS is added (two additions of 15 
µL, 20 mM with 20 minutes of stirring between each addition). The SPR was tracked by UV 
(Figure 5.11) to monitor the binding. The particles were then passed through a Sephadex G-
50 column to remove any unbound molecules. After purification, the particles were made up 
in 100 mM NaCl, 10 mM phosphate buffer (pH 7.0) and then the second strand of RNA was 
added to the coated particles, forming siRNA.1-AuNP-Ru particles. These were sized at 15 




Figure 5.11 SPR shift for siRNA.1-AuNP-Ru coating 
Binding initially with RNA.3 (9 µL, 35 µM) (diamond) and then RubpySS (15 µL, 20 mM)(triangle). 1 
mL of AuNP at 3  nM in 10 mM phosphate buffer, pH 7.0.  
5.7.1 Knockdown using siRNA.1-AuNP-Ru 
 
Upon testing the knockdown efficiency of the siRNA.1-AuNP-Ru particles, there was a clear 
decrease in the production of CLEC-14A (Figure 5.12).  
 
Figure 5.12 Western blot for CLEC14A knockdown using siRNA.1-AuNP-Ru  
(Left) Developed film for a single siRNA.1-AuNP-Ru experiment indicating relative expression levels of 
target protein CLEC-14 and reference protein, Tubulin. (a) Control experiment showing normal 
expression levels of both proteins. (b) siRNA.1-AuNP-Ru at 0.025 nM (c) siRNA.1-AuNP-Ru at 0.05 nM 
(Right) Percentage knockdown of CLEC-14A compared to the negative control, each experiment 


























It therefore appeared that the ruthenium probe had delivered the desired affects with 
regards to the siRNA knockdown mechanism, and the siRNA could be successfully cleaved off 
the AuNP surface and induce gene silencing.  
Although these results were extremely encouraging, it had to be determined that the effects 
observed were a direct result of the siRNA being cleaved and inducing knockdown through 
the siRNA mechanism, or whether the ruthenium probe was having some effect on the cell 
causing a decrease in CLEC-14A production.  
 
 
Figure 5.13 Western blot for CLEC14A using various standards 
(Top) Developed film indicating relative expression levels of target protein CLEC-14 and reference 
protein, Tubulin. (a) Negative control (b) P.1L-AuNP (c) P.1L-AuNP-Eur (d) P.1L-AuNP-Ru (e) siRNA.1-
AuNP-Eur (f) siRNA.1-AuNP-Ru. (Bottom) Percentage knockdown of CLEC-14A compared to the 
negative control, each experiment normalised to its own tubulin expression. Results are average of 

















































Therefore two control experiments were done; firstly the siRNA was replaced with the 
anthracene probe used previously, which should result in no knockdown of CLEC-14A. Whilst 
in the second experiment, the ruthenium probe was replaced by a neutral Europium probe 
(Eur; provided by Johnathon Lilley) which will show whether the effects observed were 
caused by co-coating the particles with a second probe, or whether they are directly caused 
by the ruthenium probe. The effect these changes had on the levels of CLEC-14A were then 
tested (Figure 5.13).  
It is apparent from the results of the control experiments that the reason for the observed 
knockdown in siRNA.1-AuNP-Ru is the presence of the ruthenium probe. It appears that the 
siRNA pathway is not the route that leads to the decrease in CLEC-14A production, as the 
reduction in CLEC-14A is still observed for the ruthenium probe coated AuNP even when no 
siRNA is bound to the AuNP. Also, when the ruthenium probe is replaced by a Europium 
probe, the knockdown is not observed, indicating the ruthenium is causing the knockdown 
of CLEC-14A.  
These results suggest that the ruthenium probe alone causes the cell to produce less CLEC-
14A. It is difficult to envisage how this could be a specific interaction with CLEC-14A, and it is 
more likely that it is some non-specific anti-angiogenic effect being observed. The 
mechanism of which is caused by the presence of the ruthenium probe. The deduction of 
this mechanism which leads to the knockdown of CLEC-14A is outside the scope of this 
project. However, from literature, it is seen that ruthenium (II) based compounds have been 
found to display anti-angiogenic properties.43,44,45 
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5.8 Conclusions and future Work 
 
In this work a new method for modifying RNA so that it is able to bind to AuNP has been 
developed. This modified siRNA still retains its ability to induce gene silencing at a similar 
level to non-modified siRNA. A method for controllably binding the modified siRNA onto 
AuNP in a covalent manner has been developed. These particles were able to be taken up by 
HUVECs, however no gene silencing was observed. Further modifying these particles with a 
ruthenium probe gave interesting, if ultimately unsuitable, results, causing the down 
regulation of the protein of interest even when no siRNA was present. Investigating these 
anti-angiogenic properties of the ruthenium probe would be interesting future work. 
The observed lack of activity of the siRNA strands once bound to the AuNPs, could be caused 
by a number of factors which should be further investigated. The use of a cleavable linker 
group to the AuNPs has been investigated by some groups,26 where a cleavable disulphide 
group was placed between the siRNA AuNP (Figure 5.14). The siRNA was released once the 
particle entered the reducing environment of the cytoplasm. However, this has not yet been 
done when using the disulphide attachment site.  
 
Figure 5.14 Incorporation of a cleavable linker to aid siRNA release from AuNP by Lee et al..26 
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As the aim of the project was to attempt to track the delivery of siRNA to cells, alternative 
fluorophores need to be investigated. The observed activity caused by the ruthenium probe 
makes this unsuitable, especially for tracking the CLEC-14A protein knockdown. Alternative 
AuNP binding dyes have been developed within the Pikramenou group, such as Europium 
and Iridium metal based dyes. 
A route which may prove interesting would be to tag one of the strands of the siRNA duplex 
with an organic dye. These can be readily purchased and coupled to oligonucleotides during 
DNA synthesis. This has already been explored with DNA within the Tucker group, to prove 
duplex formation in cells.46 This would determine whether the siRNA is cleaved from the 
AuNP surface, as the emission of the dye would increase upon removal from the quenching 
AuNP.  
Alternative nanoparticles to gold could also be investigated; this work has already started 
within the group using silica nanoparticles. The siRNA does not bind to these silica particles 
covalently but through electrostatic interactions; therefore they may suffer from the already 
discussed problems of loss of sample. However it may provide a means to successfully 
release the siRNA into the cells cytoplasm, whilst it has already been shown within the group 
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6.1 Chemical Synthesis 
6.1.1 Oligonucleotide Synthesis 
6.1.1.1 DNA synthesis 
Sequences were synthesised on an Applied Biosystems 394 DNA/RNA synthesizer as per 
normal oligo synthesis, using standard Syn Base CPG 1 µM (Link Technologies). Base de-
protection was performed off column, in 1 M ammonia heated to 55°C for 6 hours using a 
heating block (Grant Instruments). The ammonia is removed under reduced pressure, before 
the sequences were purified by semi-prep HPLC (Dionex UVD 1705) using a Clarity 5µ Oligo-
RP 150x4.6 mm (Phenomenex) column. After collecting the purified peak, the solvent is 
removed in vacuo (Thermo Scientific SAVANT SPD 131 DDA) before dissolving in water and 
passing through a NAP-10 column (GE Healthcare). The samples were then characterised by 
Mass Spectrometry and analytical HPLC (Shimadzu UFLC) on a Clarity 5µ Oligo-RP 150x4.6 
mm 5 micron (Phenomenex) column.  
6.1.1.2 NHS ester coupling reaction 
Amine modified oligonucleotide was dissolved in sodium carbonate buffer (100 µL, 0.1 M). A 
5 molar excess of the thioctic acid NHS ester was added dissolved in DMSO (5 µL). The 
reaction was vortexed and heated overnight at 37°C. The reaction was then passed through 
a NAP-5 column (GE Healthcare) using TEAA buffer (0.1 M) as eluent. The modified 





6.1.1.3  RNA synthesis 
Sequences were synthesised on an Applied Biosystems 394 DNA/RNA synthesizer as per 
standard RNA oligo synthesis, using standard RNA bases (Link Technologies). The sequences 
were left on column after the synthesis; columns were then removed from the synthesiser 
and washed with 2.5 mL ammonia: ethanol (3:1) using syringes, washing through every 30 
minutes for 2 hours. The mixture was then poured into a vial, washing the column once 
more with 1 mL ammonia: ethanol (3:1). The solution was then heated for 6 hours at 55°C. 
Once cooled, the solution was dried on a rotor evaporator. The dry sample was vortexed in 
0.5 mL of TBAF (1 M in THF) and left overnight. The samples were then passed through a 
NAP-10 column (GE Healthcare) using water as eluent. The solution was then concentrated, 
375 mL of sample was placed into a 2 mL Eppendorf, to this 0.2 mL of Sodium acetate (0.1 
M) and 1.4 mL of iso-propanol were added. The mixture was centrifuged in a refrigerated 
centrifuge at 15000 rpm at 4 °C for 15 minutes. The supernatant was removed in a speed 
vac, the pellets were recombined in 1 mL water, vortexing to re-dissolve them. The samples 
were then purified by semi-prep HPLC using a Clarity 5µ Oligo-RP 150x4.6 mm column. The 
solvent was then removed and the samples passed through a NAP-10 column to desalt. The 
samples were then characterised by Mass Spectrometry and analytical HPLC on a Clarity 5µ 







6.1.1.4 Oligonucleotide purification 
 
Probe Sequence Mass Spec ES+ 
P.UM TGG ACT CTC TCA ATG 4696 [M+H]+ 
 
Analytical HPLC UV absorption at 260 nm 
Probe Sequence Mass Spec ES+ 
P.AF W-TGG ACT CTC TCA ATG 4911 [M]+ 
W = thioctic acid modification 
 
Analytical HPLC UV absorption at 260 nm 
Probe Sequence Mass Spec ES+ 
P.1L W-TGG ACT CLC TCA ATG 5008 [M]+ 
W = thioctic acid modification  L = 1L anthracene probe  
 
   Analytical HPLC UV absorption at 260 nm           Analytical HPLC λex 350 nm λem 426 nm 
168 
 
Probe Sequence Mass Spec ES+ 
P.1D W-TGG ACT CDC TCA ATG 5008 [M]+ 
W = thioctic acid modification  D = 1D anthracene probe  
            
Analytical HPLC UV absorption at 260 nm           Analytical HPLC λex 350 nm λem 426 nm 
Probe Sequence Mass Spec ES+ 
P.5L W-CAU UGA GXG AGU CCA 5065 [M]+ 
W = thioctic acid modification  X = 5L anthracene probe  
 
Analytical HPLC UV absorption at 260 nm           Analytical HPLC λex 350 nm λem 426 nm 
Probe Sequence Mass Spec ES+ 
m.P.1L W-AAAAA TGG ACT CLC TCA ATG 6573 [M-H]- 
W = thioctic acid modification  L = 1L anthracene probe  
 
Analytical HPLC UV absorption at 260 nm       
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Probe Sequence Mass Spec ES- 
l.P.1L W-AAAAA AAAAA TGG ACT CLC TCA ATG 8139 [M-H]- 
W = thioctic acid modification  L = 1L anthracene probe  
 
Analytical HPLC UV absorption at 260 nm        
Probe Sequence Mass Spec ES+ 
DNA-T.1 CAT TGA GAG AGT CCA 4601 [M+H]+ 
 
  Analytical HPLC UV absorption at 260 nm 
Probe Sequence Mass Spec ES- 
DNA-T.2 CAT TGA GAA AGT CCA 4585 [M] 
 




Probe Sequence Mass Spec ES- 
RNA-T.1 CAU UGA GAG AGU CCA 4798 [M-H]- 
 
Analytical HPLC UV absorption at 260 nm 
Probe Sequence Mass Spec ES- 
RNA-T.2 CAU UGA GAA AGU CCA  4782 [M-H]- 
 
Analytical HPLC UV absorption at 260 nm 
Probe Sequence Mass Spec ES- 
DNA-T.3 AGC TGA GAC GCG ACT 4602 [M] 
 






Probe Sequence Mass Spec ES- 
DNA-T.4 AGC TGA GCC GCG ACT 4577 [M-H]- 
 
Analytical HPLC UV absorption at 260 nm 
Probe Sequence Mass Spec ES+ 
RNA.1 Q-CAA UCA GGG UCG ACG AGA A   6458 [M] 
Q = Compound 8 modification 
 
Analytical HPLC UV absorption at 260 nm 
Probe Sequence Mass Spec ES- 
RNA.2 UUC UCG UCG ACC CUG AUU G   5952 [M] 
 
Analytical HPLC UV absorption at 260 nm 
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6.1.1.5 UV-Vis concentration 
 
Concentration of DNA strands calculated using a Shimadzu UV-1800 UV Spectrophotometer, 
placing 10 µL of sample into a UV cuvette before making up to 1000 µL with MilliQ water 
(MilliQ water as blank). Entering the sequence onto the website 
http://biophysics.idtdna.com/UVSpectrum.html allowed the absorption coefficient of the 
strand to be determined. The Beer-Lambert law is then used to calculate the concentration 
of the DNA sample using the absorption value at 260 nm. 
6.1.1.6 Duplex melting temperature 
 
A 1 µM solution of the duplex DNA was made up with 10 mM phosphate buffer (pH 7.0) and 
100 mM NaCl, the solution is thoroughly mixed using a pipette, the sample is placed in a Tm 
cuvette and made up to 1000 µL using deionised water. A sample made up of 10 mM 
phosphate buffer (pH 7.0) and 100 mM NaCl was used for blank correction. The samples 
were run on a Cary-5000 UV-Vis-NIR Spectrophotometer fitted with a Cary Temperature 
Controller. The absorption at 260 nm was monitored at a temperature range of 15°C-85°C. 
Measurements were taken every 0.5°C, with a heating rate of 0.5°C per minute, each 
temperature was held for 3 minutes before the reading is taken.  
6.1.1.7 Fluorescence spectroscopy 
 
A 1 µM solution of the duplex DNA was made up with 10 mM phosphate buffer (pH 7.0) and 
100 mM NaCl, the solution is thoroughly mixed using a pipette. For DNA-AuNP samples, 2.5 
nM AuNP sample was made up with 10 mM phosphate buffer (pH 7.0) and 100 mM NaCl, 
the solution is thoroughly mixed using a pipette. For samples run on Shimadzu RF-5301 PC 
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Spectrofluorophotometer, anthracene λex = 350 nm λem = 370-550 nm, slit widths for 
excitation were 5 nm and emission 10 nm. Each run dwell time 1.0 second, 1 nm bandwidth 
1 accumulation. For samples run on FLSP920 Times Resolved Spectrometer (Edinburgh), 
anthracene λex = 350 nm λem = 390-550 nm, slit widths for excitation 5 nm and emission 10 
nm. Each run dwell time 1.0 second, 1 nm bandwidth 1 accumulation. For the ruthenium 
probe, λex = 465 nm λem = 580-800 nm, slit widths for excitation 15 nm and emission 15 nm. 
Each run dwell time 1.0 second, 3 nm bandwidth 3 accumulations. 
6.1.1.8 Circular Dichroism 
 
9 nM AuNP sample was made up with 10 mM phosphate buffer (pH 7.0) and 100 mM NaCl, 
the solution is thoroughly mixed using a pipette. A sample made up of 10 mM phosphate 
buffer (pH 7.0) and 100 mM NaCl was used for blank correction. The samples were run on a 
JASCO J-810 Spectropolarimeter. 10 scan accumulations were made at a data pitch of 0.2 nm 
at 200 nm/min. 
6.1.2 Ion exchange for RubpySS 
 
Two spatulas (1 x 2 cm) of Dowex beads (Dowex 1 x 8 200-400 MESH Cl) were placed in a 100 
mL beaker containing 50 mL deionised H2O. The pH of the H2O was lowered to pH 5.0 using 
concentrated hydrochloric acid and allowed to stir for 1 hour before the beads are removed 
using filter paper. The Dowex beads are rediluted in MeOH (50 mL) to which the RubpySS is 
added (2 mL, 200 µM). The solution is allowed to stir vigorously for 4 hours before removing 
the Dowex beads by filtration taking care to rinse the beads with plenty of MeOH. The 
MeOH is then removed under reduced pressure. 
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In a round bottomed flask 1.84 g N-(3-Dimethylaminopropyl)-N′- ethylcarbodiimide 
hydrochloride was dissolved in anhydrous DCM (20 mL). 1.7 mL of N,N-
Diisopropylethlyamine (DIPEA) was added the reaction and the reaction was allowed to stir 
for 10 minutes. The reaction vessel was placed in an ice bath before 1.29 g of N-Hydroxy 
succinimide (NHS) was added to the mixture and allowed to stir. 1.643 g of thioctic acid was 
firstly dissolved in 10 mL of anhydrous DCM, then added to the reaction over 5 minutes. The 
reaction was then left to stir overnight at room temperature. The reaction was washed with 
HCl (aq) (5% [v/v], 50 mL) twice and then with 50 mL water. The organic layer was dried over 
Na2SO4 and then solvents concentrated in vacuo. The residue was dry loaded onto Na2SO4 
and purified by column chromatography (50% EtAc : 50% Hexane) giving the purified product 
(compound 1) as a yellow powder (0.451g, 1.49 mmol, 19%). 
Rf = 0.57 in EtAc: Hexane 50:50; 1HNMR (300 MHz, DMSO) δ 3.56–3.65 (1H, m, H3),  3.12–3.21 (2H, 
m, H1), 2.81 (4H, s, H10), 2.69 (2H, t, J 7.1, H7), 2.38–2.46 (1H, m, H2), 1.84–1.93 (1H, m, H2), 1.4–1.7 
(6H, m, H4 H5 H6); 
13CNMR (100 MHz, DMSO) δ 170.2 (2 x C9), 168.9 (C8), 55.9 (C3), 40.1 (C2), 38.1 (C1), 
33.8 (C4), 30.0 (C7), 27.6 (C5), 25.4 (2 x C10), 24.0 (C6),  





6.1.4 Anthracene probe synthesis 
6.1.4.1 Synthesis of acetate (Compound 2) 
 
 
In a round bottomed flask anthrone (5.83 g) and K2CO3 (4.15 g) were dissolved in degassed 
acetone (200 mL) and stirred for 15 minutes in the dark. Ethyl Bromoacetae (3.3 mL) was 
then syringed into the flask and the reaction refluxed under N2 overnight in the dark. The 
solution was filtered to remove the K2CO3 and the solvent removed in vacuo. The solid was 
re-dissolved in DCM (100 mL) and washed with water (50 mL) before drying with MgSO4. The 
solvent was removed by reduced pressure and the solid (compound 2) purified by column 
chromatography (10% hexane: DCM) giving a yellow solid (1.91 g, 23%). 
Rf = 0.54 in 10% hexane: DCM; 1HNMR (300 MHz, CDCl3) δ  8.23 (2H, d, J 8.5, H7), 8.09 (1H, s, H12), 
7.84 (2H, d, J 8.1, H10), 7.28-7.44 (4H, m, H8 H9), 4.66 (2H, s, H4), 4.24 (2H, q, J 7.1, H2), 1.23 (3H, t, J 
7.1, H1);  








6.1.4.2 Synthesis of Carboxylic acid (Compound 3) 
 
 
In a round bottomed flask, 1 g of 2-(anthracen-9-yloxy) acetate was dissolved in 10% NaOH 
in EtOH 1:1 (200 mL), this was refluxed overnight in the absence of light under N2. The EtOH 
was removed in vacuo and water was added (400 mL), conc HCl was then added dropwise 
whilst swirling the solution until a creamy precipitate appears and does not disappear upon 
mixing, to give a cream solid (800 mg, 89%).  
1HNMR (300 MHz, CDCl3) δ 8.34 (1H, s, H10), 8.31 (2H, d, J 8.3, 2 x H5), 8.06 (2H, d, J 8.0, 2 x H8), 7.49-
7.60 (4H, m, 2 x H6,H7), 4.91 (2H, s, H2); 
13CNMR (100 MHz, CDCl2) 172.1 (C1), 149.5 (C3), 132.6 (2 x C9), 
128.9 (2 x C8), 127.2 (2 x C6), 126.1 (2 x C7), 125.7 (2 x C6), 123.6 (C10), 121.6 (2 x C5), 71.2 (C2); 







6.1.4.3 Synthesis with L-threoninol (Compound 4) 
 
 
In a round bottomed flask the 2-(anthracen-9-ylox) acetic acid (300 mg) was dissolved in dry 
DMF (20 mL) under inert conditions. 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HBTU) (0.455 g) was added and the solution stirred for 15 minutes in 
the dark. L-threoninol (0.126 g) and DIPEA (0.21 mL) were added and the solution stirred at 
40°C for 40 hours. The solvent was removed in vacuo the product was then purified by 
column chromatography (5% MeOH: DCM) giving a pale yellow solid (203 mg, 49%).  
Rf = 0.27 in DCM : 5% MeOH; 1HNMR (300 MHz, CDCl3) δ 8.38 (1H, s, H15), 8.30-8.35 (2H, m, H10),  
8.06-8.11 (2H, dd J 8.4 & 2.0, H13), 7.49-7.60 (4H, m, H11 ,H12), 4.74 (2H, d, J 5.8, H7), 4.15-4.23 (1H, m, 
H2), 4.07-4.14 (1H, m, H3), 3.83 (2H, m, H4), 1.35 (3H, d, J 6.4, H1); 
13CNMR (100 MHz, CDCl3) δ  132.1 
(C14), 128.3 (C13), 125.7 (C11), 125.3 (C12), 124.0 (C9), 122.9 (C15), 121.1 (C10), 73.2 (C7), 65.6 (C2), 61.6 
(C4), 55.8 (C3), 19.3 (C1); 








6.1.4.4 DMT protection of primary alcohol (Compound 5) 
 
 
In a round bottomed flask 2-(anthracen-9-yloxy)-N-((2S,3S)-1,3-dihydroxybutan-2-
yl)acetamide (200 mg) was dissolved in pyridine (30 mL) under an inert atmosphere. To this 
4,4’-Dimethoxytrityl chloride (0.20 g) and 4-(Dimethylamino)pyridine (0.01g) were added 
and the solution was stirred for 24 hours under N2. The solvent was removed under reduced 
pressure and the product was then purified by column chromatography (EtAc: Hexane: TEA, 
49: 50: 1) giving a yellow crystalline solid (151 mg, 43%). 
Rf ; 0.52; 1HNMR (300 MHz, CD3CN) δ 8.21 (1H, s, H15), 8.12 (2H, d, J 8.3, H10), 7.91 (2H, d, J 8.3, H13), 
7.48 (1H, d, J 9.0, H5), 7.32-7.42 (4H, m, H12 H23) 7.24-7.31 (6H, m, H11 H18) 7.17 (2H, m, H24) 7.06-7.12 
(1H, m, H25), 6.71 (4H, d, J 8.9, H19), 4.57 (2H, s, H7), 3.98-4.13 (2H, m, H3, H2), 3.59 (6H, s, H21), 3.06-
3.29 (2H, m, H4), 1.10 (3H, d, J 6.3, H1);  
13CNMR (100 MHz, CD3CN) δ 168.8 (C6), 159.2 (C20), 149.7 
(C8), 145.8 (C22), 136.7 (C17), 132.8 (C14), 130.5 (C18), 129.1 (C13), 128.6 (C23), 128.4 (C24), 127.4 (C25), 
126.5 (C11), 126.3 (C12), 124.7 (C9), 123.7 (C15), 122.1 (C10), 113.6 (C19), 86.5 (C16), 74.3 (C7), 66.7 (C2), 
63.9 (C4), 55.4 (C21), 54.9 (C3), 20.4 (C1);  








In a round bottomed flask, the DMT protected 2-(anthracen-9-yloxy)-N-((2S,3S)-1,3-
dihydroxybutan-2-yl)acetamide (100 mg) was dissolved in dry DCM (5 mL) under an inert 
atmosphere. To this DIPEA (0.22 mL) was added. (i-Pr2N)PClO(CH2)2CN (0.054 mL) was added 
dropwise to the reaction mixture, the reaction was then left to stir for 2 hours. Once the 
reaction was complete, degassed ethyl acetate (5 mL) was added, the solution was then 
washed with degassed Na2CO3 (2M, 2 x 50 mL) then degassed brine (50 mL) before being 
dried over Na2SO4. The solution was filtered and dried under reduced pressure before being 
purified by column chromatography on activated alumina (EtAc: Hexane: TEA, 50:49:1) the 
compound was then bottled up and placed under argon until used on the DNA synthesiser 
(88 mg, 73%) 
Rf ; 0.85; 1HNMR (300 MHz, DMSO) δ 8.28 (1H, s, H15) 8.13 (2H, d, J 8.7, H10) 7.98 (2H, d, J 8.2, H13) 
7.35-7.48 (5H, m, H5 H12 H23) 7.26-7.37 (6H, m, H11 H18) 7.09-7.26 (3H, m, H24 H25) 6.72-6.80 (4H, m, 
H19) 4.61 (2H, s, H7) 4.15-4.37 (2H, m, H3 H2) 3.63 (6H, s, H21) 3.40-3.81 (4H, m, H26 H29) 3.27-3.38 (2H, 
m, H4) 2.47-2.61 (2H, m, H27) 1.09 (3H, d, J 3.1, H1) 0.92 (12H, dd, J 20.0,7.29, H30); 
31PNMR (120 MHz, 
MeCN)  δ 146.1; 
180 
 
6.1.5 Thioctic acid phosphoramidite synthesis 




In a round bottomed flask, thioctic acid (0.71 g) and HOBt (0.46 g) were dissolved in dry DMF 
(10 mL) and stirred over ice. To this, EDC.HCl (0.66 g) was added and the mixture was stirred 
for 1 hour, still over ice. The solution was allowed to warm to room temperature for 1 hour. 
In a separate flask, 4-ethylmorpholine (0.39 g) and 2-aminoethan-1-ol (0.15 g) was dissolved 
in dry DMF (5 mL), this was then added to the thioctic acid containing solution and then 
allowed to stir overnight. The solution was washed with DCM: H2O, the DCM was then 
removed under reduced pressure. The product was purified by column chromatography on 
silica (5% MeOH, CHCl3) giving the product as a yellow solid (455 mg, 73%). 
Rf = 0.41 in CHCl3: 5% MeOH; 
1HNMR (300 MHz, CDCl3) δ 6.57 (1H, s, H9), 3.58-3.77 (2H, m, H11), 3.45-
3.56 (1H, m, H3), 3.28-3.40 (2H, m, H10), 3.20-2.97 (2H, m, H1), 2.40 (1H, dq, J 12.6, 6.1, H2a), 2.16 (2H, 
t, J 7.3, H7), 1.85 (1H, dq, J 13.2, 6.7, H8b), 1.52-1.72 (4H, m, H4 H6), 1.33-1.45 (2H, m, H5); 
13CNMR 
(100 MHz, CDCl3) δ 174.2 (C8), 61.9 (C11), 56.4 (C3), 42.4 (C10), 40.3 (C2), 38.5 (C1), 36.3 (C7), 34.6 (C4), 
28.9 (C5), 25.4 (C6);  





6.1.5.2 2-(5-(1,2-dithiolan-3-yl)pentanamido)ethyl (2-cyanoethyl) 




In a round bottomed flask, the 5-(1,2-dithiolan-3-yl)-N-(2-hydroxyethyl)pentanamide (125 
mg) was dissolved in dry DCM (5 mL) under an inert atmosphere. To this DIPEA (0.716 mL) 
was added. (i-Pr2N)PClO(CH2)2CN (0.314 mL) was added dropwise to the reaction mixture, 
the reaction was then left to stir for 2 hours. Once the reaction was complete, degassed EtAc 
(5 mL) was added, the solution was then washed with degassed Na2CO3 (2 M, 2 x 50 mL) 
then degassed brine (50 mL) before being dried over Na2SO4. The solution was filtered and 
dried under reduced pressure before being purified by column chromatography on activated 
alumina (EtAc: Hexane: TEA, 50:49:1) giving a yield of 75%. 
Rf ; 0.9; 1HNMR (300 MHz, CD3CN) δ 3.44-3.90 (7H, m, H3 H11 H12 H14) 3.34-3.44 (2H, m, H10) 2.99-3.17 
(2H, m, H1) 2.60 (2H, t, J 6.2, H15) 2.40 (1H, dtd, J 12.9,6.6,5.5, H2) 2.13 (2H, t, J 7.5, H7) 1.84 (1H, dq, J 
12.7,7.0, H2) 1.5-1.73 (4H, m, H4 H6) 1.33-1.47 (2H, m, H5) 1.12 (12H, dd, J 6.9,4.6, H13); 
13CNMR (100 
MHz, CD3CN) 173.0 (C8), 117.8 (C16), 62.5 (C11), 58.9 (C14), 56.9 (C3), 54.6 (C7), 43.3 (C12), 40.6 (C10), 
38.8(C2), 36.1(C1), 34.8(C4), 29.0(C5), 25.6(C6), 24.6 (C13), 20.4 (C15); 
31PNMR (120 MHz, CD3CN)  δ 
148.0; 
TOF-MS-ES+ [M+H]+ 450, [M+Na]+ 472.  
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6.2 Gold Nanoparticle synthesis 
6.2.1 13 nm gold nanoparticles  
 
All glassware was soaked in aqua regia for at least 30 minutes prior to reaction, the 
glassware was then rinsed 10 times with deionised water and placed in an oven prior to use. 
In a 250 mL round bottomed flask fitted with a condenser, 100 mL of 2.75 mM citrate buffer 
(75:25 sodium citrate: citric acid) was heated until boiling, ensuring a vortex is formed by the 
vigorous stirring. After 15 minutes of boiling, 1.6 mg of Ethylenediaminetetraacetic acid 
(EDTA) was added to the solution. In a separate flask, 25 mL of HAuCl4.3H2O (Sigma Aldrich) 
(8.5 mg) is placed in an oven to heat until 90°C. The solution of gold was then added rapidly 
to the centre of the vortex of the citrate buffer solution and allowed to boil for 20 minutes. 
After 20 minutes the heat is turned off, and the solution is allowed to cool to room 
temperature still with vigorous stirring.  
SPR = 519 nm, number distribution = 12 nm (± 3 nm), intensity distribution = 21 nm (± 6 nm)  
6.2.2 100 nm gold nanoparticles  
 
The larger particles are grown by the particle seeding method starting with 13 nm particles, 
which are synthesised as described above (6.2.1). Initially stock solutions of the reactants 
were made up as: 5 mM HAuCl4.H2O (100 mg in 50 mL deionised H2O), 57 mM ascorbic acid 






25 nm gold nanoparticles 
A solution of 30 mL 13 nm AuNP (2 nM) was diluted to 40 mL with deionised water in a 250 
mL three necked round bottomed flask. The solution was vigorously stirred. Two solutions 
were then made up using the stock solutions, solution A = 1 mM HAuCl4.H2O (20 mL) 
solution B = 2.85 mM ascorbic acid and 1.7 mM trisodium citrate dehydrate (20 mL). 
Solution A and B were then added to the AuNP solution using a peristaltic pump over 45 
mins. Once added, the AuNP solution was refluxed for 30 minutes and allowed to cool to 
room temperature.  
Number distribution =22 nm (± 5 nm), intensity distribution = 31 nm (± 8 nm) 
50 nm gold nanoparticles 
A solution of 9 mL 25 nm AuNP (0.7 nM) was diluted to 40 mL with deionised water in a 250 
mL three necked round bottomed flask. The solution was vigorously stirred. Two solutions 
were then made up using the stock solutions, solution A = 1 mM HAuCl4.H2O (20 mL) 
solution B = 2.85 mM ascorbic acid and 1.7 mM trisodium citrate dehydrate (20 mL). 
Solution A and B were then added to the AuNP solution using a peristaltic pump over 45 
mins. Once added, the AuNP solution was refluxed for 30 minutes and allowed to cool to 
room temperature, the solution was neutralised with 0.01 M NaOH. 
Number distribution = 38 nm (± 9 nm), intensity distribution = 56 nm (± 16 nm) 
100 nm gold nanoparticles  
A solution of 40 mL 50 nm AuNP (80 pM) was placed in a 250 mL three necked round 
bottomed flask. The solution was vigorously stirred. Two solutions were then made up using 
the stock solutions, solution A = 4 mM HAuCl4.H2O (20 mL) solution B = 11.4 mM ascorbic 
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acid and 3.4 mM trisodium citrate dehydrate (20 mL). Solution A and B were then added to 
the AuNP solution using a peristaltic pump over 45 mins. Once added, the AuNP solution was 
refluxed for 30 minutes and allowed to cool to room temperature. 
SPR = 561 nm, number distribution = 68 nm (± 20 nm), intensity distribution = 105 nm (± 32 
nm) (100%) 
6.2.3 Characterising AuNP 
6.2.3.1 Inductively Coupled Plasma Mass Spectrometry 
The DNA/ruthenium coated AuNP were synthesised and purified. 3 mL of 1 nM coated AuNP 
was dissolved using 5% aqua regia. These samples were sent to Warwick University to be 
analysed by ICP-MS by Professor Lijiang Song.  
6.2.3.2 Sizing 
1 mL of 2 nM AuNP sample is placed into a disposable DT50012 cuvette (SARSTEDT) before 
sizing the particles on a Zetasizer NANO (Malvern). Each sample was run 12 times, repeating 
this 3 times and taking an average of the value. 
6.2.3.3 Zeta Potential 
800 µL of 2 nM AuNP sample is injected into a disposable DTS 1070 cuvette (Malvern) using 
a 1 mL syringe. The samples were then run on a Zetasizer NANO (Malvern). Each sample was 
run 30 times, repeating this 10 times and taking an average value.  
6.2.3.4 Transmission Electron Microscopy 
Using tweezers to hold the copper grid (3 mm, FORMVAR) in a clean and safe area, 20 µL of 
2 nM sample of AuNP is pippeted onto the grid. The sample is left to settle for 20 minutes, 
after 20 minutes wick away excess using filter paper. The samples were then imaged using a 
JEOL 1200 Transmission Electron Microscope. Coated AuNP procedure 
185 
 
6.2.4 Coating AuNP procedures 
6.2.4.1 Coating 13 nm AuNP with DNA 
In an Eppendorf containing a magnetic stirrer, citrate coated AuNPs (13 nm, 3 nM) are made 
up in 10 mM pH 7.0 phosphate buffer. Thioctic acid modified DNA (0.99 µM) is added to the 
AuNPs and stirred for 2 minutes before the solution is sonicated for 20 seconds. The UV-vis 
spectrum of the particles is taken prior to purification. This process is repeated a further two 
times giving a final DNA concentration of 2.97 µM. The particles are passed through a 
Sephadex G-50 column (stored in 20% ethanol) with deionised water as eluent. A final UV-vis 
spectrum is taken to confirm concentration (explained in 7.1.3), histogram sizing data in 7.5. 







Citrate AuNP 519 12 (± 3) 21 (± 6) 100% -35 (± 10) 100% 
P.UM-AuNP 520 13 (± 4) 48 (± 34) 96% -32 (± 10) 57% 
+7 (± 8) 42% 
P.AF-AuNP 522 14 (± 4) 48 (± 32) 96% -37 (± 12) 97% 
P.1L-AuNP 522 14 (± 4) 34 (± 17) 96% -23 (± 8) 99% 
P.1D-AuNP 522 14 (± 4) 30 (± 11) 96% -26 (± 7) 96% 
m.P.1L-AuNP 522 14 (± 3) 24 (± 12) 95% -37 (± 6) 96% 
l.P.1L-AuNP 522 15 (± 4) 39 (± 21) 97%  -32 (± 8) 97% 
P.5L-AuNP 522 15 (± 4) 32 (± 16) 97% _ 
 
6.2.4.2 Coating 13 nm AuNP with DNA and RubpySS  
In an Eppendorf containing a magnetic stirrer, citrate coated AuNPs (13 nm, 3 nM) are made 
up in 10 mM pH 7.0 phosphate buffer. Thioctic acid modified DNA (0.33 µM) is added to the 
AuNPs and stirred for 2 minutes before the solution is sonicated for 20 seconds. This process 
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is repeated a further two times giving a final DNA concentration of 0.98 µM. RubpySS (1.5 
µM) probe is added to the particles and allowed to stir for 20 minutes. This process is 
repeated, giving a final RubpySS concentration of 3 µM. The particles are passed through a 
Sephadex G-50 column (stored in 20% ethanol) with deionised water as eluent. A final UV-vis 
spectrum is taken to confirm concentration (explained in 7.1.3), histogram sizing data in 7.5. 





P.AF-AuNP-Ru 524 14 (± 4) 40 (± 19) 97% 
P.1L-AuNP-Ru 524 14 (± 4) 34 (± 17) 96% 
P.1D-AuNP-Ru 524 14 (± 4) 23 (± 9) 87% 
286 (± 97) 10% 
l.P.1L-AuNP-Ru 524 16 (± 5) 36 (± 6) 96% 
P.5L-AuNP-Ru 524 15 (± 4) 35 (± 16) 96% 
 
6.2.4.3 Coating 100 nm AuNP with P.1L  
In an Eppendorf containing a magnetic stirrer, citrate coated AuNPs (100 nm, 40 pM) are 
made up in 10 mM pH 7.0 phosphate buffer. P.1L (0.73 µM) is added to the AuNPs and 
stirred for 2 minutes before the solution is sonicated for 20 seconds. The UV-vis spectrum of 
the particles is taken prior to purification. This process is repeated a further two times giving 
a final DNA concentration of 2.23 µM. The particles are then spun down to form a pellet at 
13000 rpm for 90 seconds. The supernatant is removed, with care taken to not disturb the 
pellet. The particles are re-dispersed in deionised water. 
SPR = 564 nm, number distribution = 69 nm ± 21 nm, intensity distribution = 105 nm ± 34 nm 
(100%), histogram sizing data in 7.5. 
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6.2.4.4 Coating 100 nm AuNP with P.1L and RubpySS 
In an Eppendorf containing a magnetic stirrer, citrate coated AuNPs (100 nm, 40 pM) are 
made up in 10 mM pH 7.0 phosphate buffer. P.1L (0.25 µM) is added to the AuNPs and 
stirred for 2 minutes before the solution is sonicated for 20 seconds. This process is repeated 
a further two times giving a final DNA concentration of 0.75 µM. RubpySS (1.13 µM) probe is 
added to the particles and allowed to stir for 20 minutes. This process is repeated, giving a 
final RubpySS concentration of 2.3 µM. The particles are then spun down to form a pellet at 
13000 rpm for 90 seconds. The supernatant is removed, with care taken to not disturb the 
pellet. The particles are re-dispersed in deionised water. 
SPR = 565 nm, number distribution = 73 nm ± 26 nm, intensity distribution = 106 ± 38 nm, 
histogram sizing data in 7.5.  
6.2.4.5 Coating 13 nm AuNP with siRNA  
In an Eppendorf containing a magnetic stirrer, citrate coated AuNPs (13 nm, 3 nM) are made 
up in 10 mM pH 7.0 phosphate buffer. siRNA.1 (0.99 µM) is added to the AuNPs and stirred 
for 2 minutes before the solution is sonicated for 20 seconds. The UV-vis spectrum of the 
particles is taken prior to purification. This process is repeated a further two times giving a 
final RNA concentration of 2.97 µM. The particles are passed through a Sephadex G-50 
column (stored in 20% ethanol) with deionised water as eluent. A final UV-vis spectrum is 
taken to confirm concentration (explained in 7.1.3). The particles are made up in 10 mM pH 
7.0 phosphate buffer and 100 mM NaCl. To this solution RNA.2 (1.2 µM) is added. 
SPR = 522 nm, number distribution = 14 nm ± 3 nm, intensity distribution = 28 nm ± 17 nm, 
histogram sizing data in 7.5. 
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6.2.4.6 Coating 13 nm AuNP with siRNA and RubpySS 
In an Eppendorf containing a magnetic stirrer, citrate coated AuNPs (13 nm, 3 nM) are made 
up in 10 mM pH 7.0 phosphate buffer. RNA.1 (0.33 µM) is added to the AuNPs and stirred 
for 2 minutes before the solution is sonicated for 20 seconds. The UV-vis spectrum of the 
particles is taken prior to purification. This process is repeated a further two times giving a 
final RNA.1 concentration of 0.98 µM. RubpySS (1.5 µM) is added to the particles and stirred 
for 20 minutes. This process is repeated, giving a final RubpySS concentration of 3 µM. The 
particles are passed through a Sephadex G-50 column with deionised water as eluent. A final 
UV-vis spectrum is taken to confirm concentration (7.1.3). The particles are made up in 10 
mM pH 7.0 phosphate buffer and 100 mM NaCl, to this RNA.2 (0.4 µM) is added. 
SPR = 524 nm, number distribution = 15 nm ± 3 nm, intensity distribution = 30 nm ± 15 nm, 
histogram sizing data in 7.5.   
6.2.4.7 Coating 100 nm AuNP with siRNA 
In an Eppendorf containing a magnetic stirrer, citrate coated AuNPs (100 nm, 40 pM) are 
made up in 10 mM pH 7.0 phosphate buffer. RNA.1 (0.73 µM) is added to the AuNPs and 
stirred for 2 minutes before the solution is sonicated for 20 seconds. The UV-vis spectrum of 
the particles is taken prior to purification. This process is repeated a further two times giving 
a final RNA.1 concentration of 2.23 µM. The particles are then spun down to form a pellet at 
13000 rpm for 90 seconds. The supernatant is removed, with care taken to not disturb the 
pellet. The particles are re-dispersed in deionised water, before making up in 10 mM pH 7.0 
phosphate buffer and 100 mM NaCl. To this solution RNA.2 (0.9 µM) is added. 
SPR = 526 nm, number distribution = 71 nm (± 19 nm), intensity distribution = 159 nm (± 74 
nm), histogram sizing data in 7.5. 
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6.3 Biological Techniques 
6.3.1 Reagents 
6.3.1.1 Medium 199 
To a bottle of Medium 199 (450 mL, GE Healthcare) was added Foetal Bovine Serum (50 mL, 
Gibco), Penicillin Streptomycin (2 mL, Gibco), L-glutamine (2 mM, Gibco), Heparin (1 mL) and 
brain extract (0.5 mL). The solution was mixed before passing through a filter (0.22 µm, 
Corning incorporated) into an autoclaved bottle. This solution was kept refrigerated and 
used within 6 months.  
6.3.1.2 Dulbecco’s Modified Eagle’s Medium 
To a bottle of Dulbecco’s Modified Eagle’s Medium (450 mL, Sigma life sciences) was added 
Foetal Bovine Serum (50 mL), Penicillin Streptomycin (2 mL) and L-glutamine (2mM). The 
solution was mixed before passing through a filter (0.22 µm) into an autoclaved bottle. This 
solution was kept refrigerated and used within 6 months.   
6.3.1.3 Phosphate Buffered Saline (PBS) 
For 1L 2.5 x PBS tablets (Sigma) dissolved in deionised water with vigorous stirring. The 
solution is then autoclaved. 
6.3.1.4 0.1% Gelatin solution 
0.1% gelatin (Fluka) by weight of gelatin in PBS, the solution is then autoclaved before use. 
6.3.1.5 Radioimmunoprecipitation assay RIPA buffer 
1:1 NP40 lysis buffer (2x conc): deionised water plus 1 % protease inhibitor. 
6.3.1.6 Loading buffer 
For 100 mL of 2x loading buffer (non-reducing): 5 mL 1 M Tris pH 7.0, 25 mL 20% SDS, 20 mL 
glycerol, 2 mg bromophenol blue, bring up the volume to 100 mL with deionised water. 
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6.3.1.7 Running buffer 
For a 10 x solution: 30.2 g of Tris Base (Sigma), 187.6 g of glycine (Promega), 50 mL of 20% 
sodium dodecyl sulphate (SDS) top up solution to 1 L with deionised water.  
6.3.1.8 Transfer buffer 
For a 10 x solution: 30.2 g Tris Base, 144 g glycine, make up the solution to 1L with deionised 
water. 
6.3.1.9 Phosphate Buffer Saline Tween-20 (PBS-T) 
To 1 L of PBS solution add 0.1% by volume of Tween-20 (Sigma) with vigorous stirring. 
6.3.1.10 10 % SDS Page gel 
Resolving gel 
4 mL deionised water, 3.3 mL Protogel (Geneflow), 2.6 mL Resolving buffer (1.5 M Tris base, 
0.4% SDS, pH 8.8), 100 µL 10% Ammonium Persulfate (APS) (Sigma) mixed together in a 
falcon tube. 10 µL of tetramethylethylenediamine (TEMED) (Sigma) is added to the mixture 
and stirred, then the mixture is quickly poured into a gel cassette until ¾ full before adding a 
small amount of EtOH on top to ensure a flat top. The gel is allowed to set for 10 minutes. 
Stacker gel 
The excess ethanol is poured off the gel. 2.1 mL deionised water, 500 µL Protogel, 380 µL 
Stacking buffer (0.5 M Tris base, 0.4% SDS, pH 6.8), 30 µL 10% APS mixed together in a falcon 
tube. 3 µL of TEMED is added to the mixture and stirred, before quickly pouring the mixture 
on top of the set resolving gel, well combs are pushed into the top of the cassette and the 
gel allowed to set for 10 minutes. The gel is either used immediately or wrapped in damp 
tissue and clingfilm and kept at 4°C for up to 2 months. 
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6.3.2 Cell Splitting 
 
Assuming working with 10 cm petri dish of cells, the media was removed and the cells 
washed with Phosphate Buffer Saline twice. The cells were then treated with tripsin (1.5 mL, 
2x conc, (Gibco), after swirling the mixture to ensure it has covered all cells the dish is left for 
10 minutes. After 10 minutes the dish is firmly tapped on the side to dislodge the cells, 
media (4.5 mL) is then added to the cells and the solution is pipetted up and down 
vigorously a number of times. The solution is pipetted into a 15 mL falcon tube and 
centrifuged at 1200 rpm for 5 minutes. The supernatant is removed; the pellet is then re-
suspended in media with vigorous pipetting to break up the cells. 10 µL of the cell containing 
media is pipetted into a haemocytometer and the cells counted in each 4x4 grid and 
averaged to give a number of cells per 4x4 grid. Multiplying this value by 106 gives the 
number of cells present per mL, the required number of cells can then be seeded.   
6.3.3 Imaging cells 
Cells were plated onto 2.5 cm glass cover slips. Once treatment completed, the cells were 
washed 3 times with PBS. The cells were then covered with 4% paraformaldehyde (PFA) for 
10 minutes, upon which the PFA is removed and the cells washed with PBS and then water. 
The cover slip containing the cells is then mounted onto the glass slide using Hydromount 
media (national diagnostics) before sealing the edges with clear nail varnish. The slides could 
be imaged after letting them dry at 4°C for 2 hours. Reflectance microscopy was done on a 
Leica SP2 inverted confocal microscope using a 100 x objective lens. λex = 488 nm λem = 478-




6.3.4 Freezing / Defrosting cells 
 
Assuming working with 10 cm petri dish of cells, the media was removed and the cells 
washed with Phosphate Buffer Saline twice. The cells were then treated with tripsin (1.5 mL, 
2x conc, after swirling the mixture to ensure it has covered all cells the dish is left for 10 
minutes. After 10 minutes the dish is firmly tapped on the side to dislodge the cells, media 
(4.5 mL) is then added to the cells and the solution is pipetted up and down vigorously a 
number of times. The solution is pipetted into a 15 mL falcon tube and centrifuged at 1200 
rpm for 5 minutes. The supernatant is removed and the cells re-dispersed with a solution of 
90% Foetal calf serum (FCS) and 10% DMSO (3 mL), the cells are placed into CRYO.S tubes 
(Greiner bio-one) then clearly labelled and placed in a -80°C freezer.  
To bring out cells from the freezer, they are removed from the freezer and quickly defrosted 
by rubbing in hands. The solution is placed into a 15 mL Falcon tube and media added to this 
(4 mL), the cells are then centrifuged at 1200 rpm for 5 minutes, before removing the 
supernatant and re-dispersing in media (5 mL). The cells are then plated in a 10 cm plate, 
when they are confluent, they can be split and used for assays. 
6.4 HUVEC isolation from umbilical chord 
 
In a sterile fume hood, a metal dissection tray was lined with tissue and sprayed with 70% 
EtOH. Taking care, the cord was placed onto the dissection tray (6 inches of cord = cells for 1 
T25 plate). The outside of the cord was wiped with tissue and examined for damage; any 
damaged areas were removed by cutting the cord cleanly at a right angle to the length of the 
cord. The cord was sprayed with 70% EtOH. The vein was identified at one end of the cord; 
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into this a sterile balloon canula was inserted, ensuring that the canula was inserted far 
enough so it was secure. The cord was attached to the canula tube using cable ties. PBS was 
then injected into the cord pushing through any clots out of the other end. Enough PBS was 
passed through until it came out clear, at least 20 mL was used. The cord was then flushed 
with 20 mL of air. The other end of the cord was then cannulated as stated above. Clamps 
were then attached to both ends but left open initially. A syringe filled with collagenase 1A 
(0.1 mg/mL) in M199 media (serum free) is attached to one end of the cord, and passed 
through until it filled the large balloon in the canula at the far end of the cord (the cord 
should be tilted upward to avoid any bubbles being trapped inside). The far end of the cord 
is clamped, before clamping the end near the syringe.  The cord was then placed in an 
autoclave bag and incubated for 20 minutes at 37°C. Whilst waiting, the metal dissection 
tray should be cleaned and tissue replaced before again spraying with 70% EtOH.  
The cord was carefully tipped out of the bag onto the newly cleaned tray ensuring the cable 
ties remain tight.  PBS (20 mL) was passed through the cord collecting the contents in a 50 
mL Falcon tube, then 20 mL of air was flushed though before another 10 mL of PBS finishing 
with a further 20 mL of PBS. Throughout flushing the cord, the syringe is held highest and 
the cord is tilted downwards towards the 50 mL Falcon tube.  
The cells were spun down in the Falcon tube at 1200 rpm for 6 minutes. The supernatant 
was aspirated before re-dispersing the cells in M199 media. The cells were then plated onto 
a gelatin coated T25 flask; the media was changed after 2 hours and then again after a 




6.5 Western Blot 
6.5.1 siRNA transfection of HUVEC in 6 well plate 
175000 HUVEC were plated onto a gelatin coated 6 well plate and allowed to grow 
overnight. After 24 hours, the cells were treated with siRNA duplexes. The siRNA duplexes 
(2.5 µL of 20 µM) were mixed with 167 µL of Opti-MEM™ (Gibco). In a separate Eppendorf, 3 
µL of RNAiMAX lipofectamine (Invitrogen) is mixed with 27 µL of Opti-MEM™. Both of these 
mixtures were kept at room temperature for 10 minutes after which the RNAiMAX 
containing mixture was added to the other and incubated for 10 minutes at room 
temperature. The seeded cells were washed with PBS (2x). 800 µL of Opti-MEM™ is added to 
the cells before adding the 200 µL mix containing the siRNA duplex. The cells are incubated 
at 37 °C for 4 hours; the Opti-MEM™ is then removed and replaced with antibiotic free 
medium. The cells were then left for 48 hours in an incubator before performing the 
Western Blot assay. 
6.5.2 AuNP-siRNA addition to HUVEC in 6 well plate 
 
175000 HUVEC were plated onto a gelatin coated 6 well plate and allowed to grow 
overnight. After 24 hours, the cells were treated with siRNA duplexes. The siRNA-AuNP 
duplexes (100 µL of 2.5 nM) were mixed with 100 µL of Opti-MEM™ and kept at room 
temperature for 10 minutes. The seeded cells were washed with PBS (2x), then 800 µL of 
Opti-MEM™ is added to the cells before adding the 200 µL siRNA-AuNP containing mix. The 
cells are incubated at 37 °C for 4 hours; the Opti-MEM™ is aspirated off and replaced with 




6.5.3 Developing Western Blot   
The supernatant was removed from the cells and the cells washed with PBS. The cells were 
then removed from the plate using a cell scraper and 100 mL PBS. The cells were spun down 
for 2 minutes at 13000 rpm and the supernatant was removed. The cells were re-dispersed 
in 50 µL of RIPA buffer (6.3.1.5) passing through a 50 µL needle (Terumo) to break up the 
cells. The cell/RIPA mixture was left on ice for 30 minutes. The cell/RIPA solution was then 
spun at 14000 rpm for 15 minutes at 4 °C in a refrigerated centrifuge. The supernatant was 
removed and kept; this supernatant could then be stored at -80 °C before being used in the 
next step. 
Loading buffer (6.3.1.6) was added to the cell lysate and boiled for 2 minutes before being 
loaded to the gel. The samples were run on a 10 % SDS page gel (6.3.1.10Error! Reference 
ource not found.) using running buffer (6.3.1.7) to run the gel. The gel was run at 80 volts 
for 1 hour, then 140 volts for another hour. 
The transfer membrane and all foam layers were soaked in transfer buffer (6.3.1.8) and 
loaded into the transfer module with the gel. The transfer module was filled with transfer 
buffer and run for 2 hours at 30 mV in a cold room.  
The membrane is removed from the transfer module and washed 3 times with PBS-T for 5 
minutes. The membrane is then blocked in a 10 % milk PBS-T solution for 2 hours. After 
washing the membrane again with PBS-T (3 x 5 minutes), the membrane is cut at a known 
position so that each protein of interest (CLEC-14A and Tubulin) can be treated with its own 
specific antibody. Each half of membrane is then treated with its own primary antibody for 2 
hours, washed 5 x 5 minutes PBS-T, and treated with the secondary antibody for a further 2 
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hours. For CLEC-14A an anti-sheep primary antibody was used (Anti-CLEC14A, R & D 
Systems) at a dilution of 1 in 1000, followed by horseradish peroxidase (HRP) tagged anti 
sheep (Antisheep IgG HRP, R & D Systems) secondary antibody at a dilution of 1 in 5000. For 
Tubulin an anti-mouse primary antibody (Anti-Tubulin Mouse, Sigma) was used at a dilution 
of 1 in 2000, followed by HRP tagged anti mouse (Polyclonal Goat anti mouse 
Immunoglobulins HRP, Dako), at a dilution of 1 in 5000. After treating with the secondary 
antibody, the membranes are washed 5 x 5 minutes with PBS-T.  
The membranes were soaked in a 1:1 mixture of Detection reagent 1 and 2 (GE Healthcare) 
for 30 seconds on each side of the membrane; excess solution was wicked off using a paper 
towel. The membranes were then developed using Amersham Hyperfilm™ ECL (GE 












































7.1 Chapter 3 
7.1.1 Calculating the concentration of 13 nm gold nanoparticles  
 
Original Turkevich method 
 
Mass of HAuCl4 (49 % Au by assay) = 0.09889 g 
Mass of Au = 0.49 × 0.09889 = 0.04846 g 
Moles of Au = 0.04846 / 197 = 2.4597 × 10-4 moles 
Concentration of Au = 2.4597 × 10-4 moles / 0.275 dm3 = 8.944 × 10-4 M. 
Estimated atomic radius of gold = 140 pm 
Number of gold atoms per 13 nm nanoparticle = (6.5 × 10-9)3 / (140 × 10-12)3 = 106,802 
(assuming the particles are perfectly spherical). 
Concentration of 13 nm gold nanoparticles = 8.944 × 10-4 M / 100,000 = 8.944 nm ≈ 9 nM. 
Improved Turkevitch method 
Mass of HAuCl4 (49 % Au by assay) = 0.0085 g 
Mass of Au = 0.49 × 0.0085 = 0.004165 g 
Moles of Au = 0.004165 / 197 = 2.114 × 10-5 moles 
Concentration of Au = 2.114 × 10-5 moles / 0.125 dm3 = 1.6914 × 10-4 M. 
Estimated atomic radius of gold = 140 pm 
Number of gold atoms per 13 nm nanoparticle = (6.5 × 10-9)3 / (140 × 10-12)3 = 106,802 
(assuming the particles are perfectly spherical). 





7.1.2 ICP-MS calculations 
 
Example calculation for P.AF-AuNP 
Au ppb convert to mg/L 
= 1163/1000000 
= 0.001163 mg/L of Au 
 
Convert mg/L of Au to mg/L of AuNP 
= 0.001163/78717 = 1.477 x 10-8 mg/L of AuNP 
 
Convert mg/L of AuNP to concentration of AuNP 
= 1.447 x 10-8 / 196.97 
= 0.075 nM 
 
Repeat for phosphorus 
P ppb convert to mg/L 
= 38.75/1000000 
= 0.00003875 mg/L of P 
 
Convert mg/L of P to concentration of P 
= 0.00003875/ 31 
= 1250 nM 
 
16 P atoms in each strand of DNA, therefore conc of DNA is: 
= 1250/16 
= 78.125 nM 
 
Therefore number of DNA strands per AuNP: 
= 78.125/0.075 










7.1.3 Tracking nanoparticle concentration 
 
Initial concentration of nanoparticles after preparation is calculated as stated previously 
(section 7.1.1). Concentration is then known through tracking dilution. Prior to Sephadex G-
50 column purification, UV-vis absorption of particles is recorded, the maximum absorbance 
at SPR band is recorded. Once particles are passed through the column, the absorbance 
band of SPR for the newly purified particles is recorded. Comparing the ratio of the 
absorbance values before and after column, allows the level of dilution during purification to 
be calculated. 
7.1.4 UV-vis absorption for varied length probes 
 
Appendix 7.1 Tracking binding of varied length 1L probes to AuNP using UV 
UV absorption of SPR band showing before and after addition of DNA strands with varying distance 
between anthracene and the AuNP. Black=s.P.1L Green = m.P.1L, Red = l.P.1L. Particles at 3 nM in 
deionised water and 10 mM pH 7.0 phosphate buffer. 
 
7.1.5 Anthracene signal strength on AuNP for varied length probes 
 
The concentration for AuNP was assumed constant for each experiment, calculated using 
the method described above (section 7.1.3). The number of probes per AuNP was then 









































P.1L 10921 21726 450 24.3 48.3 
m.P.1L 15408 24219 525 29.3 46.1 




7.1.6 SPR track of DNA coating 100 nm AuNP 
 
  
Appendix 7.3 UV-vis absorption spectrum of SPR band of 100 nm AuNP showing before and after 
addition of P.1L.  










































DNA added (µM) 
202 
 
7.1.7 Brightfield images for AuNP uptake 
 
 
 Appendix 7.4 Transmission microscopy images of 100 nm P.1L-AuNP treated CHO cells 
Z-stack of transmission microscopy images showing slices of CHO cell treated with 4 pM P.1L-100 nm 
AuNP. Images taken after cells treated for 2 hours. Slices taken at 0.24 µM intervals. 
7.2 Chapter 4 
 
7.2.1 Percentage change in emission upon target addition for P.1L-AuNP-Ru and P.1D-
AuNP-Ru 
 
Appendix 7.5 Percentage emission change values of anthracene and ruthenium signal upon target 
hybridisation for P.1L-AuNP-Ru and P.1D-AuNP-Ru. 
Percentage change in emission for anthracene (λex=350 nm, λem=426 nm) and ruthenium (λex=465 nm, 
λem=630 nm) probes after the addition of targets. Average of three separate AuNP preparation 
repeats. 
  anthracene ruthenium 
P.1L-AuNP-Ru + DNA-T.1 -67 -18 
P.1L-AuNP-Ru + DNA-T.2 65 -19 
P.1D-AuNP-Ru + DNA-T.1 -72 -19 
P.1D-AuNP-Ru + DNA-T.2 -63 -12 
P.1L-AuNP-Ru + Random -8 6 




7.2.2 P.1D-AuNP-Ru percentage change of ruthenium and anthracene 
 
 
Appendix 7.6 Percentage emission change of anthracene and ruthenium signal upon target 
hybridisation for P.1D-AuNP-Ru 
Bar chart showing percentage change in emission for anthracene (grey, 426 nm) and ruthenium 
(dashed line, 630 nm) probes after the addition of SNP targets, for the particles 1D-AuNP-Ru. Error 
bars indicate the standard deviation of three repeats using three different preps of probe coated 
AuNP. 
 
7.2.3 T-test comparing difference in ruthenium emission for P.1L-AuNP and l.P-1L-AuNP  
 
A t-test tests whether the null hypothesis of two data sets can be rejected. Here the null hypothesis 
is that the difference in ruthenium emission between the two data sets is not significant. If t Stat > t 













+             
DNA-T.2 
Mean -17.530 -12.905 -18.577 -23.241 
Variance 106.973 55.674 137.776 152.001 
t Stat -0.76636  0.566091 
 t Critical two-tail 2.446912  3.182446   
For neither target can the null hypothesis be rejected, therefore the difference in ruthenium 














7.2.4 Integrated emission response for P.1L-AuNP-Ru and l.P.1L-AuNP-Ru  
 
Appendix 7.7 Comparing anthracene and ruthenium emission response upon target addition for 
P.1L-AuNP-Ru and l.P.1L-AuNP integrating fluorescence response 
Chart showing the percentage change in emission for anthracene (λex = 350 nm, λem = 370-550 nm) 
and ruthenium (λex = 465 nm, λem = 580-800 nm) signals for the P.1L-AuNP-Ru (dark grey) and the 
l.P.1L-AuNP-Ru (dashed line) after the addition of the SNP targets: fully complementary DNA-T.1 and 
single mismatch DNA-T.2. Error bars are the standard deviation of 3 repeats, each repeat is with a 
fresh preparation of particles. 2 nM AuNP in deionised water with 10 mM pH 7.0 phosphate buffer, 
100 mM NaCl at room temperature. 
 
7.2.5  ICP-MS data for ruthenium coating of AuNP 
 
Appendix 7.8  ICPMS values for ruthenium coating of AuNP co-coated with DNA 
Data for DNA strands without any anthracene modification and DNA strands with 1L anthracene 
modification. Values given assume particles are 13 nm in size, containing 100082 gold atoms. 
 



























7.2.6 Integrated emission for ratiometric sensing for P.5L-AuNP-Ru 
 
Appendix 7.9 Ratiometric response for P.5L-AuNP-Ru integrating anthracene and ruthenium signal 
Percentage variation in anthracene (λex = 350 nm, λem = 370-550 nm) and ruthenium (λex = 465 nm, 
λem = 580-800 nm) for P.5L-AuNP-Ru particles once probe is fully hybridised with target. Percentage 
of the targets containing A (DNA-T.3) or C (DNA-T.4) SNP variant on x-axis. Error bars are standard 
deviation of three repeats.2 nM AuNP in deionised water with 10 mM pH 7.0 phosphate buffer, 100 
mM NaCl at room temperature. 
 
7.2.7 SPR track of DNA and RubpySS coating 100 nm AuNP 
 
Appendix 7.10 UV-vis absorption spectrum of SPR band of 100 nm AuNP showing before and after 
addition of P.1L and RubpySS probes.  
Particles at 40 pM in deionised water and 10 mM pH 7.0 phosphate buffer. 
 
 














































































7.2.8 Brightfield images tracking uptake of 100 nm P.1L-AuNP-Ru 
 
 
Appendix 7.11 Transmission microscopy images of uptake of 100 nm P.1L-AuNP-Ru by CHO cells 
Z-stack of transmission microscopy images showing slices of CHO cell treated with 4 pM 100 nm P.1L-

















7.3 NMR spectra 





























































7.3.8 2-(5-(1,2-dithiolan-3-yl)pentanamido)ethyl (2-cyanoethyl) 











7.4 Using semi-prep HPLC to estimate reaction yield 
Semi-prep HPLC of successful modification of DNA with thioctic acid analogue (P.1L). Analysing the 
integral of the peak at 40.4 minutes, estimated yield of the reaction is 77%. Peaks at 38.5 and 39.7 






7.5 DLS number distribution histogram 
 
Bare AuNP (13 nm) 
 












P.UM-AuNP (13 nm) 
 
P.AF-AuNP (13 nm) 
 




P.1L-AuNP (13 nm)  
 
P.1L-AuNP (100 nm) 
 




P.1L-AuNP-Ru (100 nm) 
 
P.5L-AuNP (13 nm)  
 




P.1D-AuNP (13 nm) 
 
P.1D-AuNP-Ru (13 nm) 
 













siRNA-AuNP-Ru (13 nm) 
 
siRNA-AuNP (100 nm) 
 
 
 
